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Motile cilia are localised to tissues and cells where fluid movement and cellular 
locomotion is required. Mutations in genes associated with ciliogenesis and cilia 
motility give rise to diseases called ciliopathies. Primary Ciliary Dyskinesia 
(PCD), a heterogeneous genetic disorder, is the most common form of 
ciliopathy that arises from defects in motile cilia. Several systematic 
approaches have led to the identification of numerous genes with putative 
function in ciliogenesis and ciliary motility. We interrogated existing data and 
identified several novel candidate genes temporally associated with 
ciliogenesis. Expression of these genes were analysed in mouse airway 
epithelial cells during mucociliary differentiation at the air liquid interface (ALI) 
and different mouse tissues. This thesis focuses on a poorly characterized gene 
encoding the protein ‘PIERCE1’.  
             Transcriptional analysis of Pierce1 revealed an expression pattern 
temporally associated with ciliogenesis during differentiation of ALI mouse 
airway epithelial cells. Pierce1 also shows enriched expression in motile ciliated 
mouse tissues. Transient morpholino knock down of pierce1 in zebrafish 
showed phenotypes consistent with abnormalities in motile cilia and live 
imaging showed severe cilia motility defects in Kupffer’s vesicle. Finally, we 
generated maternal zygotic loss-of-function alleles at the zebrafish pierce1 
locus using the CRISPR/Cas9. These mutants showed mild laterality defects. 
A custom-made antibody against mouse full length PIERCE1 protein, was used 
to carry out immunofluorescence microscopy on ALI cultured mouse airway 




expressed in motile ciliated cells. A yeast 2-hybrid assay carried out on human 
lung and testis libraries identified PIAS2, as a possible interacting partner of 
PIERCE1.  With these findings, we propose that PIERCE1 may be involved 
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Chapter 1 : Introduction 
1.1 Cilia 
Cilia are one of the oldest known organelles, first described in protozoa by 
Antonie van Leeuwenhoek (father of microbiology and the first acknowledged 
microscopist) in 1675. He was fascinated by these ‘incredibly thin feet, or little 
legs’ used by cells to generate currents and swim in the fluid environment ((van 
Leewenhoek, 1932).  
In 1785, a century later, the term ‘cilium’, from Latin word for eyelash, 
was coined by Otto Muller (Muller, 1786). Although the existence of cilia was 
known for centuries, only in the last few decades, an understanding of the 
formation, structure and function of cilia begun to emerge. They are membrane 
bounded hair-like cellular organelles, derived from centrioles and assembled 
by microtubules that have been conserved evolutionarily in eukaryotes (Satir, 
1995, Satir and Christensen, 2008). 
1.1.1 Primary and motile cilia 
In vertebrates, cilia are broadly classified as immotile (primary cilium) and 
motile. These were traditionally distinguished on basis of the architecture of the 
axoneme, the central microtubular core, and their motile properties 
(WHEATLEY et al., 1996, Ibañez-Tallon et al., 2003, Satir and Christensen, 
2007). As shown in Figure 1.1, the motile cilia have a central pair (CP) of singlet 
microtubules surrounded by 9 doublet microtubules and possess molecular 
motors, axonemal dyneins which are responsible for ciliary movement. In 
contrast, the CP is missing in primary cilia and they also lack the axonemal 




2014d, Satir and Christensen, 2007, Takeda and Narita, 2012, Thomas et al., 
2010, Satir et al., 2010). However, there are exceptions to this rule of distinction 
e.g. there are 9+0 cilia that lack radial spokes and CP in the node that are motile 
(Bellomo et al., 1996, Ishikawa, 2017).  
Primary cilia are widely distributed in many cell types and are usually 
involved in sensory functions, for example, the monocilia lining the kidney 
tubules have a role in sensing urine flow (Praetorius and Spring, 2001, Pazour 
and Witman, 2003). Primary cilia were once thought to be vestigial organelles. 
This view has changed considerably since it is now known that they have 
important roles in physiology (Satir and Christensen, 2007, Abou Alaiwi et al., 
2009, Veland et al., 2009, Satir et al., 2010). More and more research groups 
are studying these organelles, shedding further light into this area.  
In contrast, motile cilia are highly restricted to tissues where fluid 
movement and cellular locomotion is required. They function by exerting 
mechanical force e.g. in the respiratory tract, ciliated cells are required for 
mucus clearance (Satir and Christensen, 2008, Roy, 2009, Satir and 
Christensen, 2007). Dysfunction in either motile or immotile cilia can give rise 
to devastating genetic disorders collectively known as ciliopathies (Fliegauf et 
al., 2007, Roy, 2009). 
The understanding of a large portion of the genetic and biochemical 
pathways of ciliogenesis originated from studies on flagellation of 
Chlamydomonas and other model organisms (Pazour et al., 2005, Smith et al., 
2005, Ostrowski et al., 2011). These studies lead to characterisation of many 






Figure 1-1 Structure of cilium 
Cilia axoneme is nucleated by basal body that anchors itself on apical surface of plasma membrane through transition fibres. The 
elongation of axoneme requires bidirectional Intraflagellar transport (IFT) trafficking system in which kinesin-2 molecular motors carry 
protein and axonemal building blocks in to axoneme from cytoplasm and dynein-2 motors bring the turnover products from ciliary tips to 
basal body. The plus ends of microtubules at the ciliary tips allow the axoneme to grow and ciliary tip also harbours numerous receptors 
that allow cilia to sense the environment. Both primary cilium and motile cilium is basically formed of 9 sets of microtubule doublets 
enclosed by ciliary membrane. However, motile cilium possesses a pair of microtubule singlets that is connected to outer microtubule 





1.1.2 Origins of Cilia 
The origins of this multifunctional organelle are still a matter of debate. In 2011, 
Wickstead and Gull suggested that the ancestor cilium was a non-motile 
sensory organelle (Wickstead and Gull, 2011). On the other hand, most 
researchers believe that the prototype of cilia was a hybrid with both sensory 
and motility functions. These proposals arose through observations made in 
unicellular organisms that occupy the lower branch of evolutionary map 
(Silverman and Leroux, 2009, Mitchell, 2017).  It is also thought that the motile 
9+2 cilium was present in the last evolutionary common ancestor (LECA) 
(Mitchell, 2017). So how did cilia arise in the eukaryotes? One suggestion is 
that cilia came through the same cell lineage as the eukaryotic nucleus, by viral 
invasion.  Hence, LECA might have had cilia for efficient motility and a nucleus 
for chromosome replication and information transfer (Satir et al., 2007, Satir, 
2017). However, this area needs further clarity.  
Nevertheless, my interests are more focused on motile cilia, captivated 
by the diverse functional roles they play in conception, development and 
physiology of vertebrate organisms. So, what makes these organelles so 
remarkable?   
1.2 Motile cilia 
Eukaryotic motile cilia/flagella are mainly involved in movement of extracellular 
fluids and cellular locomotion. Many unicellular organisms and some 
invertebrate larvae possess and utilize motile cilia for locomotion (Ibañez-Tallon 
et al., 2003, Pazour et al., 2005). On the other hand, in vertebrates, motile cilia 
are restricted to few tissues where fluid flow is required for physiology and the 




also show diversity in terms of their morphology and type of motility (Satir and 
Christensen, 2007). Early during development, the monomotile cilia present in 
the ventral node of the mouse, beat in a rotary fashion to drive nodal flow.  This 
is the first step in breaking the bilateral symmetry of the organism (Wagner and 
Yost, 2000, McGrath and Brueckner, 2003). In adult physiology, multimotile 
ciliated cells (MCC) harbouring >200 cilia per cell, that move in a metachronal 
wave  like pattern, line the respiratory tract and play a pivotal role in mucus 
clearance (Brooks and Wallingford, 2014a, Tilley et al., 2015). Multiciliated cells 
also line the brain ventricles and fallopian tubes for driving the cerebrospinal 
fluid flow and ovum transport, respectively (Brooks and Wallingford, 2014a).  
The core structure of the cilium and flagellum is very well conserved (Carvalho-
Santos et al., 2011, Konno et al., 2015).  
Although the traditional view regarding the function of motile cilia is fully 
focused on its motility, recent findings have shown that motile cilia also have 
sensory functions (Shah et al., 2009, Bloodgood, 2010, Jain et al., 2012).  This 
suggests that there is more to be learnt about these well-conserved organelles, 
since their functions are more complex than previously thought. For decades, 
the structure and function of cilia have been studied extensively. However, 
recent advances in proteomics, molecular biology and gene editing have shed 
more light on the assembly and function of cilia. 
1.2.1 Structure of motile cilia 
Cilia are made up of three parts. 1) The basal body anchors cilia to the cell 
surface, 2) the axoneme forms the main extracellular part of cilia and 3) the 




regions are connected continuously by microtubule cytoskeleton wherein the 
basal body is composed of 9 microtubule triplets, and has a cartwheel structure, 
(Li et al., 2012a, Geimer and Melkonian, 2004),and the 9 microtubule doublets 
make up the TZ and axoneme. The axoneme is encapsulated by the plasma 
membrane, which in turn is extended from the cell plasma membrane. The 
axoneme is composed of microtubule doublets and many other proteins (Satir 
and Christensen, 2008, Ishikawa, 2017). 
In the typical motile cilia axoneme that has the 9+2 architecture, each 
microtubule doublet extends from the triplet microtubule (A-tubule, B-tubule and 
C-tubule) in the basal body and is enclosed in one complete cylindrical 
microtubule (A-tubule) and one incomplete tubule (B-tubule) bound to the A-
tubule.  A-tubules and B-tubules in the basal body are slightly different from the 
doublet in the axoneme (Paintrand et al., 1992, Nigg and Raff, 2009). Adjacent 
microtubule doublets are connected by dynein arms, nexin and the radial 
spokes that link the microtubule doublets and CP (Gibbons and Rowe, 1965, 
Smith and Yang, 2004, Ishikawa, 2017). Dyneins, radial spokes and nexin form 
a structure with a consistent 96-nm periodicity along the microtubule doublets 
(Lindemann, 2003, Ishikawa, 2017). The TZ is located on the microtubule 
doublet close to the edge of basal body and the dyneins, radial spokes and CP 
are positioned distal to the TZ (Omran, 2010, Williams et al., 2011, Fisch and 
Dupuis-Williams, 2012, Ishikawa, 2017). The current understanding of the 




So, what are the mechanisms underlying the formation of this essential 
and sophisticated organelle? I will first start with the regulatory mechanisms 
that initiate the process of motile ciliogenesis.  
1.2.2 Transcriptional control of ciliogenesis 
1.2.2.1 FOXJ1 transcription factors are the master regulators of motile 
ciliogenesis 
FOXJ1 (HFH4), a forkhead /winged-helix transcription factor, has been shown 
to be an essential factor required for motile ciliogenesis (Yu et al., 2008, Stubbs 
et al., 2008).  In mice, Foxj1 was found to be specifically expressed in motile 
ciliated tissues such including the embryonic node, airway epithelium, choroid 
plexus and testis and found to have a nuclear localisation (Clevidence et al., 
1994, Hackett et al., 1995, Murphy et al., 1997, Blatt et al., 1999).  High levels 
of expression was observed prior to motile ciliogenesis in the airway epithelium, 
oviducts, in ependymal cells lining the brain ventricles and the spinal column 
and also detected prior to the appearance of flagella in the spermatids (Blatt et 
al., 1999, Tichelaar et al., 1999). These findings strengthened the perception 
that FOXJ1 is a transcription regulator of motile ciliogenesis. Hereafter, two 
independent studies confirmed the importance of FOXJ1 in motile ciliogenesis. 
Foxj1 knockout mice had complete absence of motile cilia axonemes in 
airways, brain ventricles and oviducts. They also exhibited situs abnormalities 
indicating defects in mono motile cilia present in the embryonic node (Brody et 
al., 2000). Independent studies also showed that Foxj1 is also required for the 
formation of monomotile cilia present in the embryonic node and for flagella 
formation of spermatids (Chen et al., 1998). Loss of Foxj1 resulted in loss of 




was also observed that in multiciliated cells, although generation of multiple 
basal bodies occurred normally, these failed to dock at the apical cell 
membrane to nucleate multiple cilia (Brody et al., 2000, Gomperts et al., 2004, 
You et al., 2004a, Alten et al., 2012, Choksi et al., 2014d). Thus, FOXJ1 is 
necessary for the docking of basal bodies at the apical membrane in 
multiciliated cells.  
           The functional role of FOXJ1 in motile ciliogenesis is not only shown in 
mammals but has also been studied in other vertebrates including Xenopus 
and zebrafish. The loss of Foxj1 in zebrafish embryos and Xenopus resulted in 
loss of motile cilia (Stubbs et al., 2008, Yu et al., 2008). FOXJ1 orthologues and 
associations with motile ciliogenesis are also found in invertebrate phyla such 
as Placozoa, Platyhelminthes and Echinodermata (Vij et al., 2012). This implies 
that FOXJ1 plays a conserved role in motile ciliogenesis. 
          So how does FOXJ1 regulate motile ciliogenesis? Remarkably, 
overexpression of foxj1 induced ectopic motile cilia formation in different tissues 
in zebrafish and Xenopus embryos in (Stubbs et al., 2008, Yu et al., 2008). 
Furthermore, in chick neural tube and mouse embryonic fibroblast, formation of 
long cilia that resembled motile cilia, was induced by overexpression of foxj1 
(Cruz et al., 2010). These findings regarding the ciliogenic potential of FOXJ1 
point towards a master regulatory role in the biogenesis of motile cilia. 
        Multiple high throughput screens carried out in mouse, zebrafish and 
Xenopus have identified genes that are regulated by FOXJ1. These lists mainly 
include genes required for structural and functional aspects of the motile cilia. 




screens that have produced lists of novel candidates that may play roles in cilia 
formation and function (Hoh et al., 2012, Choksi et al., 2014b, Stauber et al., 
2017). 
Members of the RFX family of transcription factors have also been 
implicated in ciliogenesis in many model organisms. This family of proteins is 
made up of seven members (RFX 1-7) in vertebrates and they all have a highly 
conserved 76-residue winged-helix DNA binding domain. These proteins are 
important for development and mutations in them are involved in many 
devastating disease conditions (Gajiwala et al., 2000, Choksi et al., 2014d). 
Rfx1-4 have been found to be highly expressed in mouse testis indicating a 
possible role in spermatogenesis (Kistler et al., 2009).   
The loss of Rfx2 disrupted ciliary assembly in Xenopus embryos (Chung 
et al., 2012) and reduced cilia length in zebrafish Kupffer’s vesicle (KV) and 
consequently laterality defects. In mouse, loss of RFX2 resulted in abnormal 
nodal cilia associated with laterality defects (Bisgrove et al., 2012, Wu et al., 
2016).  Recently, using data derived from studies on Xenopus, Quigley et al 
proposed that Rfx2 acts as a scaffolding factor to recruit Foxj1, which is often 
bound to flanking enhancers, to the promoters of MCC genes (Quigley and 
Kintner, 2017).  
On the other hand, Rfx3 mouse mutants also displayed several 
phenotypes associated with ciliopathies including left-right asymmetry defects 
and hydrocephalus (Baas et al., 2006, Bonnafe et al., 2004). Didon et al 
proposed that RFX3 acts as a co-factor for FOXJ1 as it was shown to 




cells in human airway epithelial cell culture. Furthermore, FOXJ1 and RFX3 
were co-immunoprecipitated when these proteins were overexpressed (Didon 
et al., 2013). These results suggest a possibility that RFX factors and FOXJ1 
form a transcriptional complex that confers specificity for motile cilia genes.  
 Furthermore, RFX4 has been identified to be a key regulator required for 
the formation of primary cilia that are crucial for the transduction of the Sonic 
Hedgehog (Shh) signalling pathway that specifies neuronal cell fates(Ashique 
et al., 2009, Bay and Caspary, 2012) .   
1.2.2.2 Different transcriptional regulators and signalling pathways give 
rise to cilia diversity through FOXJ1 
As was described in the previous section, FOXJ1 plays a master regulatory role 
in motile cilia biogenesis. But different transcriptional factors and signalling 
pathways give rise to the diversity in motile cilia as reviewed by Choksi et al 
(Choksi et al., 2014d).  This is summarised in Figure 1-2.   
To get an overview on how different signalling pathways and regulators 
come together to bring diversity in motile cilia through FOXJ1/RFX family, I will 
describe the transcription regulation of motile cilium biogenesis in the 






Figure 1-2. Diversity in motile cilia is brought by different transcriptional modulators and signalling pathways working through 
Foxj1. 
There are different types of motile cilia. Different transcriptional regulators and signalling pathways give rise to this diversity. Multiciliated 
cells – the inhibition of Notch signalling is required for activation of mcc transcriptional pathway. The transcriptional cascade of GEMC1/ 
MCIDAS activates the downstream targets such as MYB, FOXJ1 and RFX factors. MCIDAS/MYB also regulates genes required for basal 
body synthesis and docking. Monomotile cilia in the node- NOTCH and WNT (the latter acting downstream of FGF signalling) induce the 
formation of rotational monomotile cilia in organs of laterality. The NOTO transcriptional regulator activates FOXJ1 and an RFX factor in 
the ciliated cells of the mouse node. Pathways generating sperm flagella are largely unknown but acts through FOXJ1. (Adapted from  




1.2.2.2.1 Monomotile ciliated cells in embryonic node 
In zebrafish, KV is the left-right organiser (Essner et al., 2005), in frog it is the 
gastrocoel roof plate (GRP) (Schweickert et al., 2007) and in chick and mouse, 
it is the node (Sulik et al., 1994, Nonaka et al., 1998b, Pownall and Isaacs, 
2010). The dorsal forerunner cells (DRC) that express the No tail protein are 
the progenitors of KV.  No tail expression is known to depend on Fibroblast 
growth factor (Fgf) signalling (Griffin et al., 1995). In zebrafish mutants of fgf8, 
the DRCs were deficient in number (Albertson and Yelick, 2005). In a different 
study, morpholino knockdown of Fgf8 and other downstream effectors of Fgf 
signalling resulted in the loss of KV cilia and varied expression of laterality 
markers including lefty and southpaw (Hong and Dawid, 2009). Notch signalling 
has also been reported as being important in cilia length control in the KV. It 
has been shown that Foxj1a acts downstream of Notch signalling since foxj1a 
was downregulated in DeltaD (Notch ligand) mutants. Foxj1 could also rescue 
the shortened KV cilia length in DeltaD mutants (Lopes et al., 2010). A role for 
Wnt/β-catenin signalling in regulating foxj1a expression in KV ciliogenesis has 
also been reported, functioning through Lef1 and Tcf7 binding to foxj1a 
regulatory sequences (Caron et al., 2012). How all these different signalling 
pathways come together and interact with each other to regulate ciliogenesis 
in KV is an interesting area for further research.  
Noto, a homeobox transcription factor, is expressed in the KV in bony 
fish, the GRP in amphibians and in the murine embryonic node (Von Dassow 
et al., 1993, Stein and Kessel, 1995, Knezevic et al., 1995, Ben Abdelkhalek et 
al., 2004, Alten et al., 2012). Loss of NOTO function in mice resulted in defects 




the Foxj1-null mouse embryos (Alten et al., 2012, Stauber et al., 2017). Noto 
mutant mouse embryos displayed laterality defects. Foxj1 is downregulated in 
the embryonic node of Noto-/- mice as well as its molecular targets. The current 
notion is that Noto induces Foxj1 which in turn activates other motile ciliary 
genes including Rfx3, Dynlrb2 etc. Alten et al (2012) also attempted to rescue 
the phenotype of the Noto mutant by Foxj1. While Foxj1 could restore the 
expression of ciliary genes and cilia axoneme formation and motility, the 
embryos continued to have laterality defects. This occurred due to the disrupted 
cilia polarity which is established by planar cellular polarity (PCP) pathway. This 
showed that Noto plays two independent roles in nodal ciliogenesis. First to 
activate Foxj1 and consequently induce other motile ciliary genes for axoneme 
formation and secondly to establish correct cilia polarity by regulating the PCP 
pathway (Alten et al., 2012). Recently, Stauber et al carried out a systematic 
screen for downstream targets of Foxj1 and Noto in mouse embryonic lung and 
node and identified 59 novel candidates as Noto/Foxj1-dependent factors in the 
embryonic node organiser that overlap in the airway epithelium (Stauber et al., 
2017). Further experiments are required to establish the functional role of these 
candidates in motile ciliogenesis.  
1.2.3.2.2 Multiciliated cells  
Previous studies have shown that Notch signalling plays a key role in specifying 
the MCC fate  during the differentiation (Morimoto et al., 2010). Notch/Delta 
signalling has a lateral inhibitory effect on ciliogenesis in airways and directs 
the cell differentiation towards the secretory cell. This was demonstrated from 
studies conditionally inactivating Pofut1 and Rbpjk that inhibited Notch 




expressed a dramatic increase in number of MCCs and prevented formation of 
club (Clara) cells in airways. Likewise, when NOTCH1 intracellular domain was 
conditionally overexpressed in mouse airway epithelium, it resulted in an 
overwhelming specification of club cells and a reduced number of ciliated cells 
(Morimoto et al., 2010, Rock et al., 2011, Brooks and Wallingford, 2014a). 
However, the pathways behind the regulation of Notch signalling in ciliogenesis 
are not fully characterised. 
  A recent study on the evolutionarily conserved microRNA miR-34/449, 
that is found to be enriched in MCCs, has provided insights in to how this 
pathway may be regulated. This study showed that miR-34/449 selectively 
accumulates in ciliated cells of human airways and Xenopus embryonic 
epidermis (Marcet et al., 2011). Further investigation in both models by 
inhibiting and overexpressing miR-34/449 indicated it has a crucial conserved 
role in vertebrate multiciliogenesis by promoting centriole multiplication and by 
directly downregulating the Delta/Notch pathway (Song et al., 2014). This 
finding emphasises the significant role played by microRNAs in regulating 
essential aspects in developmental biology. 
For MCC fate determination, two other major factors have been 
discovered recently; MCIDAS (Multicilin) and GEMC1 (Geminin Coiled-Coil 
Domain Containing). Both are related to Geminin (GMNN), a protein involved 
in cell-cycle progression and in the balance between cell proliferation and 
differentiation (Kroll, 2007). In fact, these three members of GMNN superfamily 
are involved in cell cycle progression and show high similarity in their coiled-
coil domain. GMNN is an inhibitor of pre-replicative complex formation (Wu et 




replication and cell cycle progression (Pefani et al., 2011). Balestrini et al 
showed that GemC1 mediates initiation of chromosomal DNA replication by 
facilitating TopBP1- and Cdk2-dependent recruitment of Cdc45 onto replication 
origins in multicellular organisms (Balestrini et al., 2010).  
MCIDAS was known as IDAS before it was identified by Stubbs et al as 
one of the main downstream targets induced by the inhibition of Delta/Notch 
pathway in MCC fate determination (Stubbs et al., 2012). Remarkably, Mcidas 
induced MCC fate when it was ectopically expressed in non-ciliated cells along 
with induction of mass centriole biogenesis and induction of cilia specific genes 
such as Foxj1, Myb etc. (Stubbs et al., 2012, Kyrousi et al., 2015). Moreover, a 
rare mucociliary clearance disorder called reduced generation of multiple motile 
cilia (RGMC) in humans was reported to cause by missense and recessive loss 
of function mutations in MCIDAS. RGMC results in formation of fewer cilia that 
are immotile; hence patients suffer from recurrent infections of the upper and 
lower airways (Boon et al., 2014).  Mutations in MCIDAS were confirmed by 
family pedigree analysis and Sanger DNA sequencing of coding exons in 59 
affected families (Boon et al., 2014). Ma et al (2014) characterised two of these 
mutations. They first showed  that MCIDAS induces massive centriole 
assembly, a crucial step in multiciliogenesis, by binding to transcriptional 
factors such as E2F4, E2F5 and DP1 which then transcriptionally activate many 
genes essential for centriole biogenesis (Ma et al., 2014). One of those 
characterised mutations called G335D, cause failure to bind with E2F4 and 
DP1. The other mutant, R370H, can form complex with E2F4/5 and DP1, 
however, the complex is not functionally active to induce gene expression for 




Besides MCIDAS, GEMC1 was recently found to be required for 
postmitotic commitment to MCC fate in Xenopus skin, zebrafish pronephros, 
and mouse brain (Kyrousi et al., 2015, Zhou et al., 2015). Like Mcidas, Gemc1 
was also found to be adequate to activate early commencement of 
differentiation of MCC progenitors in the mouse brain (Kyrousi et al., 2015). 
Both can induce ectopic differentiation of MCCs in mouse airway epithelia and 
Xenopus skin/kidney (Stubbs et al., 2012, Zhou et al., 2015, Kyrousi et al., 
2015). In addition, GEMC1 can interact with E2F4/5, DP1 and MCIDAS to 
regulate specification of MCC precursors (Terré et al., 2016, Arbi et al., 2016). 
Despite these similarities between MCIDAS and GEMC1, GEMC1 appears to 
act upstream of MCIDAS since Mcidas is not induced in the absence of Gemc1 
and Mcidas was not able to activate Gemc1 expression (Zhou et al., 2015, Arbi 
et al., 2016, Terré et al., 2016). Therefore, it makes GEMC1 the earliest 
transcriptional regulator in MCC formation downstream of Notch signalling. 
Recent unpublished findings from our group (Prof Sudipto Roy, IMCB) also 
provide insights into this pathway. A two-step model in the developmental 
pathway for MCC formation is proposed 1) GEMC1 regulates the specification 
of MCC precursors including MCIDAS and act downstream of Notch signalling 
2) MCIDAS amplify the expression of cilia transcriptional regulators and drive 
basal body production for MCC formation. But, there are questions still 
unanswered. What are the molecular mechanisms that regulate Notch 
signalling in MCC biogenesis?  How is the expression of GEMC1 regulated?  
In contrast, the third member of the family, GMNN, plays an inhibitory 
role in MCC formation while MCIDAS and GEMC1 are the activators. This trend 




and MCIDAS play positive regulatory roles in DNA replication and GMNN is the 
negative regulator (Caillat et al., 2015, Ma et al., 2014, Vladar and Mitchell, 
2016). How is this repression brought about? Data from biochemical 
experiments suggest that GMNN can form homo-heterodimers with MCIDAS 
and GEMC1, and thus repress their activity (Caillat et al., 2015, Vladar and 
Mitchell, 2016).  
Other transcription factors that act downstream of GEMC1/MCIDAS 
include c-MYB, several members of RFX family and FOXJ1 (Stubbs et al., 
2012, Kyrousi et al., 2015, Zhou et al., 2015). c-MYB is a transcription factor 
that upregulates S phase in many progenitor cells (Wang et al., 2015). A recent 
study identified the expression of Myb in airway epithelial cells destined to 
become multiciliated cells. They reported Myb is expressed transiently during 
multiciliogenesis. Myb is expressed in potential multiciliated cells as they exit 
cell cycle and during basal body biogenesis. Subsequently, Myb is switched off 
as the centrioles dock and multiciliated cells mature. When Myb was 
conditionally inactivated in airways, centriole amplification was impaired and 
Foxj1 expression was not detected (Tan et al., 2013a).With primary cell culture 
studies, they also provided evidence that MYB act downstream of MCIDAS 
(Tan et al., 2013a, Brooks and Wallingford, 2014a). Consequently, MYB 
induces expression of Foxj1 and centriole amplification. Recently, TAP73 was 
identified as another regulator of multiciliogenesis (Nemajerova et al., 2016a, 
Jackson and Attardi, 2016, Marshall et al., 2016). Tp73 deficient mice show 
severe phenotypes associated with cilia defects e.g. hydrocephalus, female 
infertility and rhinitis/otitis media. They also showed that TP73 acts upstream to 




and Myb by carrying out RNA sequencing on air liquid interface (ALI) cultured 
mouse tracheal epithelial cells extracted from wild type (WT) and p73 deficient 
mice (Nemajerova et al., 2016a). 
However, there is more to be learnt about the molecular interactions and 
regulation of these transcription factors and their downstream targets.  
1.2.3 Basal body formation 
The basal body or centriole where the cilia nucleate from, is cylindrically shaped 
and composed of 9 sets of triplet microtubules and a cartwheel enclosed in 
pericentriolar material (Li et al., 2012a, Geimer and Melkonian, 2004).  In 
monociliated cells, formation of only one basal body from a centriole pair is 
required to generate a motile cilium (Carvalho-Santos et al., 2011, Yan et al., 
2016). To exhibit multiciliogenesis, cells need to generate multiple basal bodies 
from which cilia axonemes are nucleated. Centriole replication and basal body 
formation prior to multiciliogenesis was first described by transmission electron 
microscopy (TEM) studies on MCCs in Xenopus epidermis, vertebrate airways 
and oviduct (Steinman, 1968, Sorokin, 1968, Kalnins and Porter, 1969, Dirksen, 
1971). Two modes of basal body generation were reported in MCCs i.e. basal 
body generation from mass centriolar duplications (MCD) and acentriolar basal 
body formation through deuterosome pathway (DD) as shown in Figure 1.3. 
Conversely, the latter appeared to account for the formation of most basal 
bodies in multiciliated cells in the airways (Klos Dehring et al., 2013, Brooks 






Figure 1-3. Basal body synthesis in ciliogenesis. 
During the G1 phase of cell cycle, a cycling cell contains a pair of mother-daughter centrioles. Once it reaches the S-phase, each centriole 
will duplicate itself to give a daughter centriole so that the number of centrioles remain same after mitosis. During the G0 phase, the 
mother centriole can become basal body to support monocilium formation. In multiciliogenesis, 100s of basal bodies are synthesised by 
two distinct pathways. MCD (mother centriole pathway) pathway is mediated by CEP63–CEP152 complex and DD (deuterosome 
pathway) pathway is mediated by DEUP1–CEP152 in which CCDC78 recruit CEP152. The protein compositions and interactions of 
functional deuterosome are not fully characterised.  Nascent centrioles or basal bodies detach from mother centriole (CD) and 




          In the centriolar mode of basal body generation in MCC, there is evidence 
from TEM studies for simultaneous development of multiple daughter centrioles 
from a single mother centriole whereas only one daughter centriole nucleates 
from mother centriole in other cycling cells (Carvalho-Santos et al., 2011). The 
latter would account for ciliogenesis in monociliated cells. Studies 
overexpressing and manipulating centriolar components required for centriolar 
replication, such as Plk4 and Sas6, generated less than 10 centrioles in non-
ciliated cells (Peel et al., 2007, Klos Dehring et al., 2013) indicating another 
mechanism other than mother centriole driven duplication, functions in these 
cells to produce >150 centrioles generated in MCCs (Klos Dehring et al., 
2013) . 
          In acentriolar basal body generation, centrioles are derived from de novo 
biogenesis without mother centriole replication but involving a “nondescript 
electron-dense structure” called the deuterosome (Klos Dehring et al., 2013, 
Sorokin, 1968). This was described by TEM studies in various vertebrate 
models. This deuterosome is formed from fibrogranular material deposited in 
the apical cytoplasm and lies in close vicinity to Golgi bodies. The growth of 
procentrioles are organised around these spherical deuterosome bodies. When 
these newly centrioles/ basal bodies mature, they line up in rows underneath 
the apical plasma membrane and from each basal body a cilium arises from its 
apex (Hoyer-Fender, 2010, Klos Dehring et al., 2013). 
The molecular biology of the deuterosome still remains somewhat 
obscure even 40 years after its discovery by TEM. Recent attempts to 
characterise their components identified a deuterosome protein, CCDC78, as 




proteins such as Sas6, Plk4 and Cep152 localise to deuterosomes. In addition, 
localisation of Cep152 did not occur in ccdc78 Xenopus morphants and 
consequently centriole biogenesis was impaired (Klos Dehring et al., 2013). So, 
this indicates that in deuterostome-mediated centriole biogenesis, CCDC78-
mediated recruitment of CEP152 is essential. CCDC78 is highly conserved in 
vertebrates as they conducted the studies in MCCs from various vertebrate 
models. In MCIDAS mutant cells, CCDC78 expression was not detected which 
further supports how MCIDAS regulates the deuterosomal pathway (DD) and 
hence centriole biogenesis in MCC (Klos Dehring et al., 2013, Brooks and 
Wallingford, 2014a, Boon et al., 2014, Nigg and Stearns, 2011).  
Another study by Zhao et al (2013) pointed out another major component 
called Deup1 as a mediator for acentriolar basal body biogenesis (Zhao et al., 
2013a). They used 3D super resolution microscopy to demonstrate that MCCs 
use both mother centriole driven replication (MCD) and deutrosomal mode (DD) 
for basal body generation. Using 3D SIM visualisation, it was also reported 
these deuterosomes are dynamic structures that can change their morphology 
from granular to ring shaped according to the stage of the basal body 
amplification. They described DEUP1 as a vital structural component that 
facilitates deuterosome assembly mediated by CEP152 during de novo basal 
body amplification. Interestingly, when Deup1 was overexpressed in non-
multiciliated cells, it induced the augmentation of ring-like structures along with 
ectopic centriole amplification. Loss of Deup1 in MCCs from mTEC resulted in 
a decrease in the number of deuterostomes and consequently de novo basal 
body amplification was impaired (Brooks and Wallingford, 2014a, Zhao et al., 




centriole during deuterostome formation in MCCs of the mouse brain (Al Jord 
et al., 2014). This shows DEUP1 is a central player in deuterosomal 
amplification of basal bodies.  
Another striking observation was that, CEP63, a paralogue of DEUP1, 
was identified as a key mediator in mother centriole dependent amplification of 
basal bodies. Both Deup1 and Cep63 interact with CEP152 to initiate centriole 
amplification in MCD and DD pathways respectively (Zhao et al., 2013a). So, it 
will be interesting to know how these interactions are regulated to ensure the 
balance between MCD and DD pathways to induce centriole biogenesis in 
MCCs.  
CCNO, a cyclin-like protein, also plays a role in the acentriolar basal 
body generation mediated by deuterostome. The molecular pathway in which 
CCNO functions is not clear, however patients with mutations in CCNO have 
MCCs with reduced number of cilia (Wallmeier et al., 2014). Loss of Ccno in 
mouse airway epithelial cells showed larger deuterostomes with fewer basal 
bodies indicating a role for CCNO in the early onset of basal body amplification 
in MCCs (Funk et al., 2015, Meunier and Azimzadeh, 2016).Furthermore, it has 
been shown that a MCIDAS/E2F complex induces DD pathway by activating 
expression of Deup1 but not Cep63 in MCCs (Balestra and Gönczy, 2014, Ma 
et al., 2014). It will be an interesting area of research to study how all these 
factors mentioned earlier interconnect in centriole biogenesis. 
1.2.4 Basal body docking and cilia formation 
Once basal bodies are formed in the cytoplasm, they fuse with vesicles from 




2014, Brooks and Wallingford, 2014a). Recent studies identified a basal body 
component called CHIBBY that plays an active role in vesicle formation. It is 
proposed that CHIBBY is recruited by basal body protein, CEP164, to the distal 
ends of basal bodies. Subsequently, recruitment and fusion of RAB8-positive 
vesicles is induced by CHIBBY, which in turn forms a ciliary vesicle at the distal 
appendages of basal bodies (Burke et al., 2014). Vesicles fuse with plasma 
membrane and thus dock the basal bodies to the apical surface of the plasma 
membrane. After docking, the ciliary axoneme, enclosed by the plasma 
membrane elongates from the basal body (Brooks and Wallingford, 2014a, 
Burke et al., 2014).  
A few decades ago, Boisvieux-Ulrich et al studied basal body migration 
in ciliogenesis in quail oviduct using cytochalasin D (CD), an actin depolarising 
agent, and they reported that in the presence of CD, polarized basal body 
migration did not occur. So, this indicated that association of basal bodies with 
actin components is necessary for basal body migration (Boisvieux-Ulrich et al., 
1990, Vladar and Axelrod, 2008). Only recently has light been shed on how this 
dynamic interaction between a meshwork of actin assemblies and basal bodies 
is regulated. Studies on Xenopus larvae by Park et al revealed the role of PCP 
proteins, including Fuzzy and Inturned, in regulating the assembly of actin 
filaments necessary for ciliogenesis (Park et al., 2006, Vladar and Axelrod, 
2008). Studies conducted by Park et al concluded another PCP protein called 
Dishvelled is important for apical actin assembly by activating RhoA (Park et 
al., 2008, Vladar and Axelrod, 2008). Further studies indicated RHOA is 
essential for the formation of apical actin meshwork. RHOA inhibitors can block 




proteins FUZZY and INTURNED, other PCP proteins also appear to play an 
important part in ciliogenesis. RhoA functions downstream of PCP proteins and 
Foxj1 (Pan et al., 2007a) but  the pathway by which RHOA mediates ACTIN 
assembly still remains unclear and further research is needed to understand 
this.  
Earlier studies had reported that FOXJ1 plays a vital role in basal body 
docking and axoneme formation. In Foxj1 null cells, actin web formation did not 
occur; it was also shown that FOXJ1 activates RHOA as the over expression 
of Foxj1 leads to increased activity of RhoA. FOXJ1 also maintains cytoskeletal 
stability by maintaining Ezrin (EZR) and other cytoskeletal elements levels by 
regulating Calpastatin expression. EZR binds to basal bodies and mediates 
basal body docking to the apical surface (Gomperts et al., 2004, Pan et al., 
2007a).  
Subsequently, a bud emerges from each basal body after docking to the 
apical surface. From their tips, each bud undergoes elongation to form the 
axoneme, but structurally distinct basal part will become the transition zone 
(Williams et al., 2011). The inner two microtubules of the basal body 
microtubule triplets give rise to axonemal doublets and as the bud extends to 
form the axoneme, it also drives the extension of plasma membrane that latter 
becomes the ciliary membrane enclosing axoneme. Proteins that are important 
in axoneme formation can be found in the TZ. There are many ciliopathies 
associated with deficiency of these proteins (Garcia-Gonzalo and Reiter, 2012). 
Proteomic analysis of human airway cilia grown in ALI culture identified more 




         Furthermore, to elongate the axoneme, the ciliary membrane expands in 
parallel by vesicle fusion at the ciliary base and diffusion of proteins and lipids 
from the adjoining plasma membrane. Since, vesicle transport plays a vital role 
in ciliogenesis, proteins involved in vesicle trafficking and budding are also 
involved in ciliogenesis e.g. CLATHRIN and AP-1 for budding; TRAPP, RAB8 
for targeting, Exocyst for tethering and SNAREs for fusion (Garcia-Gonzalo and 
Reiter, 2012) 
1.2.5 Intraflagellar transport (IFT) 
As the axoneme elongates, there is a constant turnover at the distal tip. A 
specialised transport process called intraflagellar transport (IFT), based on 
dynein and kinesin motors is used to build axonemes from basal bodies. It was 
Kozminski et al. who first initiated the series of experiments that lead to the 
discovery of this sophisticated process by observing bidirectional particulate 
movement in paralyzed flagella of Chlamydomonas reinhardtii (Kozminski et 
al., 1995). Subsequently, the biochemical nature of IFT was resolved by 
Piperno et al and Cole et al by purifying IFT components from the flagella of 
Chlamydomonas (Piperno and Mead, 1997). They identified two components 
termed complex A and complex B. Further analyses lead to the identification of 
the functional importance of these complexes. Complex B moves from base of 
the cilium to the tip, otherwise known as anterograde motion. In contrast, 
complex A moves in retrograde motion from the tip to the base of cilium. 
Furthermore, loss of complex B resulted in arrested cilia growth whereas 
mutation in complex A did not affect the cilium growth. Motor proteins such as 
kinesin-2 and dynein drive the transport in anterograde and retrograde 




(Piperno and Mead, 1997, Piperno et al., 1998, Cole et al., 1998, Cole, 2003). 
These processes are highly conserved in ciliogenesis in vertebrates. Ciliary 
precursors such as TUBULIN and other axonemal proteins are transported 
from the cytoplasm into the axoneme by the KINESIN-2 molecular motor. The 
turnover products are transported back from the axoneme tip by DYNEIN 2 
(Satir and Christensen, 2008, Garcia-Gonzalo and Reiter, 2012). This complex 
IFT process presents numerous regulatory checkpoints for axoneme operation 
(Satir and Christensen, 2007, Satir and Christensen, 2008, Garcia-Gonzalo and 
Reiter, 2012).  
1.2.6 Mechanisms of cilia motility 
In MCCs, ciliary motility is achieved by interactions between the nine outer 
axonemal doublets, situated in opposite sides, in which one set of doublets (1-
4) make the effective stroke and other set of doublets (5-9) make the recovery 
stroke. This is fuelled by ATP along with molecular motors, the dyneins. The 
dynein arms mediate the interactions between the axonemal doublets and the 
central pair of microtubules through radial spokes to generate the force required 
for ciliary beating. Axonemal dyneins are organised in two forms; the outer 
dynein arms (ODAs) composed of two heavy-chain dyneins made up of light 
and intermediate chains, and the more centrally located inner dynein arms 
(IDAs) composed of approximately seven monomeric and heterodimeric dynein 
isoforms. Ciliary beat frequency is modulated by ODAs through post 
translational modifications and the wave form of the beat is controlled in IDAs 
(Satir and Christensen, 2008, Wloga and Gaertig, 2010). Nonetheless, the 
pathway to switch from slow to fast modes in CBF and vice-versa is not clearly 




dependent on several post-translational modifications that can occur through 
multiple signalling cascades including Ca2+, cAMP, progesterone nitric oxide 
etc. (Salathe, 2007, Brooks and Wallingford, 2014a, Tilley et al., 2014, Satir 
and Christensen, 2008). 
Unlike cilia in the MCCs which beat in a planar whip-like pattern, the 
nodal cilia have a rotational beating pattern in clockwise direction. In 1996, 
Bellamo et al reported that nodal cilia lack the CP and hence has a 9+0 
arrangement in contrast to the typical 9+2 arrangement of motile cilia (Bellomo 
et al., 1996). This lead to the assumption that the absence of the CP could be 
the reason for the rotational manner or cilia beating pattern. Interestingly, in the 
zebrafish KV, both 9 + 2 and 9 + 0 cilia display rotational beating (Kramer-
Zucker et al., 2005, Ferrante et al., 2008, Wilson et al., 2009, Kreiling et al., 
2007). Recently, in contrast to the earlier belief, it was reported that cilia in 
mouse node also contain CP (Caspary et al., 2007).  So, it seems that the lack 
of CP does not contribute to the rotational beating pattern. On the contrary, in 
humans and mice it was shown that gene mutations that disrupt CP assembly 
do not affect the cilia motility in the node and do not show laterality defects. But 
the motility of other cilia such as in the airways was severely affected (Lechtreck 
et al., 2008, Olbrich et al., 2012).  Hence, it can be reasoned that CP is not 
required for motility of nodal cilia. However, the question remains: How do nodal 
cilia achieve the rotary beating pattern? In 2015, Shinohara et al proposed 
through computer simulations of structural data, that regular circular 
arrangements of microtubule doublets are necessary for a stable rotational 
motion of nodal cilia. They also reported that the lack of radial spokes plays a 




that the mouse mutant of Rsph4a gene, that encodes the head of radial spoke, 
generated airway cilia with a clockwise rotational beating pattern (Shinohara et 
al., 2015). However, it is still not known how radial spokes regulate the switch 
between the beating patterns. Hamada also proposed that the clockwise 
rotation possibly arise from the orientation of  the A and B tubules in the 
microtubule doublet and sliding direction of ODAs (Shinohara and Hamada, 
2017). Further studies are required to validate this proposition.  
1.2.7 Role of cilia in airways 
The lung has evolved a series of defence mechanisms to protect the airways 
which are continually exposed to environmental pollutants and respiratory 
pathogens (Rawlins et al., 2007). The mucociliary epithelium in the respiratory 
tract is a major innate defence mechanism that acts as a chemical and physical 
barrier to all insults. The key components of this defence include physical 
barrier provided by cellular tight junctions, various receptors to sense the 
environment that send out signals to induce release of the innate defence 
molecules and antibodies against foreign particles and pathogens, and most 
importantly the mucociliary escalator that depend on mucins, periciliary fluid 
and concerted action of ciliated cells (Knowles and Boucher, 2002, Vareille et 
al., 2011). The mucociliary escalator cleans the airways by maintaining the flow 
of mucus gel that entrap pathogens and particulates from lower respiratory 
tract, into the pharynx, where is it swallowed. When the cilia are dysfunctional, 
it results in disorders like cystic fibrosis, asthma, PCD etc. (Braiman and Priel, 




Cilia in healthy human airways beat at 12 to 15 Hz with a metachronal 
motion (Braiman and Priel, 2008, Brooks and Wallingford, 2014a). As shown in 
Figure 1.4, cilia tips penetrate the mucus layer on the powerful and rapid 
forward stroke and on the slow reverse stroke, a bend in the axoneme allow 
the tip to go underneath the mucus layer, and this highly coordinated form of 
ciliary beat form allow the propulsion of mucus in forward direction and 
maintenance of a directional mucociliary escalator (Brooks and Wallingford, 





Figure 1-4. Functional role of cilia in airways. 
The first line of innate defence in airways, mucocilairy clearance, is achieved by 
concerted action of secretory cells that secrete mucins in to mucus layer, periciliary 
layer that maintains the hydration between mucus layer and epithelial cells and ciliated 
cells that propel the mucus entrapping pathogens and other particulates out of airways 
through ciliary beating. Cilia beat constantly in a metachronal manner in which cilia 
contact mucus with a powerful and rapid forward stroke that enable ciliary tips to 
penetrate the mucus layer and then with a slow reverse stroke, mucus is propelled out 
of the airways in forward direction in to the pharynx to be swallowed (adapted from 






 Airway cilia have acquired several adaptations to aid their function in 
propelling mucus with its viscoelastic properties, including the ciliary length, 
which appears to be at 5-7 μm in the airways (Jing et al., 2017). This enables 
the cilia to engage more effectively with the mucus overlying the epithelium. 
Longer cilia would show considerable back bending, and hence would produce 
reduced kinetic energy that would not be sufficient to propel mucus in the 
normal direction of flow. Furthermore, the dense protein content at the distal tip 
of the axoneme makes it the strongest part of the cilium and therefore gives it 
adequate potential force to make contact and drive the mucus flow (Brooks and 
Wallingford, 2014a, Sedaghat et al., 2016). Lastly, ciliary motion exhibits 
metachronism phenomenon where cilia beat together with a uniform phase 
difference with adjoining neighbours displaying a moving wave pattern. This 
metachrony is particularly important when cilia are constantly in contact and 
propelling mucus that has elastic properties because it would not allow the 
mucus to discharge the imparted energy by back expansion that would impair 
the process (KNIGHT-JONES, 1954, Brooks and Wallingford, 2014a, Sedaghat 
et al., 2016). However, the mechanism of coordination that brings out this 
phenomenon is not clearly understood. 
Furthermore, airway cilia are equipped with receptors that enable them 
to sense the environment, including recently identified sensory bitter taste 
receptors (T2R) found on human airway cilia (Shah et al., 2009). Other 
receptors include CFTR and ENaC that regulate the osmolality of periciliary 
fluid by controlling conductance of certain ions (Holtzman et al., 2014) . 
Disruption in any of these receptors results in increased fluid absorption that 




like Cystic fibrosis (Brooks and Wallingford, 2014a, Satir and Christensen, 
2008, Tilley et al., 2014). 
1.2.8 Role of cilia in establishing left-right symmetry 
 
One of the earliest events in a vertebrate’s life, where motile cilia play an 
important function, is in establishing left-right asymmetry. Although from 
outside, the body appears symmetrical, the positioning of the internal organs 
and its vasculature exhibit left-right (L-R) asymmetry. For example, the 
stomach, spleen and the heart apex lie to the left and the liver to the right of the 
abdominal cavity of the human body. This asymmetry is strongly conserved 
throughout vertebrate lineage (Norris, 2012).   
As shown in Figure 1.5, the normal arrangement of the sidedness is 
known as situs solitus. However, defects in the establishment of L-R asymmetry 
during development can result in deviant arrangements. There can be a 
complete mirror-reversal of organ L-R asymmetry and this arrangement is 
known as situs inversus totalis.  However, this condition does not result in 
serious clinical complications. On the other hand, there can be situs ambigus 
otherwise known as heterotaxy, where organ positioning can be randomised. 
This arrangement can result in a wide spectrum of congenital malformations 
that affects organ function. One such example is Congenital Heart Disease 
(CHD), a clinical condition with high morbidity and mortality. The heart is the 
most left-right asymmetrical organ in a vertebrate body. The asymmetry of the 
heart is important is for its function i.e. to establish systemic and pulmonary 




associated with heterotaxy (Ramsdell, 2005, Kathiriya and Srivastava, 2000, 








Figure 1-5.  Left–right (L–R) asymmetry of human body. 
The normal positioning of organs in a human body is known as ‘situs solitus’, the heart, 
stomach and spleen are oriented to the left side, whereas the liver is present on the 
right side. In patients with ‘situs inversus’, positioning of the visceral organs occurs in 
a mirror-image along the L–R axis. R indicates the right side, while L indicates the left 






 The basis of how this L-R asymmetry is established remained a mystery 
until the discovery of the structure known as the node (Nonaka et al., 1998b, 
Sulik et al., 1994, Bellomo et al., 1996). This pit like structure is located at the 
anterior portion of the primitive streak. The process of establishing L-R 
asymmetry can be divided into 3 main steps: 1; Symmetry breaking from the 
node, 2; transfer of signals from node to lateral plate mesoderm; 3, asymmetric 
organogenesis (Hamada, 2016).  There are around 200 monomotile cilia that 
protrude from the ventral side of the node that drive a leftward fluid flow to break 
the bilateral symmetry of gene expression to determine the left and right in the 
body (Nonaka et al., 1998b, Norris and Grimes, 2012, Sulik et al., 1994). 
In contrast to the cilia in airway epithelium, the ciliary beat pattern is 
different in the node and displays a rotational motion (Nonaka et al., 1998a, 
Norris and Grimes, 2012, Hamada, 2016).  The mechanisms underlying the 
rotational motion of nodal cilia is not as explained in section 1.2.6. So how does 
the rotary beating of cilia in the node generate nodal flow that results in breaking 
of symmetry? 
Evidence from high speed video microscopy showed a posterior tilt in 
rotational axes in the nodal cilia. As shown in Figure 1.6, further studies showed 
that the nodal flow is generated by a combination of these two characteristics 
of node cilia: their clockwise beating and posterior tilt. The role of the PCP 
signalling pathway has been reported to be involved in establishing this 
posterior tilt (Nonaka et al., 2005, Klein and Mlodzik, 2005, Hamada, 2016).  






Figure 1-6. Cilia in the left-right organiser. 
There are two types of cilia in the embryonic node- motile cilia and immotile cilia. Motile 
cilia is found in the central region of node and generate the nodal flow. They are 
posteriorly tilted and beat in rotation manner in the clockwise direction. The immotile 
cilia present in the periphery sense this flow and initiate the transcriptional cascade to 
establish left-right symmetry of the organism. A indicates anterior while P indicates 







 Furthermore the current consensus is that immotile cilia present on the 
crown cells at the periphery of the node then sense the nodal flow generated 
by motile cilia through Ca2+ channels composed of PKD1 and PKD2 (McGrath 
et al., 2003, Tabin and Vogan, 2003, Yoshiba et al., 2012, Pennekamp et al., 
2002, Kamura et al., 2011). However, it is still not clear what exactly the 
immotile cilia sense during the symmetry-breaking event. On the other hand, in 
medaka, the node is devoid of primary cilia and only possess motile cilia which 
implies motile cilia should be able to generate, as well as sense, the flow in their 
system (Kamura et al., 2011). 
  The immediate effector of the nodal flow signal is Cerl2. Although 
initially, Cerl2 expression is symmetric, it becomes restricted to the right side 
as the velocity of nodal flow increases and will be downregulated in the left. 
Since Cerl2 is a Nodal antagonist, this asymmetric expression of Cerl2 renders 
nodal expression to the left side of the crown cells (Marques et al., 2004, 
Schweickert et al., 2010, Shinohara et al., 2012). This asymmetry generated by 
Cerl2 on the Nodal activity (R < L) at the node strongly correlates with the 
asymmetric pattern of Nodal expression in lateral plate mesoderm and further 
activates other factors required for asymmetric organogenesis (Kawasumi et 
al., 2011, Shinohara et al., 2012, Hamada, 2016). 
In last few decades, considerable progress has been made in this area. 
However, there are many questions that need to be resolved. How is the 
anterior-posterior information deciphered into the posterior tilt of node cilia?  




determined?  What is the action of nodal flow and how is it sensed? What is the 
role of Ca2+ signalling and how does it induce degradation of Cerl2 mRNA? 
Despite all the ambiguity, one thing that is clear is that motile cilia are required 
for establishing L-R asymmetry. Hence, it is not surprising that in patients with 
Primary Ciliary dyskinesia (PCD) (see session 1.3.1), 50% exhibit situs 
inversus totalis and heterotaxy occurs in at least 6% of individuals with PCD 
(Leigh, 2012). 
1.3 Disease manifestation by dysfunction of motile cilia 
1.3.1 PCD 
Mutations in genes associated with ciliogenesis and cilia motility will result in 
cilia dysfunction and will give rise to ciliopathies. PCD is a heterogeneous 
autosomal recessive genetic disorder and occurs in 1 in 16000 individuals. PCD 
was first known as Kartagener syndrome, and patients display the triad of situs 
inversus, bronchiectasis, and chronic sinusitis (Cowan et al., 2001, Knowles et 
al., 2013a). Subsequently Kartagener syndrome was noted to be associated 
with male infertility. Later, the syndrome was renamed as immotile cilia 
syndrome and then PCD, after observing dynein arm defects in both airway 
epithelial cells and spermatozoa. The usual clinical symptoms of PCD patients 
are chronic sinusitis, chronic otitis media, recurrent infections in lower 
respiratory tract, bronchiectasis, male infertility and situs abnormalities 
(Knowles et al., 2013a, Rossman et al., 1980, Leigh, 2012, Tan et al., 2007).  
In PCD patients, many structural defects in cilia are observed by electron 
microscopy, including short or absent ODA. Reduced or absent cilia beat 




defects. Consequently, defects in mucociliary clearance are almost always 
occur in patients with PCD.  Only a fraction of mutations leads to structural 
abnormalities in cilia and other mutations result in no ultrastructural defects in 
cilia, yet the cilia are immotile (Knowles et al., 2013a, Tilley et al., 2014). 
A major confounding factor in the treatment of PCD is the difficulty of an early 
diagnosis. Many clinical manifestations of PCD overlap with other disorders 
such as cystic fibrosis, asthma etc. Therefore, in many cases that present with 
clinical symptoms, diagnosis can be made with examining the ultrastructure of 
cilia by electron microscopy. However, since many mutations do not present 
with ultrastructural defects in cilia, genetic testing is used as the gold standard 
diagnostic tool for testing known mutations of PCD. The currently known genes 
only account for 70% of PCD cases. Hence, to make genetic testing a 
comprehensive diagnostic tool, more genes must be uncovered that will 
account for the remaining PCD mutations. In order to do so, we need a better 
understanding of the molecular components and signalling pathways that is 
required for motile ciliogenesis and its function (Knowles et al., 2013a, Roy, 
2009, Tilley et al., 2015). 
1.4 Previous attempts to define the cilium  
One of the biggest challenges in this field is identifying and characterising all 
molecular components of the motile cilium and filling the gaps left in the current 
knowledge on the formation and function of this organelle. To address this 
problem, multiple research groups have undertaken a series of high throughput 
analysis that identified numerous putative ciliary genes and proteins that may 




These large-scale screens can be classified into proteomic based and 
genomic based. In the proteomic approaches, ciliary proteins are identified 
through isolation of ciliary structures i.e. axoneme, centrosome or centrioles 
followed by protein separation by techniques like gel electrophoresis, and liquid 
chromatography-mass spectrometry (LC-MS) to identify the peptides (Pazour 
et al., 2005, Smith et al., 2005, Ostrowski et al., 2002a, Broadhead et al., 2006). 
These studies have yielded hundreds of putative proteins. 
In addition, various genomic and transcriptomic based approaches were 
undertaken aimed at characterising the genetic makeup of the motile cilia, 
including their regulatory components. A common feature of the genomic 
approaches has been that they have produced thousands of putative ciliary 
genes and many of these require further functional characterisation to establish 
roles in motile ciliogenesis (Rosenbaum et al., 1969, Li et al., 2004, Stolc et al., 
2005, Ross et al., 2007, Hoh et al., 2012, Choksi et al., 2014c, Nemajerova et 
al., 2016b, Stauber et al., 2017) . 
This aspect is further explored on chapter 4.  Functional characterisation 
of these putative genes in motile ciliogenesis is the basis of my thesis. For this 
purpose, mouse airway epithelial cells cultured at ALI were used as an in vitro 
model and the zebrafish was used as the in vivo model. So, what makes these 
models ideal for studying motile ciliogenesis? 
1.6 In vitro culture of mouse tracheal and nasal epithelial cells at 
Air Liquid Interface as a model to study multiciliogenesis 
The study of ciliogenesis in vivo is difficult and there are not many cell lines 
available that can form motile cilia. In 2002, You et al developed an ingenious 




vitro (You et al., 2002). Hence, this model offers a good system to study 
motile cilium biogenesis. Now, this model is very well established and is used 
extensively by many research groups to study various aspects of airway 
epithelium e.g. role of airway epithelial cells in chronic lung diseases and 
infection, molecular and genetic components involved in the differentiation of 
airway epithelial cells like ciliated cells etc. (Vladar and Brody, 2013, Tan et 
al., 2013b, Nichols et al., 2014, Nemajerova et al., 2016a, Eenjes et al., 
2018a).  
In brief, airway epithelial cells are freshly isolated from the trachea or 
nasal septum. These cells consist of multiple cell types. During in vitro 
culture, the cells are first grown in submerged conditions on inserts that 
allows the basal cell population (the epithelial progenitor population) to 
expand.  Once the cells become confluent, cells are transferred into the air 
liquid interface (ALI) where the cells are exposed to air and media is supplied 
through the basal chamber. These conditions mimic the in vivo conditions in 
the airways and thus prompt the differentiation into mature airway epithelial 
cells that consist of multiciliated cells, secretory cells and basal cells (You et 
al., 2002, Vladar and Brody, 2013).  
Studying transcriptomic and proteomic data derived from different time 
points during the differentiation of these cells, will allow the identification of 
genes and specific pathways involved in formation of MCCs. In addition, it 
facilitates the comparison and analysis of specific genetic and molecular 




extracting and culturing the airway epithelial cells from these animals (Vladar 
and Brody, 2013, Hoh et al., 2013, Nemajerova et al., 2016a). 
Remarkably, motile ciliogenesis in these cultures can be modified by 
drug treatment to befit our research needs (Pan et al., 2007b, Vladar et al., 
2012, Vladar and Brody, 2013, Burke et al., 2014). Cell sorting can be used to 
extract individual cell populations that would allow further comparison among 
the MCCs and other cell types contained in airway epithelial cells cultured at 
ALI. Moreover, gene expression in airway epithelial cells grown at ALI can be 
modulated by gene transfer to study the protein of interest (Vladar and Stearns, 
2007, Horani et al., 2013b, Vladar and Brody, 2013, Marshall et al., 2016).  
1.5 Zebrafish as a model for characterising novel cilia markers 
and generating Primary Ciliary Dyskinesia phenotype 
In the last few decades, the zebrafish, a tropical fish originally from river 
Ganges, has become a popular model for biomedical research due to its 
embryonic transparency, rapid development, high nucleotide and amino acid 
identity with humans, and its adaptability for genetic analyses (Song et al., 
2016a). It has been reported that 70% of human genes have orthologues in 
zebrafish, and over 82% of genes implicated in human disease described in the 
Online Mendelian Inheritance in Man (OMIM) database have at least one 
zebrafish orthologue (Howe et al., 2013a, Song et al., 2016a). Hence, these 
characteristics make zebrafish a great tool for exploring and demonstrating the 
genetic and molecular basis of human development and disease.  
For cilia research, zebrafish has many advantages and can be a 




in diverse organs that can be easily observed in live transgenic embryos 
(Malicki et al., 2011). As outlined in the introduction above and is shown in 
Figure 2.7, during early stages of development, they have rotary beating mono-
motile cilia in KV,  the equivalent of the embryonic node (Essner et al., 2005). 
As the embryos develop, more tissues that possess diverse motile cilia emerge. 
We can observe clustered motile cilia bundles from MCCs in the anterior and 
middle segment of pronephric ducts (embryonic kidney tubules) while mono-
motile cilia are seen in the posterior part of the pronephric ducts (Liu et al., 
2007). There are motile cilia also present in the otic vesicle poles (Colantonio 
et al., 2009) (Stooke-Vaughan et al., 2012, Yu et al., 2011).  The axoneme of 
the most motile cilia have the 9+2 architecture, however, the zebrafish spinal 
cord contains both 9+0 and 9+2 motile cilia (Kramer-Zucker et al., 2005, 



















Figure 1-1-7. Motile cilia in the zebrafish embryos. 
A) In the initial stages of development, monomotile ciliated cells are present in KV which is equivalent to the mammalian embryonic node. 
B) As the embryo develops, there are many different motile ciliated tissues such as pronephric duct, otic vesicle, brain ventricle, floor plate 






 Phenotypes associated with motile cilia defects can easily be 
characterized using bright field microscopy, antibody staining or transgenic 
analysis (Malicki et al., 2011). A large-scale mutagenesis screen done by Howe 
et al identified many zebrafish cilia mutants including genes that cause human 
ciliopathies (Howe et al., 2013a). Moreover, gene editing techniques like 
TALEN and CRISPR/Cas9 technologies are very well established and have 
been extensively used in the zebrafish, and therefore can be explored to model 
human ciliopathy gene mutations. Recently, Choksi et al carried out a 
systematic screen for novel ciliary genes by overexpressing foxj1 in zebrafish 
embryos and identified hundreds of novel candidates with putative function in 
ciliogenesis and cilia motility (Choksi et al., 2014b).  Overall, this information 
highlights the value of the zebrafish in ciliogenesis research. 
1.7 Aims and hypothesis of the thesis 
 
Despite the importance of cilia, the mechanisms regulating the transcriptional 
control and maintenance of motile ciliogenesis are incomplete, and we are only 
beginning to understand the mechanisms underlying the development and 
function of cilia. By identifying the transcriptional cascade that regulates these 
processes, it will give us a more thorough understanding of the biology of cilia 
and associated disorders. Therefore, better understanding of how signalling 
pathways modify this transcriptional cascade and identifying cell type-specific 
transcription factors that activate specific target genes will help in improving 
the diagnosis and treatment of ciliopathies like PCD. 
To aid these goals, several systematic approaches have been taken 




and transcriptional profiling of FOXJ1 induced genes (Hoh et al., 2012, Choksi 
et al., 2014b). These, and other studies, have identified numerous novel ciliated 
cell markers involved in cilia formation and function. However, these data just 
form a map for treasure hunters since it requires further characterisation of 
individual candidates to understand and fill the gaps in the field of ciliogenesis. 
Identification and characterisation of novel ciliary genes would also help early 
diagnosis and treatment of ciliopathies like PCD.  
          Therefore, my project was focused on the following aims: 
1. To undertake a systematic analysis of published data sets to identify 
potential novel ciliogenesis genes.  
2. To establish primary mouse airway epithelial cell culture model and use it 
to characterise the expression of potential novel ciliogenesis genes to 
identify candidate gene for further analysis.  
Having achieved these aims, Pierce1 was selected as a potential ciliogenesis 
gene for further characterisation. Subsequently, my hypothesis was that 
Pierce1 plays a role in motile ciliogenesis.  This hypothesis was tested with 
following aims:  
1. To characterise the functional role of PIERCE1 using an in vitro model 
and in vivo model with the following objectives.   
 A) To study the transcriptomic and proteomic expression of PIERCE1 
in primary mouse airway epithelial cell culture. 














Chapter 2 :   Materials and methods 
2.1 Studying ciliogenesis in primary mammalian airway epithelial 
cells cultured in vitro 
2.1.1 Culture of mouse tracheal and nasal epithelial cells  
Epithelial cells from mouse nasal septum and trachea were isolated from 
C57BL/6 mice and cultured in ALI culture conditions following published 
methodologies as outlined below. 
2.1.1.1 Maintenance of mouse stock 
 
C57BL/6 mice were obtained from Charles River and maintained in a specific 
pathogen free environment in open top cages. Animals were fed ad-lib rodent 
diet and provided with filtered tap water. All work involving animals was 
performed in accordance with the Animal (Scientific procedures) Act 1986 and 
was approved by the University of Sheffield animal welfare and ethical review 
body. Work was carried out under procedure project license 40/3726 (David 
Dockrell).  
2.1.1.1 Harvest of mouse trachea 
The mice were euthanized by administrating 50mg/ml pentobarbital (100µl/ 
mouse) by intraperitoneal injection that was followed by exsanguination by 
cutting the inferior vena cava by research technician with appropriate animal 
handling licence. Mouse carcasses were sprayed with 70% industrial 




scalpels, the skin around the tracheal area was removed until the trachea was 
exposed. After making an incision on the abdominal area a midline incision was 
made along the sternum and rib cage was removed to access the trachea within 
the thoracic cavity. With the aid of surgical forceps, the trachea was lifted, and 
blunt dissection was used to separate oesophagus from the posterior surface 
of trachea. Tracheae were then cut off at the proximal end and dissection was 
carried out down to the tracheal bifurcation. The resected tracheae were then 
placed in cold sterile filtered mTEC basic media (Ham's F12 Media (Life 
Technology, 31330-038) containing 2% Penicillin/ streptomycin (Life 
Technology, 15070-063). After transferring the resected tracheal tissues into a 
sterile 100 mm Petri dish containing 10 ml sterile antibiotics containing Ham's 
F12 media, the connective tissue and attached glands were dissected from the 
trachea and discarded under a dissection microscope using sterile forceps. The 
tracheae were subsequently transferred in to a new sterile 100 mm Petri dish 
with 10 ml Ham's F12 media containing antibiotics. Using a pair of sterile 
surgical scissors and forceps, the lumen of the tracheae was cut open before 
transferring into 5mL 0.15% Pronase (Sigma Aldrich, 10165921001) solution (1 
trachea per ml) and was incubated overnight at 4°C. Dissection of mouse 






Figure 2-1. Harvest of mouse trachea. 
A. WT C57BL/6J mice was used. B. Skin around tracheal area was removed. C. 
Midline incision was made along the sternum and rib cage was removed to access 
the trachea within the thoracic cavity. D. Trachea was lifted, and blunt dissection was 
used to separate trachea from surrounding tissues. E. Tracheas were then cut off 
from the proximal end and distal end. F-H. The connective tissue and attached 
glands were dissected from the trachea under a dissection microscope using sterile 






2.1.1.2 Harvest of mouse nasal septum 
Mice were euthanized by administrating 50mg/ml pentobarbital (100uL/ mouse) 
by intraperitoneal injection that was followed by exsanguination by cutting as 
outlined above. Mouse carcasses were sprayed with 70% industrial methylated 
spirit (IMS) to sterilize the field. Using a sterile dissecting scissors, an incision 
was made at the nape of the neck that carried on around the entire neck through 
which the head was completely separated from the rest of the body. The loosely 
attached skin was then removed completely using the fine scissors that 
exposed the skull and nose. The posterior coronal plane in the skull was 
sectioned and bony outer layer was removed that exposed the brain followed 
by the complete removal of brain by forceps. The scissors were then inserted 
in to the oral cavity and the mandible (lower jaw) was separated which further 
exposed the upper palate.  The scissors were then inserted into posterior nasal 
cavity and an incision was made along the suture line to extract the bony 
septum from the tissue. The resected nasal septae were then transferred into 
a 100 mm petri dish with 10 ml sterile Ham’s F12 media with added antibiotics. 
Under the dissection microscope, further dissection was carried out to remove 
attached hairs, elastic tissues and anterior nasal tip. Subsequently, the tissues 
were transferred into a 15 ml falcon tube with 6 ml 0.15% Pronase solution (for 
5 nasal septums) and were incubated overnight at 4°C. The dissection of the 





Figure 2-2. Harvest of mouse nasal septum. 
A. WT C57BL/6J mice was decapitated. B. Head was skinned. C-D. The mandible 
(lower jaw) was separated which further exposed the upper palate. E-F. The posterior 
coronal plane in the skull was sectioned and bony outer layer was removed that 
exposed the brain followed by the complete removal of brain by forceps. The scissors 
were then inserted in to posterior nasal cavity and incision was made along the suture 
line to extract the bony septum from the tissue along the dotted lines. G. Extracted 














2.1.1.3 Epithelial cell isolation from mouse tracheal and nasal septum 
Following pronase digestion, the tubes containing tracheae and nasal septae 
were left to stand in room temperature for 10 minutes and were given a gentle 
shake to dissociate more cells into the suspension. 500 µl of FBS (Sigma 
Aldrich, F2442) was added to the tubes to neutralise the pronase activity and 
the tubes were inverted 20 times. The tissues were then transferred to a second 
set of tubes (nasal and trachea separately) containing 2 ml Ham’s F12 media 
with antibiotics and 10% FBS, inverted again 20 times. The tissues were again 
transferred into third set of tubes and step was repeated and subsequently 
tissues were discarded. The contents of three tubes were pooled together into 
fresh tubes for nasal septum and trachea.  The cells were pelleted by 
centrifugation at 400g for 10 min at 8ºC. The cell pellets were then suspended 
in 1 ml of Ham’s F-12/pen strep containing crude pancreatic DNase I (Roche, 
11284932001) and 10 mg/ml BSA (Sigma, A9418) and left to incubation in ice 
for 5 min. Meanwhile, 10µl of cell suspension was suspended in 10µl of Tryptan 
blue and was loaded in to haemocytometer to take cell count using Nikon 
inverted light microscope at 10X magnification. Following the incubation, the 
cell suspension was again centrifuged at 400 g for 5 min at 8ºC. The cell pellets 
were suspended in Ham’s F12 media with 10% FBS and incubated in 15 mm 
tissue culture plates for 3-4 hours in 5% CO2 at 37ºC. Following the incubation, 
the non-adherent cells were collected from the plates and centrifuged at 400g 
for 5 min at 8ºC.  The pellet was resuspended in 1 ml of MTEC plus media (see 
appendix 1). An appropriate amount of this cell stock solution was then 





2.1.1.4 Culture of respiratory epithelial cells 
The mTEC and mNEC were seeded on rat-tail collagen-1 coated 0.4 um porous 
transwells (BD Bioscience). The seeding density for both mTEC and mNEC 
were 30,000 cells per transwell. The culture conditions were already optimised 
and established in our laboratory (Akram et al., 2014, Mulay, 2017, Akram et 
al., 2015). The cells were cultured to confluence in submerged culture for 5-7 
days using defined mTEC plus media (see appendix 1)(You and Brody, 2013). 
Cells were then induced to ALI culture using defined serum free media (MTEC-
SF, see appendix 1) (You and Brody, 2013)and culture continued for 14 days 
in a standard culture environment to allow differentiation of cells that mimicked 
mouse tracheal and nasal airway epithelium. During ALI culture apical wash 
and cell lysates were collected on day-0, -2, -5, -7 and 14 of ALI culture for 
transcriptional and translational analysis of epithelial cell differentiation. At day 
14, this epithelial cell layer mimics the original mouse tracheal/nasal epithelium. 
The cell culture model is illustrated in Figure 2.3.  Original mTEC and mNEC 
cells which were isolated from mice but were not cultured, were utilised as 














Figure 2-3. Epithelial cells are extracted from mouse nasal septum and trachea 
and grown in submerged culture. 
Cells were seeded on collagen coated 0.4µm pore membrane transwells. Cells 
undergo proliferation while submerged in mTEC/ Plus medium for 6-7 days until fully 
confluent. Cells are then differentiated to day 14 by Air Liquid Interface (ALI) conditions 
using mTEC/ SF medium. ALI culture apical wash, cell lysates were collected and cells 
were fixed  on day-0, -2,-5,-7 and 14 of ALI culture for transcriptional and translational 






2.1.2 RNA extraction  
RNA was extracted from the cell lysates collected at different time points of ALI 
culture of mouse nasal and tracheal epithelial cells. 250µl of sample was initially 
thawed and equilibrated at room temperature for 10 minutes. 40µl of chloroform 
was added into the sample and mixed by vortex, followed by incubation in room 
temperature for 10 minutes. Following this step, the suspension was 
centrifuged at 13000 rpm at 8ºC for 15 minutes. As a result, the suspension 
resolved in to 3 phases which was visible as 3 layers. The aqueous layer with 
the RNA was carefully extracted and transferred to a fresh Eppendorf tube and 
was suspended in 100µl isopropanol by vortex. The samples were then left to 
stand in room temperature for 10 minutes. Samples were centrifuged at 13000 
rpm and 4ºC for 10 minutes that allowed the formation of RNA pellet. After 
discarding the supernatant, 200µl of 75% ethanol was added to the pellet. 
Sample was again centrifuged at 13000 rpm at 8ºC for 10 minutes and the 
supernatant was discarded. Subsequently the pellet was air-dried to remove 
any residual ethanol. The RNA pellet was then re-suspended in 20 µl of RNase-
free water. RNA concentration was quantified using a nanodrop 
spectrophotometer. All extracted RNA underwent DNase free treatment to 
remove residual genomic DNA in the sample (see appendix 8.2). 
2.1.3 Reverse transcription 
Reverse transcription was carried out using Promega Reverse Transcription kit 
using AMV Reverse Transcriptase (Promega, A3500). 200 ng of RNA sample 




added followed by incubation at 70ºC for 10 minutes. Then, 6µl master mix 
made up of 1.5µl dNTPs, 5µl Promega AMV buffer, 0.75µl RNAsin and 0.75µl 
AMV RT was added to the tube. Reaction mixture was then incubated at 42ºC 
for 1 hour. 
2.1.4 Amplification by Polymerase Chain Reaction (PCR) 
End-point PCR was carried out using Maxima Hotstart (Thermo Scientific, 
K1051). For all PCR reactions, 1µl of appropriate forward and reverse primers 
and 1 µl of sample DNA was added to 10µl of Maxima Hot start master mix 
along with 6.5 µl nuclease free water. The PCR reaction was run on the 
following setting: 90°C for 1 minute, 60°C for 1 minute, 72°C for 1 minute for 
25- 35 cycles. The primers used for amplifying mouse genes are shown in 
Appendix 3. 
2.1.9 siRNA transfection of primary mouse nasal and tracheal epithelial 
cells 
2.1.9.1 Transfection Reagents 
Four different transfection reagents (Dharmafect 1, 2, 3, 4) from DharmaconTM 
were tested.  The efficiency and toxicity of transfections were compared by 
fixing the cells and assessing the number of cells emitting green fluorescence 
by transfection of siGLO and nuclear fragmentation by DAPi staining. All 
reagents were lipid based. All transfection reagents and volume ranges per 




2.1.9.2 Transfection protocol 
The siGLO green transfection indicator (DharmaconTM), a fluorescent 
oligonucleotide duplex that is restricted to the nucleus, thus concentrating its 
signal to permit explicit visual assessment of transfection efficiency, was first 
diluted with Opti-MEM® I (Gibco®, Invitrogen, Paisley, UK) with a concentration 
ranging from 25nM-200nM. Transfection reagents were also diluted in Opti-
MEM® I. Reagent dilutions were mixed by pipetting and let to incubate in room 
temperature (RT) for 10 mins. 30 µl of the reagent dilution was suspended in 
30µl of siRNA dilution. The siRNA Reagent complex was incubated at RT for 
20 minutes. 240µl of antibiotic free mTEC plus media was added to the siRNA-
Reagent complex and mixed well. Subsequently, this transection medium was 
added to the apical surface of the 60% confluent mNEC and mTEC cells 
growing on rat-tail collagen-1 coated 0.4 um porous transwells. After 48 hours 
incubation at 37°C, 5% CO2 in cell incubator, the transfection medium was 
discarded. Cells were fixed with 10% formalin and stained with DAPi for visual 
assessment of toxicity and efficiency. Cells were also trypsinised for cell 
sorting. 
 2.1.9.3 Flow cytometry 
Following transfection, the cells were trypsinised and suspended in 1 ml of 
mTEC plus media. The cell suspension was handed over to the Core Cell 
Sorting facility, Medical School, University of Sheffield to carry out cell sorting 
to separate transfected cells (green fluorescence attached) from non-
transfected cells. Once the cells were sorted, the transfected cells and non-




porous transwells. After proliferating them for 7 days, the cells were fixed with 
10% formalin and stained with DAPI to visualise the transfected cells under 
epifluorescence microscope. 
2.1.10 Western Blotting  
Cell lysates and apical washed collected from ALI cultured cells at different time 
points were mixed with 2xSDS buffer (1:1) and heated at 95oC for 10 minutes. 
Samples were resolved on 12 % SDS-PAGE gels by loading 20 µl - 40µl of the 
sample. Gels were run at a voltage of 150V for1 hr 30 minutes. Trans-Blot 
Turbo (Bio-rad) was used to transfer the gel to methanol activated PVDF 
membrane. Following the transfer, membranes were blocked in 5% non-fat milk 
(Anlene) dissolved in 1 xTris Buffered Saline-Tween (TBS-TWEEN) for 1hr at 
room temperature. Primary antibodies (see Table 2-1) diluted in the same 
blocking solution were added to the membrane and incubated overnight at 4oC. 
The primary antibodies were washed 3 times with TBS-TWEEN at 10mins 
interval. Secondary antibody (polyclonal goat-anti rabbit conjugated with HRP, 
DAKO P0448) diluted (1:2000) in same blocking solution were added to the 
membrane and incubated for 1 hour at room temperature, followed by vigorous 
3 X TBS-TWEEN washes at 10mins interval. Enhanced chemiluminescent 
(ECL) substrate (Geneflow) was used to detect the signal from the HRP 
conjugated secondary antibody. Information regarding the preparation of the 




Table 2-1. Primary antibodies in Western blotting. 
 
 
2.1.11 Immunofluorescence microscopy 
2.1.11.1 ALI Culture Sample fixation 
The apical surface of the transwell membrane was washed with warm (37oC) 
PBS and sample was incubated in the incubator for 30 minutes. After the 
incubation, the medium was aspirated from the basal compartment. 300µl of 
10% buffered formalin (equilibrated at room temperature) was added to the 
apical chamber and 700 µl to the basolateral compartment of the transwell and 
left at room temperature for 1 hour. The apical and basolateral surfaces of 
transwells were washed 3 times by PBS (equilibrated at RT) by repeated 
pipetting. Finally, 300 µl of PBS was added to the apical chamber and 700 µl of 
PBS in to the basolateral chamber. The sample was stored at 4ºC until the next 
step. 
2.1.11.2 Fluorescence immunocytochemistry 
PBS was aspirated from both compartments of the transwells. 300 µl of 
permeabilization/blocking buffer (Goat serum or Rabbit serum according to (the 
source of detection antibody) diluted 1:10 in PBS with 0.5% Triton X) was added 
to the apical surface. The plate was then placed on a shaker for 1 hour at room 
Primary Antibody Manufacturer Dilution 
BPIFA1 (Rabbit Ab, 
polyclonal) 
Prepared in lab (Musa 
et al., 2012) 
1:200 
PIERCE1 (Rabbit Ab, 
polyclonal) 
Gift from Dr Dominic 





temperature at 80 rpm. The permeabilization/blocking buffer was aspirated 
from the apical surface. Both apical and basal surfaces were washed with PBS 
once. The primary antibody (see Table 2-2) in permeabilization/blocking buffer 
was prepared as shown in the table below and 300 µl primary antibody solution 
was added to the apical chamber of the transwell. The plate was then placed 
on a shaker in the cold room at 80 rpm overnight. 
    Table 2-2. Primary antibodies in immunostaining. 
Primary antibody Manufacturer Dilution 
BPIFA1 (Rabbit Ab, 
polyclonal) 
Prepared in lab 
(Musa et al., 2012) 
1:200 





β-tubulin (Mouse Ab, 
monoclonal) 
Sigma (T5201) 1:100 
Mouse/human P63 











PIERCE1 (Rabbit Ab, 
polyclonal) 





              Following the overnight incubation, the primary antibody was aspirated 
from the apical surface. The apical and basal surface of the transwell was 




2-3) solution in permeabilization/blocking buffer was prepared as shown in the 
table below and 300 µl antibody solution was added to the apical chamber of 
the transwell and the plate was wrapped in aluminium foil. The plate was placed 
on a shaker for 1 hour at 80 rpm at RT.  
Table 2-3. Secondary antibodies in immunostaining. 
Secondary antibody Dilution Primary antibodies used 
against 
Alexa Fluor 568 Goat anti-rabbit 
Ab. Cat No- A11011. (Red)  
1:200 PIERCE1, MUC5B, 
BPIFA1 
Alexa Fluor 488 Goat anti-
mouse Ab. Cat No- A11001. 
(Green) 
1:200 P63, β-TUBULIN, FOXJ1 
          The secondary antibody was aspirated and the apical and basal surfaces 
of the transwell were washed three times with PBS under dim light. The 
membrane holding the cells were cut out using a scalpel and placed on a 
microscope slide (with the cell side up) using forceps. 1 drop of DAPI mounting 
medium (Vectashield, Vector Laboratories) was added on top of the cells and 
left to stand in RT for 2 minutes. The coverslip was transferred on to the 
prepared slide. Excess DAPI was diffused out to the edges. Nail polish was 
used to seal the coverslip to the slide and allowed the nail polish to set in RT 





2.1.12 Quantification of intracellular localization of epithelial cells 
 
ALI day 14 mNEC cells immunostained for FOXJ1 were analysed using 
Olympus Fluoview 1000 confocal microscope. Using 40x magnification, 8 
adjacent fields spanning the whole membrane were imaged. Z-stacks were 
analysed and merged using ImageJ software to create the maximum intensity 
single image.  The number of ciliated cells (FOXJ1 +ve cells) was studied using 
mean integrated fluorescence using ImageJ software. The percentage of cell 
expressing FOXJ1 was quantified using ImageJ as follows: 
Number of nuclei expressing FOXJ1 
Total number of nuclei stained by DAPT 
 
2.1.13 Quantitative PCR 
 
For qPCR to quantitate expression Pierce1 and Foxj1 in the differentiated 
mNEC grown at ALI treated with and without DAPT, 500 ng of total RNA was 
used for cDNA synthesis by Promega Reverse Transcription kit. Primer 
sequences (see Appendix 3) were taken from a recent study by Stauber et al 
(2017) that had identified downstream targets of FOXJ1 in murine embryonic 
airway epithelium and mouse embryonic node (Stauber et al., 2017). The 
internal control was Hprt. cDNA was diluted 1:50. The qPCRBIO SyGreen Blue 
Mix Lo-ROX (PCRBIOSYSTEMS, Cat. No- PB20.15-05) was used to carry out 
q-PCR (three repeats for each sample). qPCRs were carried out in a Rotor 
Gene Q qPCR cycler, using software Rotor Gene 2.1.0.9 (Qiagen).  Reagents 






Table 2-4 Components for Quantitative PCR 
Reagent Volume (each well) 
cDNA  6 µl 
SYBR green master mix 3.5 µl 
Forward primer (5 uM) 0.5 µl 
Reverse primer (5 uM) 0.5 µl 
 
            Fold differences in the gene expression levels were generated from the 
Ct values after normalizing against the internal controls using Microsoft excel. 




2.2 Analysing ciliogenesis in zebrafish embryos 
2.2.1 Zebrafish strains and husbandry 
Zebrafish strains used in the study were maintained at the Institute of Molecular 
and Cell Biology-zebrafish facility following standard protocols. The facility has 
a controlled temperature of 28.5°C and operates a 14-hr light and 10-hr dark 
light cycle. All the experiments with zebrafish were conducted with the approval of 
The Singapore National Advisory Committee on Laboratory Animal Research. 
The zebrafish strains used in the thesis are listed in the following Table 2-5. 
Table 2-5 Zebrafish strains used in the study 
Line Purpose 
AB  Wild-type 
hsp70::foxj1a Used to overexpress Foxj1 
pierce1 KO c.178_179ins(29 bp) To assess the function of Pierce1 
pierce1 KO c.176_180del To assess the function of Pierce1 
 hsp70: foxj1a line was generated in Prof Sudipto Roy’s lab (Choksi et al., 
2014c). 
2.2.2 Zebrafish Morpholino experiments 
2.2.2.1 Overview 
All zebrafish morpholino experiments were conducted with the purpose of 
characterising the consequence of knockdown of a gene by either interfering 
with translation or splicing at mRNA level, on the subsequent development, 




phenotypes that could arise from motile cilia defects such as abnormal otoliths, 
hydrocephalus, laterality defects, curved axis and pronephric cyst formation. 
 
2.2.2.2 Morpholino design and preparation 
Morpholino oligonucleotides (see Table 2-6) were designed and synthesized 
by GeneTools LLC. They were reconstituted to 1mM by suspending it in double 
distilled water and stored at room temperature. Using a N2 gas injector (PLI-
100 from Harvard Apparatus), one cell stage zebrafish embryos were initially 
injected with a volume of 1nl, 0.75nl and 0.5nl of morpholino (100% 
concentration) into the animal pole. When there were embryos with more than 
25% lethality, data were rejected. Reduced dose of morpholino was used to 
repeat the injection. 
 
  Table 2-6 Morpholinos used in the study 
Type of Morpholino Sequence 
Pierce1 start (23rd November 
2015, Genetools) 
TCGTTTGTGCTCATGTTTGTGTTGA 
Pierce1 splice (4th January 2016, 
Genetools) 
GCTGGCTCTTCTTACCTGTATCTGA 
   
2.2.3 Fixation of embryos for immunofluorescence 
Approximately 30 embryos from each group were transferred into screw top 
eppendorfs. Embryos were fixed in 1 ml Fish fix (4% paraformaldehyde, 4% 
sucrose dissolved in PBS) for 2-3 hours in room temperature or overnight in 




with 30min intervals. PBS was then discarded, and embryos were kept in 100% 
methanol (MeOH) and stored in -20oC. In methanol, embryos can be kept up to 
1 year. 
 
2.2.4 Whole mount immunohistochemistry on zebrafish embryos 
For immunohistochemistry, fixed embryos stored in 100% MeOH were 
rehydrated by washing with progression from 75%, 50% and 25% methanol to 
1x PBS for 5 minutes at room temperature. Subsequently, embryos were 
washed in 1x PBS for 4 times with 2 minutes intervals. Then, PBS was 
discarded, and embryos were treated with 1ml ice-cold acetone and were 
stored in 20oC for 7 minutes. Acetone was then discarded, and embryos were 
further washed with 1x PBS for 4 times with 2 minutes intervals. Afterwards, 
embryos were incubated in blocking solution consisting of 2% sheep serum 
diluted in PBDT (PBDT consist of 1% BSA, 1 % DMSO and 0.5% Triton-X100 
diluted in PBS and stored at 4oC) for 1 hour at room temperature in a glass 
cavity dish on a nutator at 65 rpm.  The blocking solution were then removed 
and primary antibody (see Table 2-7) diluted in PBDT was added to the 
embryos.  
Table 2-7.Primary antibodies in immunostaining 
Primary antibody Manufacturer Dilution 
Anti-GFP (polyclonal) 
 
Torrey Pines, TP401 1:500 
Anti-acetylated-alpha-tubulin 
(rabbit monoclonal) 






Sigma, T6793 1:500 







Anti-Myc (mouse monoclonal) Santa Cruz 
Biotechnology (#sc-
789  ) 
1:500 
 
          Embryos were incubated overnight at 4oC. The following day, the primary 
antibody was removed, and the embryos were washed in PBDT for 4 times with 
30 minutes intervals on a nutator (80 rpm). Appropriate secondary antibodies 
(Table 2.8) and DAPI (1:2000) diluted in PBDT was then added to the embryos 
and incubated for 3-4 hours at room temperature on a shaking platform at 60 
rpm. After removing the secondary antibody, embryos were washed with PBDT 
for 4 times with 30 minutes intervals. Embryos were subsequently transferred 
to 70% glycerol (in sterile water). Stained embryos were mounted using 70% 
glycerol. 
Table 2-8. Secondary antibodies in immunostaining 
Secondary antibody Dilution 
Alexa Fluor 555 Goat anti-mouse Ab 
(Invitrogen) 
1:500 








2.2.5 Zebrafish molecular biology techniques 
2.2.5.1 RNA isolation from zebrafish embryos 
RNA was isolated from WT embryos, hsp70: foxj1 embryos, morpholino 
injected embryos and pierce1 mutant embryos to check for pierce1 mRNA 
expression and to validate morpholino and mutations. RNA was first isolated 
and 1µg RNA was reverse transcribed to make cDNA. This cDNA was 
subsequently used for endpoint PCR and qPCR. 
            Approximately 30 embryos from each group were transferred into screw 
top eppendorfs. Embryos were first washed in 1 ml 0.1% DEPC treated sterile 
water. After discarding the water, 1 ml Trizol was added to embryos in a fume 
hood. Embryos were then lysed using 1 ml syringe and needle and incubated 
for 5 minutes at room temperature. 200 µl chloroform was added to the lysate 
and then vortexed for 15 seconds. The sample was then incubated for 3 
minutes at room temperature. The chloroform-lysate solution was then 
centrifuged at 12,000 rpm for 15mins at 4ºC, that resulted in separation of the 
mixture into three phases. The aqueous phase containing the RNA was moved 
into fresh 1.5 ml Eppendorf tube. RNA was precipitated by adding 500 µl 
isopropanol and incubated at room temperature for 10mins, then centrifuged at 
12,000 rpm for 10mins at 4ºC. Consequently, the RNA pellet was observed at 
the bottom of the Eppendorf tube. The RNA pellet was then washed and 
vortexed in 1ml of 75% ethanol and centrifuged at 7,500 rpm for 5mins at 4ºC.  
Ethanol was then discarded, and the RNA pellet was air dried for 5-10mins at 
room temperature.  The RNA pellet was then dissolved in 20 µl RNase free 
water. 1 µl DNase was added to the RNA solution and incubated for 20 minutes 




quantified using Nanodrop 1000 spectrophotometer (Thermo Scientific, US). 
RNA stocks were stored at -80oC. 
2.2.5.2 Reverse transcription 
Equal concentrations of RNA were used in each experimental group by diluting 
with RNase free water where required.  First-strand cDNA was synthesized 
using the Superscript First Strand Synthesis Kit (Invitrogen, USA). The reaction 
was assembled as indicated in Table 2-9 below. 
Table 2-9. Components for First-strand synthesis of cDNA 
Reagent Volume 
RNA 1 µg 
Oligo dt 1 µl 
10 mM dNTP 1 µl 
DEPC water Up to 10 µl 
              The mixture was incubated at 65°C for 5 min and was then left on ice 
for 5 min. The reverse transcription was carried out by the addition of the 





Table 2-10. Components for Reverse Transcription (RT) 
Reagent Volume 
10X buffer 2 µl 
25mM MgCl2 4 µl 
0.1M DTT 2 µl 
RNase Out 1 µl 




           Afterwards, the mixture was incubated at 42°C for 1h. The reaction was 
terminated by a short incubation for 5 min at 85°C and subsequently chilled. 
Any excess RNA was removed by the addition of 1 µl of RNase H and 
incubation at 37°C for 20 min. cDNA was stored at -20oC.  
2.2.5.3 Polymerase Chain Reaction (PCR) 
 
A web-tool, Primer3plus, (https://primer3plus.com/) was used to facilitate 
design of specific primers. Primers (see Appendix 4) for PCR were purchased 
from IDT (earlier1st-Base) Singapore. For PCR reactions to generate products 
for further sequencing and cloning, Roche Expand high fidelity kit (See Table 
2-11) was used with PTC100 thermal cycler (MJ Research). A 50 µl reaction 
volume was used. The cycling conditions consisted of denaturation at 95°C for 
30s, followed by annealing for 30s at a range of temperatures from 55°C to 
65°C, and finally, an extension at 68°C. Extension time was set at the rate of 




Table 2-11. Components for PCR with Roche Expand high fidelity kit  
Reagent Volume 
10 mM dNTP 1 µl 
10 µM Forward primer 1 µl 
10 µM Reverse primer 1 µl 
10 x buffer 5 µl 
Enzyme 1 µl 
cDNA 1 µl 
dH2O 40 µl 
 
PCR products were then visualised by gel electrophoresis on 1-2% agarose 
gels in TAE buffer (See appendix section 2.2).  
            For PCR reaction for genotyping zebrafish embryos to identify pierce1 
mutants, a MyFi mix (Bioline) containing DNA Polymerase, dNTPs and MgCl2 
was used as shown in Table 2-12.  A reaction volume of 20 µl was used. The 
cycling conditions consisted of initial denaturation at 95°C for 1 min, followed 
by denaturation for 30s at 95oC, annealing for 30s at a range of temperatures 
from 55°C, and finally, an extension at 72°C. This was followed by final 






Table 2-12. Components for PCR with MyFi mix 
Reagent Volume 
MyFi Mix 10 µl 
dH2O 7 µl 
10 µM Forward primer 1 µl 
10 µM Reverse primer 1 µl 
gDNA (~100 ng) 1 µl 
 
PCR products were then visualised by gel electrophoresis on 1-2% agarose 
gels in 1X TAE buffer (See Appendix 2.2).  
2.2.5.4 Excision of RT-PCR bands and PCR clean-up 
To extract a band of interest from agarose gel, the gel was positioned on top of 
a UV transilluminator.  The band was cut away from the gel using a scalpel by 
cutting around the edges of band.  Subsequently, the cut out gel containing the 
band was place in a 1.5 ml Eppendorf tube and subsequently weighed to 
determine the mass of the gel (e.g. 100 mg is equivalent to 100 µl). Extraction 
of DNA from the gel was carried out using Qiagen gel extraction kit and the 
manufacture’s protocol.  An appropriate volume (3x volume of gel) of QG buffer 
was added to dissolve the gel by heating in 50oC up to 10 minutes. The gel 
mixture was then transferred to a spin column and centrifuged for 1 minute at 
13000 rpm. The flow through was discarded. 500 µl of buffer PB was added to 
the column and again centrifuged for 1 min at 13,000 rpm. The flow through 




times 1 min centrifugation at 13000 rpm. Subsequently, 15 µl RNase /DNase 
free water was added to the column and incubated in room temperature for 5 
minutes. Afterwards, it was centrifuged for 1 min at 13,000 rpm and DNA was 
eluted as flow through. Eluted DNA was stored at -20oC. 
2.2.5.5 TOPO-TA cloning   
 
For sequencing PCR products and sub-cloning into zebrafish expression 
vectors, gel extracted PCR amplified product for a gene of interest i.e. pierce1, 
was used for TOPO cloning (Thermofisher, K4620-01). The cloning reaction 
consisted of mixing the following reagents:   
Table 2-13. Components for TOPO-TA cloning 
Reagents Volume 
DNA (25 ng/ µl) 4 µl 
pCR II TOPO vector 1 µl 
Salt 1 µl 
 
          The reaction mixture was incubated at room temperature for 20 minutes 
and subsequently transferred to ice. Afterwards, the reaction mixture was 
transferred in to One Shot DNH5α T1 competent E. coli cells and incubated on 
ice for 20 minutes before heat shocking in 42oC for 40 seconds. Subsequently, 
it was incubated on ice for another 5 minutes before plating antibiotic containing 
LB agar plate with 50 µl X-GAL and incubated overnight at 37°C. White colonies 




2.2.5.6 Extraction of plasmid DNA from bacterial cultures 
Miniprep was carried out as per the manufacturer’s protocol (QIAGEN, 
Valencia, CA, USA) from the 3 ml of bacterial culture using ion-exchange 
columns. 
2.2.5.7 Restriction enzyme digestion 
Restriction enzymes (New England Biolabs) were used for restriction digest to 
validate plasmids, cloning etc. To digest or linearize a particular vector or a 
construct, the following setup was used as shown in Table 2-14. 
Table 2-14. Components for Restriction digest reaction 
Reagents Volume 
DNA 3 µg 
NEB Cutsmart buffer 5 µl 
Restriction enzyme 
 
2 µl (Double digest – 1.5 µl of each 
enzyme) 
Water Up to 50 µl 
 
            The reaction mixture was incubated for 3 hours at 37°C.Afterwards, 
digested fragments were resolved on a 1% agarose gel and the desired product 
was extracted from the gel. 
2.2.5.8 DNA Sequencing  
DNA sequencing was carried out at DNA sequencing facility at the Institute of 
Molecular and Cell biology, A*STAR, Singapore. Sequencing was performed 
using Big Dye Terminator v3.1 and appropriate primers. Results were viewed 




2.2.5.9 Cloning and sub-cloning   
In order to express tagged (MYC or GFP) Pierce1 in zebrafish embryos, primers 
were designed with appropriate restriction sites to amplify pierce1 ORF with 
cloning restriction sites. PCR product was gel extracted and cloned into pCR II 
TOPO. pierce1 TOPO plasmid with the engineered restriction sites were 
verified by miniprep followed by sequencing. Next, I proceeded to sub-clone 
pierce1 (with the engineered restriction sites) in to either 6 x myc -PCS2 vector 
or PCS2-GFP xlt vector. Pierce1-TOPO plasmid with engineered restriction 
sites and the vector were digested with same restriction enzymes for 3 hours 
at 37°C. Digested pierce1 (the insert) from the TOPO plasmid and digested 
vector was gel extracted. The insert and vector were mixed in a 3:1 molar ratio 
as shown in Table 2-15. 
Table 2-15. Components for ligation reaction 
Reagents Volume 
Insert ( 50 ng) 3 µl 
Vector (50 ng) 1 µl 
 T4 DNA Ligation Buffer 10 µl 
T4 DNA ligase 1 µl 
Water  Up to 20 µl 
 
         The ligation mixture was incubated at 16°C overnight. Following day, 6µl 
of the ligation mixture was mixed with 100 µl One Shot DNH5α T1 competent 
E. coli cells and incubated on ice for 20 minutes before heat shocking in 42oC 




before plating antibiotic containing LB agar plate and incubated overnight at 
37°C. Colonies were picked for miniprep to extract plasmid DNA. Restriction 
digest and sequencing was carried out on the extracted plasmid DNA to 
validate the construct. 
2.2.5.10 In vitro transcription of linearized construct 
1 µg linearized plasmid construct (6X myc-pierce1-PCS2, pierce1-PCS2-GFP 
xlt) were transcribed in vitro to synthesise mRNA using mMESSAGE 
mMACHINE SP6 or T7 kit (Ambion) according to manufacturer’s protocol by 
adding transcription components and incubation for 2hrs at 37oC. 
Subsequently, excess DNA was removed by adding DNase1 followed by 
incubation for 15mins at 37oC. This was followed by lithium chloride 
precipitation at -20oC. Next day, RNA was pelleted by centrifugation at 12,000 
rpm for 30mins followed by wash with 70% ethanol. After discarding the 
ethanol, pellet was dissolved in 20µl of 0.1% DEPC water. The synthesized 
mRNA was stored at -80oC. 1nl of synthesised RNA (200 ng µl) was injected 
into the animal pole of one-cell stage zebrafish embryos.  
2.2.5.11 Quantitative PCR  
 
For carrying out qPCR to look at the pierce1 expression in hsp70: foxj1 
zebrafish embryos (heat shocked), WT (WT) embryos and hsp70: foxj1 
zebrafish embryos (non-heat shocked), embryos were collected at 24 hpf for 
RNA extraction. 1 µg of total RNA was used for cDNA synthesis by Superscript 
III (Invitrogen, #18080-051). Primers (see appendix 4) were designed at 3’ end 
and flank exon-intron boundaries to test for genomic DNA contamination. 




mix (Invitrogen, 11780200) was used to carry out q-PCR on a 90 well plate 






Table 2-16 :  Components for Quantitative PCR 
Reagent Volume (each well) 
cDNA (2 ng/µl) 6 µl 
SYBR green master mix 10 µl 
Forward primer (5 uM) 2 µl 
Reverse primer (5 uM) 2 µl 
 
        Quantitative PCR was performed on a Fast 7900HT real time machine 
(Applied Biosystems) with the included SDS2.4 software. Fold differences in 
gene expression levels from experimental control were generated from the Ct 
values after normalizing against the internal controls using Microsoft excel. 
           Three biological replicates were measured for pierce1. Statistical 
significance was determined by using a Student’s t-test, with p values < 0.05 
considered significant. Primers for qPCR can be found in the appendix. 
2.2.5.12 Extraction of genomic DNA from embryos  
Individual embryos were picked and placed in 0.5 ml Eppendorf tubes. Embryos 
were washed with 200 µl sterile water once. 10µl of lysis buffer (25 mM NaOH, 
0.2 mM EDTA) was then added to each embryo and embryos were incubated 
for 20 min at 95oC. Subsequently, the reaction was chilled in ice for 5 minutes 
prior to addition of 10µl neutralisation buffer (40 mM Tris-HCl, pH 8.0). The 





2.2.5.13 Extraction of DNA from adult zebrafish  
Adult zebrafish were anaesthetized in 0.02% 3-amino benzoic acid ethylester 
(tricaine). Roughly, 5 mm of the tail fin was cut and placed in 0.5 ml Eppendorf 
tube. 40µl of lysis buffer (25 mM NaOH, 0.2 mM EDTA) was then added to each 
tube and were incubated for 20 min at 95oC. Subsequently, the reaction was 
chilled in ice for 5 minutes prior to addition of 40µl neutralisation buffer (40 mM 
Tris-HCl, pH 8.0). The mixture was vortexed for 1 minute. The DNA was 
subsequently used in PCR reactions. 
2.2.6 Making pierce1 knockout with CRISPR/Cas9 gene editing technique  
In order to generate stable genetic mutant lines for pierce1 in zebrafish, the 
CRISPR/Cas9 system, a recently developed gene editing technique that induce 
double stranded breaks in the DNA, was utilised. 
2.2.6.1 Designing and synthesising gRNAs 
Target sites for CRISPR were identified by locating PAM sites (NGG) within the 
UTRs and exons of pierce1 DNA. This was carried out using a web tool called 
“CHOPCHOP”. The 18bp sequence upstream of the identified PAM site was 
used as a template to generate gRNA along with the sequence that recruits 
Cas9 and the T7 promoter from which the guide RNA is transcribed. 
Subsequently, this ultramer was purchased from IDT. The ultramers were 
resuspended in sterile water to a final concentration of 100μM. Using a 
standard reverse primer, the ultramers (see appendix 4) were amplified with 




Table 2-17.Components for gRNA template amplification 
Reagents Volume 
5 x Phusion buffer 20 μl 
Phusion polymerase 1 μl 
Designed ultramer (100 μM) 2.5 μl 
Reverse primer 2.5 μl 
dNTP (10 mM) 2.5 μl 
DMSO 2.5 μl 
Water 64 μl 
 
            The cycling conditions consisted of initial denaturation at 98°C for 30 
seconds, followed by denaturation for 10s at 98oC, annealing for 30s at 60°C, 
and finally, an extension at 72°C for 15 seconds. This was followed by final 
extension at 72°C for 10 minutes. The PCR reaction was 35 cycles. PCR 
product was subsequently purified PCR purification kit by QIAGEN according 
to manufacturer’s protocol. The PCR product was then eluted in 10μl of dH2O.  
           The gRNA was transcribed from the purified PCR product using the 
MEGAshortscript T7 kit (Life Technologies) according to the manufacturer’s 
instructions. The transcription reaction was assembled as shown below in 





Table 2-18. Components for gRNA in vitro transcription 
Reagents Volume 
10 x buffer 2 μl 
ATP 2 μl 
GTP 2 μl 
CTP 2 μl 
UTP 2 μl 
PCR purified product 8 μl 
T7 enzyme 2 μl 
 
              The reaction was incubated at 37oC for 3-4 hours. Subsequently, 2μl 
of DNAse was added to the reaction to remove the remaining DNA incubating 
for further 20 minutes. In order to precipitate gRNA, 115 μl nuclease free water 
along with 15 μl ammonium acetate was added to reaction and mixed well by 
vortex. Afterwards 300 μl EtOH (100%) was added and incubated at -20 oC 
overnight. Next day, the RNA is pelleted as shown in section 2.2.5.10. RNA 
concentration was measured by nanodrop. 
2.2.6.2 In vitro validation of gRNAs 
In order to test the efficiency of gRNAs, an in vitro reaction was assembled as 
follows in Table 2-19 in a 0.5 ml Eppendorf tube. The negative controls were 




Table 2-19. Components for gRNA in vitro validation 
Reagent Volume 
Plasmid DNA/ PCR product 
containing target site 
sequence (100 ng/ μl) 
1 μl 
NEB buffer 3 1 μl 
10 x BSA 1 μl 
gRNA (450 ng/ μl) 1 μl 
Cas9 ( 400 ng/ μl) 1 μl 
Water 5.5 μl 
 
              The mixture was then incubated at 37 oC for 1 hour. Subsequently, the 
mixture was run on 1-2% agarose gels by gel electrophoresis and viewed under 
UV exposure to validate cleavage of plasmid DNA/ PCR product. If the DNA 
was cleaved, the gRNA was considered to be efficient. 
2.2.6.3 Injection of gRNA + cas9 into zebrafish embryos 
The injection mixture was made by adding 1μl of each gRNA (1.5 μg/μl) and 
1μl of cas9 RNA (1.6 μg/μl). 1nl of this mixture was injected into the animal pole 
of one-cell stage embryos. The embryos were then incubated in petri dishes at 





2.2.6.4 Determination of CRISPR efficiency  
gDNA was extracted from 8 CRISPR injected embryos and 8 uninjected 
embryos at 24 hpf. Primers were designed to amplify region spanning the target 
site. PCR was performed on injected and WT samples side by side with these 
primers using MyFi Hotstart kit. The PCR products were run on 1%-2.5% 
agarose gel to determine if any large deletions are detectable. The PCR 
products were then gel extracted and cloned to pCR II TOPO. 6 colonies were 
picked from each plate and plasmid was extracted by miniprep. The extracted 
plasmids were sent for sequencing to detect small insertions or deletions in the 
target site. If we were able to detect indels in target site, the CRISPR was 
considered efficient.  
           If the CRISPR cas9/gRNA injection was considered efficient, embryos 
were sent to nursery. Once the fishes became adults (2.5 months old), they 
were genotyped by fin-clip followed by gDNA extraction and PCR. 
2.3 Statistical tests and analysis  
All data analysis and statistical tests were performed using Graphpad prism 
V6.02 (Graphpad). The number of biological replicates of the experiments is 
indicated by the n number. Error bars represent the standard error of the mean 
(SEM). All data was analysed with a Student’s t-test, one way ANOVA or two 
way ANOVA unless otherwise states. P values < 0.05 was considered 











Chapter 3 :  Validation of mammalian airway epithelial cells 
cultured at air liquid interface as an in vitro model for analysing 
ciliogenesis 
3.1 Preface 
MCC beat in a coordinated and polarized manner to drive directional fluid flow 
across tissues and are essential for proper development and adult physiology. 
They are important for the function of airway, ependymal, and oviduct epithelia. 
Primary cells that can generate multiple motile cilia, such as mouse nasal 
epithelial cells (mNEC) and mouse tracheal epithelial cells (mTEC) described 
here, are of use since motile cilia formation is difficult to study in vivo and cell 
lines with multiciliated cells are not available. Protocols for culturing and 
differentiating primary airway epithelial cells from mouse nasal septum (mNEC) 
and trachea (mTEC) at an air-liquid interface (ALI) have been established (You 
et al., 2002, Antunes et al., 2007b).  
mNEC and mTEC preparations generated using these protocols are 
valuable models to study different characteristics of airway epithelial cell 
differentiation and function, host response to infection, and disease 
pathology(Newby et al., 2007, Stubbs et al., 2012, Vladar and Brody, 2013). 
Vladar and Brody (2013) have shown mTECs cultured at ALI are a good in vitro 
model to study motile ciliogenesis. They are also suitable models to study 
specific genes and pathways from mutant or other genetically manipulated 
mouse strains. Several studies have shown that motile ciliogenesis in these in 
vitro culture systems can be manipulated by drug treatment (Vladar and Brody, 




           The basic technique is as follows.  mNEC and mTEC are isolated from 
mice, plated on transwells and cultured under submerged conditions for 5-7 
days. Once confluent cells are transferred into ALI culture where the media is 
removed from the apical chamber of transwell Cells are cultured for up to 14 
days when they become fully differentiated airway epithelium and can be used 
for functional studies as determined in previous studies using this in vitro 
model. Samples taken during this process can be used to study aspects of 
ciliogenesis.  
In this chapter I describe how this in vitro model was validated as a good 
model to study MCC formation and function by analysing mRNA expression of 
epithelial cell markers by end-point RT-PCR, detection of airway epithelial 
secretory proteins by western blotting and visualization of the localization of 
airway epithelial markers by immunofluorescence microscopy. I also tested 
whether ciliogenesis could be modulated by drug treatment in ALI cultured 
model. The efficiency of siRNA transfection was also explored with the intention 
of modulating gene expression of putative ciliary genes. 
3.2 Results 
3.2.1 Culturing and differentiation of mNECs and mTECs at the ALI 
The culture conditions for mTECs and mNECs were already optimised and 
established in our laboratory (Akram et al., 2014, Mulay, 2017). The average 
number of mNECs isolated was 231,250 cells per nasal septum (n=17 WT 
batches). The average number of mTECs isolated was 156,250 cells per 
trachea (n=12 WT batches). The cells were grown in the presence of ROCKi 




seeding density of 30,000 cells per transell was used for both mNEC and 
mTEC. The formation of a confluent monolayer was achieved within 5-7 days 
of seeding.   
3.2.2 Transcriptional expression of airway epithelial markers during ALI 
culture of mNEC and mTEC 
 
In order to validate the differentiation of mNEC and mTEC cultured at the ALI, 
end-point RT-PCR was carried out. This was carried out on cells at ALI day 0, 
(cell population of progenitor cells), ALI day 14 (expected to be a population of 
differentiated airway epithelial cells), the original cells taken prior to 
establishment of culture (representative of differentiated airway epithelial cells 
present in the original tissue) and fibroblasts isolated from the same mice (as an 
additional control).   
The Oaz1 gene is a housekeeping gene (de Jonge et al., 2007) and 
this was used as the control for all of the PCRs carried out. As shown in the 







Figure 3-1 mRNA expression of airway epithelial markers during air liquid 
interface (ALI) of mNEC and mTEC.  
End-point RT-PCR was carr ied out on samples collected on day 0 and day 14 of 
ALI cultured mNEC and mTEC to compare mRNA expression of epithelial markers and 
to validate that the cells have differentiated at Day 14.  The original samples (org), 
airway epithelial cells isolated from nasal septum and trachea before plating, were 
used as the positive control. Fibroblasts extracted from mouse nasal septum and 













           Tekt1 encodes TEKT1 protein that is expressed in the axoneme of 
motile cilium and is required for cilia motility (Ryan et al., 2018). Therefore, 
Tekt1 is a marker for ciliated cells.  The expression of Tekt1 is absent on day 
0 in both mNECs and mTECs, indicating absence of ciliated cells. On day 14, 
expression is comparable with that in the original cells denoting presence of 
differentiated ciliated cells. Mouse fibroblasts cDNA was used as the negative 
control and absence of band as expected indicates absence of ciliated cells. 
The Muc5b gene, encodes the secretory gel forming mucin protein 
MUC5B that is secreted by secretory cells of airway epithelium (Fahy and 
Dickey, 2010). Expression of Muc5b was very low on day 0 in both in both 
mNECs and mTECs whereas the presence of a dense band on day 14 for both 
mNEC and mTEC indicates the presence of more differentiated secretory cells. 
These results indicate our day 14 ALI cultured cells from both mNEC and 
mTEC show gene expression signatures consistent with mature airway 
epithelial cells. 
The Krt5 gene encodes KRT5 protein, a known  marker of basal cells, 
which are considered as the progenitors of the airway epithelium (Rock et al., 
2009, Zuo et al., 2015). On day 0, band intensity was highest and as expected, 
during cell differentiation at the ALI, the band intensity decreased by ALI day 
14 in both mNECs and mTECs. This suggested that the population of basal 
cells at ALI day 0 has differentiated into distinct  airway epithelial cell types 
including secretory and ciliated cells.  Again, fibroblasts served as a negative 





3.2.3 Secretion of BPIFA1 during ALI culture of mTEC and mNEC 
In order to further validate whether our cells differentiated in ALI culture, I 
compared the production of BPIFA1, a protein that is secreted by 
differentiated airway epithelial secretory cells (Musa et al., 2012, Akram et al., 
2015, Akram et al., 2017). I carried out western blot on the apical washes of 
the mTEC and mNEC collected at ALI day 0 and day 14 time points by western 
blot.  As shown in the Figure 3.2, BPIFA1 was not detected in the washes 
collected at ALI day 0 but a band of size between 25 kDA and 30 kDA 
representing BPIFA1 was detected from washes collected at ALI day 14 
indicating the presence of differentiated secretory cells that secrete BPIFA1 at 
this time. 
 
Figure 3-2. Western blot shows secretion of BPIFA1 by ALI cultures of mNEC 
and mTEC 
BPIFA1 is a secretory protein secreted by differentiated airway secretory epithelial 
cells. There is no secretion of BPIFA1 in day 0 but expression is found on day 14 of 
ALI of both nasal and tracheal cells as denoted by bands at 25 kDA. The same volume 
of apical wash fluid was loaded in each lane. Positive control is WT mouse 
bronchoalveolar lavage fluid (Akram et al., 2017). The negative control is SDS buffer. 





3.2.4 Immunofluorescence microscopy of airway epithelial markers 
during ALI culture of mTEC and mNEC 
To visualize the differentiated airway epithelial cells in the ALI culture, cells 
were fixed with 10% formalin and stained with various airway epithelial markers 
such as TP63 (basal cells), BPIFA1 (secretory cells), β-TUBULIN (Cilia) and 
PAN- CYTOKERATIN (epithelial cells) and DAPI (cell nuclei). The stained 
cells were visualized under confocal microscopy, which allows for optical 
sectioning in the Z-axis.  
As shown in Figure 3.3 Cells were co-stained with β-tubulin that allowed 
us to visualise the cilia and BPIFA1 to detect secretory cells. On day 0, 
expression of BPIFA1 and ciliated cells were absent. On day 14, cilia 
projection was found on cells in both mNEC and mTEC and BPIFA1 staining 





Figure 3-3. IF microscopy of differentiation of ciliated cells and secretory cells 
in the ALI cultured  mNEC and mTEC 
At ALI day 0, secretory cells that express secretory protein BPIFA1, and ciliated cells 
(BETA-TUBULIN staining the cilia axoneme) cannot be detected in either culture. At 
day 14, secretory cells that express BPIFA1 and ciliated cells that express Beta-








           As shown in the Figure 3.4, when the cells were co-stained with TP63 
and BPIFA1 on day 0, almost all nuclei w e r e  s h o w n  t o  be positive for 
T P63 indicating these are basal cells but BPIFA1 staining was not seen in 
either mNEC or mTEC cultures. In day 14 cultures, cytoplasmic BPIFA1 
staining was present denoting differentiated airway secretory cells and the 
number of Tp63 stained nuclei were much fewer than in the day 0 cultures. This 
suggests that the cells had differentiated from a population of basal cells 
(airway progenitor cells) on day 0 to a differentiated airway epithelial cell 





Figure 3-4.  IF microscopy showing TP63 localised to basal cells during ALI 
culture. 
At ALI day 0, most cells are found to be positive for Tp63 denoting they are airway 
progenitor cells. At day 14, there are fewer Tp63 positive progenitor cells and secretory 






          Both mNEC and mTEC cells from ALI day 14 cultures were stained for 
Pan-cytokeratin, marker of all epithelial cells. As shown in Figure 3.5, all the 
cells at ALI day 14 for both mNEC and mTEC were stained which indicates 
successful and efficient airway epithelial cell extraction and culture. 
 
Figure 3-5. IF staining of cells with Pan-cytokeratin on differentiated airway 
epithelial cells. 
In both mNEC and mTEC cultures all cells appear to stain for Pan-Cytokeratin, 






3.2.5 mRNA analysis of cilia markers during ALI differentiation of mNEC 
and mTEC 
 
In order to study the expression pattern of genes known to be required for or 
associated with ciliogenesis during ALI differentiation, endpoint RT-PCR was 
carried out on cDNA collected on days 0, 2, 5, 7, and 14 of ALI culture from 
both mNEC and mTEC. Original cells were used as a positive control whilst 
fibroblast served as a negative control. 
As shown in Figure 3.6, genes encoding major regulators of 
ciliogenesis such as Mcidas and Foxj1 were expressed from day 0 and were 
upregulated during the differentiation of both cell types at the ALI. Mcidas had 
peak expression at day 2-5 and appeared to decrease from day 7. The peak 
expression for Foxj1 was found from day 5/7.  Expression of Tekt1 was 
detected from day 2 and a gradual increase occurred until peak expression 






Figure 3-6. mRNA expression of genes involved in ciliogenesis during the ALI 
differentiation of mNEC and mTEC 
End point RT-PCR was performed as described. oaz1 is a  housekeeping gene used 
as a positive control.  Foxj1 and Mcidas encode main transcription factors in involved 
in multiciliogenesis and expression can be seen from day 0. Tekt1 encodes structural 
component of cilia and transcriptional expression can be seen from day 2 of ALI culture 
of mNEC and mTEC. All genes involved in ciliogenesis are upregulated during the 
differentiation of mNEC and mTEC at ALI (n=3). 
 
3.2.6 ALI differentiation of mNEC from Dnah11civ/iv mice 
        Next, I wanted to know whether the mNEC and mTEC cultured at ALI were able 
to recapitulate the functional phenotype of original cells in situ. To do this, we 
used Dnah11civ/iv mice. These mice harbour a missense mutation at the outer 
arm dynein heavy chain 11 locus (Dnah11c). Hence, they have immotile 
tracheal cilia with normal ultrastructure and reduced sperm motility. These mice 
exhibit gross rhinitis, sinusitis, and otitis media and therefore an excellent model 




3.2.5.2 Identification of cilia in ALI culture of mNEC from Dnah11civ/iv 
mice 
 
To visualize the differentiation of airway epithelial cells in WT and Dnah11civ/iv 
mNEC cells at day 14 of ALI, the cells were fixed and stained for FOXJ1 
(ciliated cells) and MUC5B (secretory cells). As shown in Figure 3.7, ciliated 
cells (FOXJ1+) and secretory cells (MUC5B+) were detected on mNEC at ALI 
day 14 derived from both WT and Dnah11civ/iv mice. This experiment was only 
carried out once.  
 
Figure 3-7. IF microscopy of differentiation of ALI cultured mNEC from and 
Dnah11civ/iv mice. 
At ALI day 14, differentiation of Dnah11c
iv/iv
 mNEC cultures was similar to wt. 
Secretory cells were stained with MUC5B and ciliated cells by FOXJ1 (n=1). 








I next wanted to test whether mNEC cells isolated from Dnah11civ/iv 
retained their cilia abnormality.  These mice have immotile cilia due to a 
missense mutation in the dynein heavy chain gene Dnah11c. The IF 
microscopy showed that the cultures have normal ultrastructure however cilia 
motility was shown to be absent. This was confirmed by high-speed video 
microscopy of d a y 14 mNEC from WT and Dnah11civ/iv mice. Ciliary beating 
was visible in WT cells but absent in Dnah11civ/iv cells (See attached video 
files). This indicates that the ALI cultured cells recapitulated the morphological 
phenotypical characteristics of the original tissue. 
 
3.2.7 Modulation of the number of ciliated cells with NOTCH inhibitor 
treatment. 
Many studies have shown that the differentiation of multiciliated cells in ALI 
culture can be modulated by drug treatment (Pan et al., 2007b, Vladar et al., 
2012, Vladar and Brody, 2013, Burke et al., 2014). Notch signalling plays an 
important role in the differentiation of MCCs such that cells with lower Notch 
signalling levels differentiate into MCCs (Deblandre et al., 1999, Tsao et al., 
2009). DAPT, an inhibitor of Notch signalling, was shown to increase the 
number of ciliated cells in mTEC cultures (Stubbs et al., 2012, Vladar and 
Brody, 2013). In order to understand whether the DAPT treatment gives same 
results in mNEC, I treated the mNEC cells with 1mM DAPT from ALI day 0 to 
day 4.  
            IF microscopy was performed with FOXJ1 antibody and the number of 
FOXJ1+ve cells out of DAPI stained nuclei were counted with and without DAPT 




FOXJ1+ve cell are expected to become MCCs.  As shown in Figure 3.8, the 
results showed that the number of FOXJ1+ve nuclei when normalised to DAPI 
stained nuclei were significantly (p-value <0.05) increased by ~2-fold in the ALI 
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Figure 3-8. The number of ciliated cells were increased in the DAPT treated 
mNEC. 
 (A) IF microscopy was carried out on ALI day 14 of control (untreated) and 
DAPT
+ve 
mNEC.  At day 14, there are more (~x2) FOXJ1
+ve 
cells in DAPT 
treated mNEC compared to the control. Error bars indicate standard error of 
mean (SEM) (n=3 independent batches of culture). *p<0.05 using paired t-test 





3.2.8 Optimizing siRNA transfection into mNEC and mTEC 
Next, I wanted to test whether siRNA transfection was efficient in these 
primary cells. To determine optimal conditions of siRNA transfection into 
mNEC and mTEC cells in vitro, the efficiency of different Dharmacon 
transfection reagents and siGLO was evaluated. Different concentrations of 
siRNA from 25-200nM were combined with Dharmafect 1 to carry out siRNA 
transfection into both cells when they were 50% confluent. As shown in Figure 
3.9, maximum transfection efficiency of approximately 10 to 12% was 
achieved using 50 nM siGLO. The transfection efficiency was assessed by eye 
counting under fluorescence microscope.  The transfection efficiency seemed 





Figure 3-9. Optimizing siRNA transfection with siGLO (green,Dharmacon) in 
primary mouse nasal and tracheal epithelial cells. 
Transfection was carried out at different concentrations; i)25nM, ii)50nM, 
iii)100nM. Iv) 200nM. Maximum transfection efficiency achieved was around 
15% in mNEC cells with 50nM siGLO. Transfection efficiency was higher in 
mNEC compared to mTEC (n=2 independent batches of culture). (Image 





           I also tested Dharmacon transfection reagents Transfect 2, 3 and 4 to 
evaluate whether they produced a difference in transfection efficiency. As 
shown in Figure 3.10, higher transfection efficiency was achieved with 
transfection reagent 1. Lower transfection efficiency was achieved using 
transfect 2, 3.and 4. The transfection efficiency was assessed by eye 
counting under fluorescence microscope. Transfection efficiency was also 
shown to be variable in different batches of cells. The experiment was repeated 
twice. 
 
Figure 3-10.Optimizing siRNA transfection with  siGLO  (green,  Dharmacon) 
using 4 different transfection reagents. 
Transfection was carried out using 4 different Dharmacon reagents. Maximum 
transfection efficiency was achieved with transfect 1 (A). Transfect 2 (B), Transfect 3 
(C) and Transfect 4 (D) had lower transfection efficiency (n=2). (Image magnification = 





           To attempt to improve the success of this technique, transfected wells 
were trypsinised and pooled together. The pooled sample was sent for cell 
sorting to sort transfected cells from non-transfected cells. The recovered 
transfected cells were then reseeded onto new collagen coated transwells and 
then grown in submerged culture for 7 days to a l l o w  proliferation. However, 
these cells did not proliferate well and did not reach confluency. I concluded 
that this technique may have had potential to be useful for introducing siRNA 
into the cells for functional work but decided that significant improvements in 
the technique would be required to allow this to be valuable for my work. 
3.3 Discussion 
In vertebrates, the functional role and morphology of multiciliated airway 
epithelial cells are conserved. In airways, the first line of host defence is 
accomplished by concerted action of multiciliated cells that drive mucus 
clearance (Brooks and Wallingford, 2014b, Tilley et al., 2015). Ciliary 
impairment and resulting mucostasis are central players in many airway 
disorders (Tilley et al., 2015, Brooks and Wallingford, 2014b).   
           PCD also known as immotile cilia syndrome is one of the most common 
forms of ciliopathy. It is a heterogeneous genetic disorder that arises due to 
mutations in many genes involved in ciliogenesis and cilia motility (Kennedy et 
al., 2007, Knowles et al., 2013b). Identifying novel genes involved in ciliogenesis 
and ciliary motility can greatly improve early PCD diagnosis (Kennedy et al., 
2007, Daniels and Noone, 2015, Knowles et al., 2013b). 
           Recently, several   high   throughput   studies   have   identified   




2007, Hoh et al., 2012, Choksi et al., 2014c).  Characterising these genes and 
their function is an important step in identifying signalling pathways and 
mechanisms in ciliogenesis and its function that will be valuable in 
understanding aetiology of and finding a cure for ciliopathies. 
The ALI differentiation of primary mNEC and mTEC shown here is a 
particularly useful model for the study motile cilia biogenesis because it is 
difficult to study in vivo and due to the nonavailability of cell lines with multiple 
cilia. To appropriately model the in vitro airway epithelium, we replicated the 
ALI culture of primary mNEC and mTEC, as these cells simulate the 
morphological and functional characteristics of the airway epithelium 
(Antunes et al., 2007, Vladar and Brody,2013). For instance, basal cells from 
the proximal human airway differentiate into a mucociliary pseudostratified 
epithelium containing ciliated, goblet and basal cells. In this in vitro cell culture 
environment, cells display beating cilia, mucus secretion, barrier properties 
similar to the native airway epithelium.  
          For my studies it was important that I could establish these cultures with 
both nasal and tracheal cells. I was able to show expression of the well-
established airway epithelial markers Muc5b, Tekt1, and Krt5 indicating that 
cultures contained the secretory cells, ciliated cells and basal cells present in 
airway epithelium. The absence of Muc5b and Tekt1 in day 0 and expression 
on day 14 indicated that the cells differentiated successfully during the 14-day 
ALI culture period. The downregulation of Krt5 from day 0 to day 14 suggested 
that the number progenitor cells decreased but the presence of Krt5 on day 14 
indicated that a population the progenitor basal cells were maintained 




           It was important to test that the differentiated epithelium was capable of 
secreting proteins onto the apical surface. I was able to show this by western 
blotting apical washes from the abundant secretory protein BPIFA1. BPIFA1 
has been reported to be one of the most highly expressed genes in 
differentiated ALI cultures (Ross et al., 2007).  It has also previously been 
shown to be a major secretory product from both mouse (Akram et al., 2017) 
and human cells (Campos et al 2004). My cultures showed the presence of 
BPIFA1 in apical washes collected from day 14 ALI cultures of both mNEC 
and mTEC which confirming the presence of functional secretory cells in the 
cultures. As expected BPIFA1 was absent from washes of undifferentiated 
cells. 
Using IF microscopy with a range of airway epithelial markers such 
including TP63, BPIFA1, β-TUBULIN and Pan-Cytokeratin it was clear to see 
that the cultures showed a  distribution of different cell types including basal 
cells, secretory cells and ciliated cells. Consistent with the Krt5 expression 
data and as we expected, the number of basal cells was lower in the 
differentiated ALI day 14 cells compared to the undifferentiated ALI day 0 cells.  
Several studies have investigated the process of ciliogenesis during 
mTEC differentiation. For example, Vladar and Brody described distinct stages 
of multiciliogenesis in ALI culture of primary mouse tracheal epithelial cells 
(Vladar and Brody, 2013). Here, we similarly used RT-PCR to analyse the 
mRNA levels of genes encoding some of the main regulators and protein 
components of cilia structure. Our results revealed that the mRNA transcripts 
for ciliogenesis regulators such as Mcidas and Foxj1 were detectable from day 




FOXJ1 (Tan et al., 2013, Takahashi et al., 2015) and in our culture model the 
peak expression appears on day 2, while peak expression of FOXJ1 was on 
day 5-14. Since the endpoint RT PCR is only semi-quantitative, it showed 
variability.  Therefore, our culture model appears to agree with the findings 
from previous studies. Since, FOXJ1 is a specific marker for ciliated cells (Yu 
et al., 2008) we can presume the cell fate decision is made prior to the 
induction of differentiation through t h e  ALI culture process. However, the 
translation only appears to start after inducing ALI as the protein was absent 
from our day 0 IF analysis. You et al showed expression of foxj1 from day 2 in 
ALI culture of mTEC (You et al., 2004b). This suggests that the transcription 
of the main regulators involved in ciliogenesis start before the induction of 
ALI differentiation of the culture in mouse cells. This could potentially be 
induced through paracrine signalling as the cells reach confluency.  The 
transcript of a gene encoding a protein component of cilia, Tekt1, appeared 
from day 2 of ALI culture followed by the induction of the regulators. 
In this study I used endpoint RT-PCR which may have limited the 
sensitivity of transcript detection. This method is semi-quantitative and 
hence not efficient for absolute quantification and more quantitative data 
could have been generated using qPCR.  I carried out these experiments in 
2014-2015 and very similar results were shown by the RNA sequencing studies 
undertaken on differentiating mTEC cultures (Nemajerova et al., 2016c). 
Comparison with all other data does confirm that our model was suitable to test 





I also had the opportunity to grow mNEC cells from Dnah11civ/iv mice 
that harbour a missense mutation in dynein heavy chain gene DNAH11 and 
hence show immotile cilia with normal ultrastructure. These animals display a 
variety of disorders such as gross rhinitis, sinusitis, and otitis media and are 
considered to be a model of many aspects of human PCD (Lucas et al., 
2012). I used these mice to confirm that the defect in cilia function was 
maintained ex vivo when the cells were established in ALI cultures. Time-lapse 
imaging confirmed that ciliary beating was absent in mNEC from 
Dnah11civ/iv mice but present in the WT cultures. This therefore confirmed that 
the cells cultured at ALI recapitulated the characteristics of original cells derived 
from the tissue. Recently, cells derived from potential PCD patients cultured at 
ALI have been utilised as useful aid in diagnosing PCD (Hirst et al., 2014, 
Shapiro et al., 2018). 
Many studies have successfully modulated the process of ciliogenesis 
in mTEC by treatment of different drugs. Nocadozole and Taxol have been used 
by several groups to arrest ciliogenesis by inhibiting centriole assembly (Vladar 
et al., 2012, Vladar and Brody, 2013, Burke et al., 2014). Likewise, DAPT, a 
known NOTCH inhibitor has been used to increase the number of ciliated cells 
in mTEC (Stubbs et al., 2012, Vladar and Brody, 2013). For my further work I 
needed to ensure that I could modulate ciliated cell numbers in my cultures. So, 
I treated mNEC with DAPT. Consistent with results from previous studies 
performed on mTEC, the number of the ciliated cells was significantly increased 
in the mNECs. The ability to modulate ciliogenesis in this cell culture model is 
a very useful tool since it allows assessment of whether expression of putative 




modulation would also be a useful model to study the functional role of cilia 
when it comes to studies of host pathogen interactions.  
          Another way of potentially modulating ciliogenesis would be by 
genetically modulating the level of specific genes. As yet we have not 
undertaken this type of work in our group. In this study, I attempted to test 
whether siRNA transfection was an efficient tool in our primary mTEC and 
mNEC ALI culture. My plan was to use this to modulate expression of my novel 
candidate genes.  To do this, siGLO (Dharamacon) was transfected to 
mNEC and mTEC cells when they were 50% confluent on submerged culture 
using Dharmafect transfection reagents (transfect 1, 2, 3, 4). siGLO 
(Dharamacon) is a fluorescent oligonucleotide duplex that restricts to the 
nucleus, thus concentrating its signal to permit explicit visual assessment of 
transfection efficiency. However, maximum transfection efficiency t h a t  I  
achieved was only around 10-12%. Transfection efficiency did appear to be 
higher in mNEC compared to mTEC, which may point out difference in the 
biophysical properties of cells obtained from two different niches. Consistent 
with the manufacturer’s notes, cell toxicity was not observed during these 
studies confirming that these transfection reagents had limited toxicity in the 
primary cells. Previous studies have reported difficulties in delivering siRNA 
into well differentiated epithelial cells (Griesenbach et al., 2006). This is 
thought to be due to the high molecular weight and polyanionic nature of siRNA 
that makes it difficult to cross the epithelial cell membrane freely. 
Pseudostratified epithelium presents significant barriers such as airway 
secretions, physical barriers and host defence mechanisms to the delivery of 




we decided to attempt to transfect cells when they were in submerged 
culture and proliferating since we thought actively proliferating cells might be 
more susceptible to nucleic acid uptake. Also we needed to establish a method 
that might allow use to repress gene expression in the early phases of 
ciliogenesis in the differentiating cultures. My results were not as useful as I 
had anticipated. Previous studies have reported tight junctions that prevent 
paracellular passage of molecules, are present within one day of seeding 
(Ramachandran et al., 2013). Furthermore, I could not  be certain whether I had 
a homogenous population of a basal cells before inducing ALI and so cell make 
up could have differed which could partially explain the variability seen in 
transfections. Ramachandran et al described “reverse transfection “as an 
efficient method for the delivery of RNA interference oligonucleotides to 
polarised pig airway epithelial cell in in vitro”. In this method, siRNA-reagent 
complexes are added at the time of seeding as opposed to standard 
transfection in which transfection is done on the pre-plated cells.   However, 
they recommended using a high seeding density of 150,000 cells 
(Ramachandran et al., 2013).  Since, I used mouse models, my seeding 
density was about 30000 cells. The cell yields I obtained  per mouse nasal 
septum and trachea ranged from 100,000-230,000 cells. Therefore, the reverse 
transfection seemed inefficient and impractical for my studies. I also attempted 
to sort transfected cells and grow them to confluency. However, my results 
showed that cell proliferation after FACS was not achieved. This suggests that 
the primary cells did not tolerate the FACS procedure following transfection. 
Multiple studies have successfully utilised lentivirus infection to modulate 




Marshall et al., 2016). This technique has not been established in our laboratory 
and therefore in the interest of time, I decided not to proceed with modulating 
gene expression in ALI cultured cells. 
In conclusion, I was able to establish mNEC and mTEC cultured at the 
ALI and show that they are a good in vitro model to study the formation and 
function of multiciliated cells in the airway epithelium. The experiments 
presented here and by other groups, show that this cell culture model facilitates 
the characterisation of novel ciliogenesis regulators and the assessment of cilia 
formation and function. To continue to utilise this model more efficiently in the 
future, further enhancement of current techniques and development of 
additional methodologies may be necessary. The main improvements can be 
focused on attaining larger cultures volumes, formulating methods to passage 











Chapter 4 :  Selecting potential novel candidate genes 
associated with ciliogenesis 
4.1 Preface 
This chapter describes analysis of data from high throughput studies to select 
potential novel candidate genes associated with the process of ciliogenesis.  
           Many of the genes and signaling pathways involved in the formation and 
function of motile cilia are still not completely resolved. This poses many 
challenges when it comes to diagnosing heterogeneous genetic disorders such 
as PCD, (Knowles et al., 2013a). One of the key goals in ciliary research is to 
identify novel molecular constituents of the cilium. A series of high throughput 
genomic and proteomic screens have identified multiple genes, thought to be 
involved in the formation and function of the cilium (Ostrowski et al., 2002a, 
Ross et al., 2007, Geremek et al., 2011, Hoh et al., 2012, Choksi et al., 2014b).  
           A common feature of these studies is that they identify hundreds of 
genes. These studies have identified a few genes with direct relevance to 
human ciliopathies.  However, nothing much can be inferred about many of the 
genes revealed by these studies. 
The main aim of this research project was to functionally characterize 
novel ciliary genes using an in vitro model, murine airway epithelial cells 
cultured at an ALI and an in vivo vertebrate model, using zebrafish embryos. In 
order to select candidate genes for the study, I reviewed the data generated by 
Hoh et al on the transcriptional profile of multiciliated cells in culture (Hoh et al., 
2012). They used the same in vitro model (mouse airway epithelial cells 




 Hoh et al determined the transcriptional profile of multiciliated cells 
during the mucociliary differentiation of mouse tracheal epithelial cells at ALI 
culture (Hoh et al., 2012). In the study, the mouse tracheal epithelial cells for 
the differentiation in the in vitro culture, were derived from mice expressing GFP 
from the ciliated-cell specific Foxj1 promoter (Foxj1: GFP). The differentially 
expressed genes in ciliating (GFP+) cells from these cultures were 
characterized at an early and a late time point during differentiation. They were 
filtered by removal of the profile of the non-ciliated GFP- cells. This study 
identified ~650 genes that were upregulated during the early phase of 
ciliogenesis, during the formation and replication of basal bodies, and ~80 
genes that were upregulated during a later timepoint, after cilia were fully 
formed (Hoh et al., 2012). 
The data generated by Hoh et al, had identified many known ciliary 
genes as well as many uncharacterized genes that were not previously 
identified as ciliary genes culture (Hoh et al., 2012). Therefore, I chose the top 
10 most differentially expressed (between FOXJ1+ve and FOXJ1–ve cells) 
uncharacterized genes for further assessment on their potential association 
with motile ciliogenesis.  
To select a candidate gene for further characterization, I proposed that 
we would select one out of the selected 10 genes that would show enriched 
expression in motile ciliated tissues, specifically localisation to ciliated cells, 
show differential expression during differentiation of mNECs and have also 
been identified in other high throughput screens for ciliary genes done in more 




Several online databases like Cildb, Human Protein Atlas, bioGPS and 
LungGens were used to gather information needed for selecting a good 
candidate. In addition, expression of these genes were analyzed using endpoint 
RT-PCR using RNA from mNEC differentiated at the ALI, where most of them 
showed differential expression like other genes known to be involved in 
ciliogenesis. Expression of these genes was also analyzed in different mouse 
tissues and some of them were found to be enriched in tissues containing 
abundant motile cilia. The proposal for selecting a candidate gene for further 
characterization of it role in motile ciliogenesis is summarized in following flow 
chart.  
 
Figure 4-1 A flowchart for the selection process of candidate gene. 
There is little information on these genes in the literature. It seems likely 
that functionally characterizing the role of these genes in cilia formation or 
function may unravel novel pathways and mechanisms that are linked to the 





Cildb (http://cildb.cgm.cnrs-gif.fr), a knowledge database that incorporates 
ciliary data from various sources, was used to see if these genes or any of their 
orthologues had been identified in ciliary screens undertaken other organisms. 
Cildb links orthology relationships among 44 species (44 eukaryotes and 3 
bacteria) to high throughput ciliary studies (Arnaiz et al., 2009, Arnaiz, 2014). 
The selected candidate genes and the ciliary screens that have identified them 




Table 4-1.Novel cilia candidate genes  
Gene / Accession  Accession Studies 




































Negative regulation of 
protein kinase activity, 
Cytokine-mediated 
signalling pathway, Negative 
regulation of JAK-STAT 
cascade, Positive regulation 
































1- McClintock et al. 2008, 2- Baker et al. 2008 ,3- Guo et al. 2010, 4- Hoh et al.,2012 ,5- 
Treutlein B. 20146- Ostrowski et al. 2002 ,7- Ross et al. 2007,8- Geremek et al. 2010 ,9- 
Datta et al. 2011, 10- Ivliev et al. 2012,11- Geremek et al. 2014, 12- Baker et al. 2008   13-
Choksi et al.2014  14. Nakachi et al. 2011 




4.2.1 Expression levels of selected cilia candidate genes during 
mucociliary differentiation at ALI culture  
To study the expression of these genes during ciliogenesis, I used end-point 
RT-PCR to study the transcriptional expression of the selected candidate genes 
during the mucociliary differentiation of mNEC cultured at the Air Liquid 
Interface (ALI). Original cells (from the primary isolation) were used as a 
positive control. Oaz1 was used as positive control in this experiment. The 
negative control was dH2O.  
All the selected genes were shown to be differentially expressed during 
establishment of the ALI culture, implying that these genes are temporarily 
associated with the process of mucociliary differentiation as shown in Figure 
4.1. Although, all the genes were upregulated during the ALI differentiation the 
pattern of expression was slightly different for each. Pierce1, C11orf88 
Homolog, Lrrc4b, C9orf135 Homolog, Maats1, Spata24 and Cbe1 were all 
observed from day 0 to day 14 at ALI. The peak expression was observed from 
day 5 to day 14, as denoted by the band density. For Spata24, the peak 
expression was observed from day 2 to day 14. This pattern corresponds to 
expression of ciliary transcriptional regulators such as Foxj1 and Mcidas 
(Chapter 3). 
Expression of C1orf194 homolog and Erich2 was observed from day 2 
to day 14 of ALI. The peak expression was observed on day 14. This pattern 
corresponds to expression of genes encoding cilia structural components such 
as Tekt1 (Chapter 3). Expression of C5orf49 homolog was only observed from 





Figure 4-2 Expression of putative ciliary genes at different time-points in ALI 
culture of mNEC. 
RT-PCR was performed as described in the materials and methods section using 







4.3.2 Expression of the cilia candidate genes in mouse tissues 
Next, expression of the candidate genes in a range of whole mouse tissues was 
investigated alongside several known cilia genes. Within these tissues 
abundant motile cilia are found in lung, embryo, testes, brain and ovary. As 
shown in Figure 4.2, Foxj1 and Tekt1 were expressed only in tissues associated 
with motile cilia. 
Like Foxj1 and Tekt1, Pierce1, C1orf194 homolog, C5orf49 homolog, 
C9orf135 homolog and Cbe1 also exhibited expression in the tissues 
associated with motile cilia. Some of the genes were expressed in a few of the 
tissues associated with motile cilia tissues, Lrrc4b, Maats1, Erich2 and 
Spata24. In contrast C11orf88 homolog was observed to be expressed in all 
tissues essentially equally.  
Having provided some evidence that these genes may be associated 







Figure 4-3 Expression of novel candidate genes in whole mouse tissues. 
RT-PCR was performed as described in the materials and methods section. (n=1). 
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4.3.3 Pierce1 (P53-Induced Expression in RB-Null Cells 1) 
 
PIERCE1 was first identified as a target of TP53 and was also found to be 
upregulated in retinoblastoma (RB) protein deficient mouse embryonic 
fibroblasts (Sung et al., 2007, Sung et al., 2010). Pierce1 has been mapped on 
to Chromosome 2, 19.38 cM, cytoband A3 in mouse and the gene encodes a 
protein of 169 amino acids. The human orthologue is known as C9ORF116.  
As shown in Table 4.1, Pierce1 was identified in ciliary gene screens 
performed on mouse airway epithelial cells (Hoh et al., 2012, Treutlein et al., 
2014a) and was identified as being expressed in ciliated cells. In addition, the 
study of human airway epithelial cells cultured at the ALI (Ross et al., 2007) and 
studies on PCD patient samples (Geremek et al., 2011, Geremek et al., 2014)  
also identified PIERCE1 as a putative ciliary gene. PIERCE1 was also identified 
in a proteomic study of human ciliated tissues, with expression in epithelia of 
the oviduct and lung (Ivliev et al., 2012). pierce1 was also found to be a 
downstream target of FOXJ1 in zebrafish (Choksi et al., 2014c). 
In humans, PIERCE1 encodes for a protein of 136 amino acids with a 
predicted molecular mass of 15.26 kDa. Multi-alignment analysis with Blastp 
and Clustal X indicates that PIERCE1 shares a high identity with orthologues 
in other species, with the highest identity of 100 % to chimpanzee, 78% identity 
to mouse, 54% identity to frogs and 44% identity to zebrafish (See Appendix 
5.1). They share a common predicted domain of unknown function, DUF4490, 
which spans 39 to 137 amino acids in the human protein. In addition, the 




1 superfamily, from 25 to 108 amino acids, that is not found in other 
orthologues.   
Analysis of the Biology Gene Portal System (BioGPS) microarray data 
set (expression in different mouse tissues, Dataset: GeneAtlas GNF1M, 
gcrma), suggests that Pierce1 is abundantly expressed in tissues with motile 
cilia, such as nasal septum, the main olfactory epithelium (MOE), trachea, lung 
and testis (Figure 4.3). The graphs from bioGPS presented in this chapter are 






Figure 4-4. Pierce1 expression in mouse tissues based on the BioGPS database. 







           The localisation of PIERCE1 was investigated by analysis of protein-
level immunostaining data from the Human Protein Atlas – a large-scale 
antibody-based resource examining protein expression in human tissues. The 
immunostaining images from airways and fallopian tubes were analysed and 
data for FOXJ1 was used as the positive control. PIERCE1 is seen to be 
enriched in ciliated cells in the airway epithelium and in the fallopian tube. It 
appears that the protein is in both the cytoplasm and axoneme of ciliated cells 
(Figure 4.4).  
 
Figure 4-5. Localisation of PIERCE1 in motile ciliated tissues. 
The images were attained by immunohistochemical staining of bronchus and fallopian 
tubes with protein-specific antibodies in the Protein Atlas project (Uhlen et al., 2010). 
The antibodies were against the following proteins: PIERCE1 (a,b),  FOXJ1 (c,d). The 
antibody-based staining is shown in brown and staining of nuclei with DAPI in blue. 
The airways ciliated cells form a continuous layer, while in fallopian tubes they are 
separated from each other by non-ciliated epithelial cells. 
a b 




           Together these data, and the identification of this gene in several other 
cilia genomic and proteomic screens, suggest that PIERCE1 may have a 
conserved functional role in motile ciliogenesis.  
4.3.4 RIKEN cDNA 1700013F07  
RIKEN cDNA 1700013F07 is mapped to chromosome 3 in the mouse and 
encodes a protein of 168 amino acids. The human orthologue is called 
C1ORF194, an uncharacterised protein. It was identified in the ciliary genes 
screens undertaken by Ross et al (2007), Hoh et al (2012) and Choksi et al 
(2014). Analysis of Cildb identified that other ciliary genomic and proteomic 
screens also identified this gene. It was identified in the proteomic profiling of 
mouse spermatozoa ((Baker et al., 2008b), the proteomic analysis of 
spermatozoa in rat (Baker et al., 2008a) and a proteomic study on sperm tails 
from Ciona intestinalis (Nakachi et al., 2011). Ostrowski et al (2002) also 
identified the protein in proteomic analysis of cilia axonemes was isolated from 
these ALI cells (Ostrowski et al., 2002b). All these findings indicate RIKEN 
cDNA 1700013F07 as a conserved component of motile ciliary axoneme. 
 
           In humans C1ORF194 encodes a protein of 157 amino acids without a 
signal peptide. The C1ORF194 protein has a predicted molecular mass of 
19.35 kD. Multi-alignment analysis with Blastp and Clustal X indicates that 
C1ORF194  shares a high identity with orthologues in other species, with the 
highest identity of  99% to chimpanzee, 74%  identity to mouse, 43% identity to 
frog and 45% identity to zebrafish (See Appendix 5.2). The human protein 





              Analysis of a BioGPS microarray data set (expression in different 
mouse tissues, Dataset: GeneAtlas GNF1M, gcrma), show it is abundantly 






Figure 4-6. C1orf194 homolog expression in mouse tissues based on the BioGPS 
database. 






           As shown in Figure 4.6, immunostaining data from the Human Protein 
Atlas, shows the protein to be localised into axoneme of ciliated cells in the 




Figure 4-7. Localization of C1ORF194 in motile ciliated tissues. 
The images were attained by immunohistochemical staining of bronchus and fallopian 
tubes with protein-specific antibodies in the Protein Atlas project (Uhlen et al., 2010). 
The antibodies were against the following proteins: C1ORF194 (a,b),  FOXJ1 (c,d). 
The antibody-based staining is shown in brown and staining of nuclei with DAPI in blue. 
The airways ciliated cells form a continuous layer, while in fallopian tubes they are 







4.3.5 RIKEN cDNA 1700001L19 gene 
RIKEN cDNA 1700001L19 gene is mapped on to Chromosome 13, in mice and 
encodes a protein made up of 182 amino acids. The human orthologue is called 
C5ORF49. It is conserved in all vertebrates. This gene was identified in many 
ciliary gene screens undertaken on mouse airway epithelial cells and ciliated 
tissues (Hoh et al., 2012, Baker et al., 2008b, McClintock et al., 2008) and in 
the proteomic analysis of spermatogenesis (Guo et al., 2010). It was also 
identified in screens done in human airway epithelial cells and proteomic 
analysis on human ciliated tissues (Ross et al., 2007, Ivliev et al., 2012). The 
gene was also identified as a FOXJ1 induced genes in the functional screen 
performed in zebrafish (Choksi et al., 2014c).   
In humans C5ORF49 encodes a protein of 147 amino acids without a 
signal peptide. The C5ORF49 protein has a predicted molecular mass of 16.99 
kDa. Multi-alignment analysis with Blastp and Clustal X indicated that 
C5ORF49 shared a high identity with orthologues in other species, with the 
highest identity of  99% to chimpanzee , 75%  identity to mouse, 60% identity 
to chicken  and  45% identity to zebrafish. No orthologue was identified in frogs 
(see Appendix 5.3). All these proteins share a common predicted domain of 
unknown function (DUF4541) spans amino acids 42 to 131 in the human 
protein.  
Analysis of a bioGPS data set (mRNA analysis in different mouse 






Figure 4-8. C5orf49 homolog expression in mouse tissues based on the BioGPS 
database. 






           As shown in Figure 4.8, immunostaining from the Human Protein Atlas, 
shows C5ORF49 to be localised to the mucociliary epithelium of bronchus and 
the fallopian tube. This data shows strong staining in the cytoplasm and 
axoneme of ciliated cells.  
 
 
Figure 4-9. Localization of C5ORF49 in motile ciliated tissues. 
The images were attained by immunohistochemical staining of bronchus and fallopian 
tubes with protein-specific antibodies in the Protein Atlas project (Uhlen et al., 2010). 
The antibodies were against the following proteins: C5ORF49 (a,b),  FOXJ1 (c,d). The 
antibody-based staining is shown in brown and staining of nuclei with DAPI in blue. 
The airways ciliated cells form a continuous layer, while in fallopian tubes they are 




4.3.6 RIKEN cDNA 4833427G06 gene 
RIKEN cDNA 4833427G06 gene is mapped to chromosome 9 in mice and it 
encodes a protein of 168 amino acids. The human orthologue is called 
C11ORF88. This protein is conserved in all vertebrates. This gene was 
identified in ciliary gene screens undertaken in the mouse (Hoh et al., 2012, 
Treutlein et al., 2014a), in human airway epithelial cells (Ross et al., 2007) and 
in zebrafish (Choksi et al., 2014c). Using Cildb, other studies that identified this 
gene were also found, including the study on the tissue expression pattern in 
mouse tissues to identify cilia genes (McClintock et al., 2008) and a proteomic 
study of human ciliated tissues identifying the protein in the  epithelia of the 
oviduct and lung (Ivliev et al., 2012). 
              In humans, C11ORF88 encodes a protein of 196 amino acids without 
a signal peptide. It has a predicted molecular mass of 19.34 kDa. Multi-
alignment analysis with Blastp and Clustal X indicates that it shares a high 
identity with orthologues in other species, with the highest identity of 98% to 
chimpanzee, 61%  identity to mouse, 35% identity to frog and  35% identity to 
zebrafish (See Appendix 5.4). No putative conserved domains have been 
identified in the protein.  
            Analysis of  expression in a BioGPS microarray data set  (expression in 
different mouse tissues, Dataset: GeneAtlas GNF1M, gcrma), shows it to be 
abundantly expressed in motile ciliated tissues such as nasal septum, MOE, 
trachea, lung with the highest expression in testis (Figure 4.9). It was also 






Figure 4-10. C11orf88 expression on mouse tissues based on the BioGPS 
database. 






No data are found in the Human Protein Atlas for protein localisation of 
C11ORF88.  
4.3.7 Leucine Rich Repeat Containing 4B (LRRC4B) 
Lrrc4b gene is mapped on to Chromosome 7, in mice and encodes a protein of 
709 amino acids. It is conserved in all vertebrates. Proteins like LRRC4B, that 
contain the Leucine-rich repeats (Lrrc), are an evolutionarily conserved class of 
proteins found across all organisms.  
           In humans, LRRC4B encodes a protein of 715 amino acids without a 
signal peptide. It has a predicted molecular mass of 76.71 kDa. Multi-alignment 
analysis with Blastp and Clustal X indicated that LRRC4B shared a high identity 
with orthologues in other species, with the highest identity of 100% to 
chimpanzee , 96%  identity to mouse, 76%  identity to chicken  and  65% identity 
to zebrafish (See Appendix 5.5). The importance of leucine-rich repeats 
containing proteins in the formation is cilia have been studied since late 90s.  
Other than the leucine-rich repeat superfamily domain in the N-terminus of the 
protein, it also contains an immunoglobulin-like domain that spans amino acids 
360 to 460. 
           Analysis of mRNA expression in a BioGPS microarray data 
set (expression in different mouse tissues, Dataset: GeneAtlas GNF1M, 
gcrma), shows it to be  expressed in brain and spinal cord. (Figure 4.10). There 
is no specific enrichment of expression in tissue associated with multiciliated 






Figure 4-11. Lrrc4b expression in mouse tissues based on the BioGPS database. 






           Immunostaining data from the Human Protein Atlas (Figure 4.11) 
identifies weak LRRC4B staining in the mucociliary epithelium of the bronchus 




Figure 4-12. Localization of LRRC4B in motile ciliated tissues. 
The images were attained by immunohistochemical staining of bronchus and fallopian 
tubes with protein-specific antibodies in the Protein Atlas project (Uhlen et al., 2010). 
The antibodies were against the following proteins: LRRC4B (a,b),  FOXJ1 (c,d). The 
antibody-based staining is shown in brown and staining of nuclei with DAPI in blue. 
The airways ciliated cells form a continuous layer, while in fallopian tubes they are 







4.3.8 RIKEN 1700028P14 gene 
The RIKEN 1700028P14 gene is mapped on to Chromosome 19, in the mouse 
and it encodes a protein of 228 amino acids. The human orthologue is called 
C9ORF135. An orthologue has not been identified in zebrafish however 
orthologues are found in other fishes e.g. spotted gar. As shown in Table 4.1, 
this gene was identified in gene screens undertaken in mouse airway epithelial 
cells, tissues and spermatozoa (Hoh et al., 2012, Baker et al., 2008b, 
McClintock et al., 2008, Treutlein et al., 2014a). It was also identified in the 
screen undertaken in human airway epithelial cells and in PCD patient samples 
(Ross et al., 2007, Geremek et al., 2011, Geremek et al., 2014). 
           In humans, the 825 bp ORF of C9ORF135 encodes a protein of 229 
amino acids without a signal peptide. The C9ORF135 protein has a predicted 
molecular mass of 26.45 kDa. Multi-alignment analysis with Blastp and Clustal 
X indicated that C9ORF135 shares identity with orthologues in other species, 
with the highest identity of 97% to chimpanzee , 64%  identity to mouse, 43%  
identity to frog  and  42% identity to spotted gar (See Appendix 5.6). The protein 
contains a predicted domain of unknown function (DUF4572) which spans 










           By analysis of BioGPS a microarray data set (expression in different 
mouse tissues, Dataset: GeneAtlas GNF1M, gcrma), it was found to have high 






Figure 4-13. C9orf135 homolog expression in mouse tissues based on the 
BioGPS database. 







           Immunostaining data from the Human Protein Atlas shows, C9ORF135 
is weakly expressed in the mucociliary epithelium of bronchus and fallopian 
tube (Figure 4.13). The staining is very weak and appears to have 
cytoplasmic/membranous localisation. It is not clear if there is specific staining 




Figure 4-14.  Localization of C9ORF135 in motile ciliated tissues. 
The images were attained by immunohistochemical staining of bronchus and fallopian 
tubes with protein-specific antibodies in the Protein Atlas project (Uhlen et al., 2010). 
The antibodies were against the following proteins: C9ORF135 (a,b),  FOXJ1 (c,d). 
The antibody-based staining is shown in brown and staining of nuclei with DAPI in 
blue. The airways ciliated cells form a continuous layer, while in fallopian tubes they 





4.3.9 Maats1 (MYCBP associated and testis expressed 1) 
Maats1 is mapped on to Chromosome 16, in the mouse and the gene encodes 
a protein made up of 783 amino acids. It is also known as AAT1 (AMY-1-
associating protein expressed in testis 1) and CFAP91 (Cilia- and flagella-
associated protein 91). The human orthologue is also known as MAATS1 
(formerly known as C3ORF15). The Chlamydomonas orthologue was shown to 
be a component of a spoke-associated complex that mediates regulatory 
signals between the radial spokes and dynein arms to regulate flagellar dynein 
activity (Dymek and Smith, 2007). It was also shown to form a complex with 
AMY-1, A-kinase Anchor Protein 84, in the mitochondria of somatic cells and 
sperm (Yukitake et al., 2002). Both MAATS1 and AMY-1 were also found to be 
expressed specifically in the testis during the process of spermatogenesis and 
to be localized in the spermatid and mature sperm (Yukitake et al., 2002). As 
shown in table 4.1, this gene was identified in multiple ciliary genomic screens 
undertaken in mouse tissues and airway epithelial cells (McClintock et al., 
2008, Hoh et al., 2012, Treutlein et al., 2014a), as well as in several screens 
performed on human airway epithelial cells and ciliated tissues (Ostrowski et 
al., 2002b, Ross et al., 2007, Ivliev et al., 2012). Since, it was identified in the 
axonemal proteome screen done human airway multiciliated cells by 
Gostkowski et al (2002), this protein could be a component of axoneme. The 
gene is also a target of FOXJ1 in zebrafish (Choksi et al., 2014a). 
           In humans, MAATS1 encodes a protein of 767 amino acids without a 
signal peptide. The MAATS1 protein has a predicted molecular mass of 89.97 




shares a high identity with orthologues in other species, with the highest identity 
of 99% to chimpanzee, 79%  identity to mouse, 61%  identity to frog  and  56% 
identity to zebrafish (See Appendix 5.7). The protein contains two domains, a 
solute carrier (proton/amino acid symporter) spanning amino acids 171 to 323 
and a SMC_N super family domain spanning amino acids 394 to 608 in human 
protein. 
           Analysis of a BioGPS microarray data set  (expression in different 
mouse tissues, Dataset: GeneAtlas GNF1M, gcrma), shows it to be abundantly 
expressed in testis and relative high expression in other  tissues associated 








Figure 4-15. Maats1 expression in mouse tissues based on the BioGPS 
database. 






No data for protein localization was found in Human Protein Atlas.  
4.3.10 Erich2 (Glutamate rich protein-2) 
 
Erich2 is mapped on to Chromosome 2, in the mouse and the gene encodes a 
protein of 456 amino acids. Erich2 was one of the differentially expressed genes 
found in in ciliating GFP+ cells by Hoh et al at (2012) during the ciliary 
differentiation of mTECs at the ALI (Hoh et al., 2012). 
           In humans, ERICH2 encodes a protein of 156 amino acids without a 
signal peptide and with a predicted molecular mass of 17.67 kDa. Multi-
alignment analysis with Blastp and Clustal X indicates that ERICH2 shares a 
high identity with orthologues in other species, with the highest identity of 99% 
to chimpanzee, 68% identity to mouse, 49% identity to frog and 75% identity to 
zebrafish See Appendix 5.8). No conserved domains were identified in the 
sequence. 
           Analysis of a BioGPS microarray data set (expression in different mouse 
tissues, Dataset: GeneAtlas GNF1M, gcrma), shows it to be abundantly 
expressed in testis (Figure 4.15). 
 





Figure 4-16. Erich2 expression in mouse tissues based on the BioGPS 
database. 






No data for protein localization was found in Human Protein Atlas.  
4.3.11 Spata24 (spermatogenesis associated 24) 
Spata24 is mapped on to Chromosome 18 in the mouse and the gene encodes 
a protein of 205 amino acids. It is also known as TIPT and TIPT2. Spata24 has 
been shown to be important for spermatogenesis. SPATA24 associate with 
TATA-binding protein (TBP)-related protein 2 (TRF2) and HP1, thus 
establishing an interesting link between transcription and chromatin modelling 
(Brancorsini et al., 2008). Pitulescu et al (2009) showed SPATA24, as a strong 
binding partner of GEMININ and suggested that interactions with basal 
transcription factors allow it to regulate transcription (Pitulescu et al., 2009). As 
shown in the Table 1, this gene came up in ciliary gene screens undertaken in 
mouse airway epithelial cells (Hoh et al., 2012, Treutlein et al., 2014a). 
           In humans, SPATA24 encode a protein of 205 amino acids without a 
signal peptide and has a predicted molecular mass of 23.59 kDa. Multi-
alignment analysis with Blastp and Clustal X indicates that SPATA24 shares a 
very high identity with orthologues in other species, with the highest identity of 
100% to chimpanzee, 100% to pig and 91% identity to mouse. No orthologues 
are found in frog and zebrafish (See Appendix 5.8). The protein contains an 









           Analysis of a BioGPS microarray data set (expression in different mouse 
tissues, Dataset: GeneAtlas GNF1M, gcrma), shows the gene to be abundantly 







Figure 4-17. Spata24 expression in mouse tissues based on the BioGPS 
database. 
 (Dataset: GeneAtlas GNF1M, gcrma; Probeset: gnf1m13353_a_at)   
http://biogps.org/#goto=genereport&id=71242 
  




4.3.12 RIKEN cDNA 1110017D15 gene 
 
RIKEN cDNA 1110017D15 gene is mapped on to Chromosome 4, in mouse 
and generates two transcripts, resulting in open reading frames with different 
carboxyl termini, but which show no homology to known proteins. The human 
orthologue is C9ORF24 and it is also known as CBE1. There are no known 
orthologues in zebrafish. It was first identified from the random sequencing of 
a cDNA library from human lung biopsies and expression was shown to be 
induced during the in vitro differentiation of bronchial epithelial cells. 
Immunochemistry showed expression of CBE1 in ciliated cells (Yoshisue et al., 
2004). In addition, Haitichi et al also showed expression in airway epithelial 
cells in relation to FOXJ1 (Haitichi et al., 2009).  As shown in Table 4.1, this 
gene was identified in ciliary gene screens undertaken  in mouse cells (Hoh et 
al., 2012, Treutlein et al., 2014a) and was also identified in studies on human 
mTEC cells (Ross et al., 2007) and in PCD patient samples (Geremek et al., 
2011). 
           In humans, CBE1 encodes a protein of 262 amino acids, without a signal 
peptide that has a predicted molecular mass of 30.17 kDa. Multi-alignment 
analysis with Blastp and Clustal X indicates that CBE1 shares a high identity 
with orthologues in other species, with the highest identity of 99% to 
chimpanzee, 81% to pig and 76% identity to mouse. No orthologues are found 
in frog and zebrafish (See Appendix 5.9). The protein contains a conserved 
functional domain (SMRP1- Spermatid-specific manchette-related protein 1) 







          Analysis of a BioGPS microarray data set  (expression in different mouse 
tissues, Dataset: GeneAtlas GNF1M, gcrma), shows that Cbe1 was found to 
be abundantly expressed in tissues associated with motile such as nasal 






Figure 4-18. Cbe1 expression in mouse tissues based on the BioGPS database. 







          Human Protein Atlas images, suggest that CBE1 was not detected in 
airway epithelial cells but low intensity staining was detected in the fallopian 
tube (Figure 4.18) with a cytoplasmic/membranous location.  It does not appear 




Figure 4-19. Localisation of CBE1 in motile ciliated tissues. 
The images were attained by immunohistochemical staining of bronchus and fallopian 
tubes with protein-specific antibodies in the Protein Atlas project (Uhlen et al., 2010). 
The antibodies were against the following proteins: CBE1 (a,b),  FOXJ1 (c,d). The 
antibody-based staining is shown in brown and staining of nuclei with DAPI in blue. 
The airways ciliated cells form a continuous layer, while in fallopian tubes they are 





4.3.13 Expression analysis of the candidate genes during ALI 
differentiation of mTEC by RNA sequencing 
To characterise the functional role of TP73 in multiciliogenesis, Nemajerova et 
al compared the transcriptomes of WT and Tp73-/- mTECs at day 0, 4, 7 and 
14 of ALI differentiation (Nemajerova et al., 2016a). They used RNA 
sequencing to generate lists of all genes expressed during distinct stages of 
cell differentiation at ALI.  I used the raw data showing the RNA sequencing 
(seq) read counts to plot the graphs in Figure 4.19 that show how the 
transcriptional expression of these genes change during the differentiation of 
cells at ALI. This helps to further validate my endpoint PCR results (Figure 4.1) 
that were generated in 2015. All the candidate genes, with the exception of 
Lrrc4b were upregulated during the ALI differentiation of mTEC (Figure 4.30). 
In the Tp73-/- mTEC, many of these genes were shown to be downregulated. 
Pierce1, C1orf194 Homolog, C9orf135 Homolog, Maats1, Erich2 and Cbe1 
were shown to have lower expression during the ALI differentiation of Tp73-/- 
mTEC. It is also important to note that the scales of the graphs are not same 
since the levels of expression were very different from gene to gene. It was 
better to use different scales for the graphs to show the change in expression 






Figure 4-20. Expression of the candidate genes in ALI cultured WT mTEC vs 
Tp73 KO mTEC. 
Nemajerova et al (2016) acquired RNA seq reads from 3 independent cultures for WT 







4.4.14 Expression of candidate genes in developing lung by single cell 
gene expression. 
 
Using data from ‘LungGENS’, an online tool for mapping single-cell gene 
expression in the developing lung the expression of the candidate genes in 
diverse types of airway epithelial cells was also investigated. The LungGENS 
website is based on single-cell RNA sequencing data from normal fetal mouse 
lung (Du et al., 2015, Du et al., 2017). 
           The data for average RNA expression for each gene in 9 distinct cell 
types of developing lungs of embryonic day 18.5 mice, was used to plot the 
graphs in Figure 4.20. The cell types that were included in the study were Type 
I alveolar cells, Type II alveolar cells, Ciliated cells, Club cells, Endothelial cells, 
Myeloid/immune cells, Lipofibroblast, Matrix fibroblast and Myofibroblast. As 
shown in the graphs, 9 out of 10 of the candidate genes were significantly 
expressed in expressed in ciliated cells. Lrcc4b was the outlier and showed 
expression in Ciliated cells, Myeloid/immune cells, Lipofibroblast, Matrix 









Figure 4-21. Expression of the candidate genes in 9 distinct cell types of E18.5 
fetal mouse lung. 
The graphs were plotted from the average mean expression data acquired from the 
LungGENS.   The data were collected from mouse fetal airway cells sequenced from 
E18.5 mouse lung, processed using Fluidigm C1 microfluidics technology. The count 
of samples for each cell types are as follows: Epi-AT1-7, Epi-AT1-9, Ciliated cells-2 , 
Club cells- 2, Endothelial cells- 18, Myeloid/ Immune cells-8, Lipofibroblast-8,  Matrix 







The complexity of the pathways involved in ciliogenesis has prompted many 
research groups to perform high throughput genomic and proteomic screens to 
identify putative ciliary genes and components. The results of these studies 
have identified lists of thousands of genes. A few of these have been 
functionally characterised and their relevance to human ciliopathies have been 
resolved. However, little can be said about the rest of the genes revealed by 
these studies. The causative genes for 30% of the PCD cases are still not 
known and analysis of novel ciliary genes is still required to fully elucidate the 
pathways governing ciliogenesis 
           To identify novel genes involved in this process, I selected 10 
uncharacterised genes that came up on the high throughput screen carried out 
by Hoh et al to define the transcriptome of multiciliated cells in mouse airways. 
The difficulties with using confident interpretation of data mined from high 
throughput studies are that the sensitivity of the high-throughput screens can 
be variable and it can include false positives or omit true positives.  
Once I had selected the 10 candidate genes, I used Cildb to find more 
genomic and proteomic screens that had identified them. This analysis allows 
estimation of the conservation level of the signature genes. Most of my 
candidate genes had come up on 5 or more studies undertaken in distinct 
species; human, mouse and zebrafish. It seems likely that the more ciliary 
screens that identified a specific gene, the more relevant the gene could be in 




Vladar and Brody described distinct stages of multiciliogenesis at ALI 
culture of primary mouse tracheal epithelial cells (Vladar and Brody, 2013). In 
chapter 3, I described how I used endpoint RT-PCR to analyse the mRNA levels 
of genes encoding some of the main transcription factors and protein 
components of cilia structure. The transcriptional expression of main 
transcription regulators such as Mcidas and Foxj1 are expressed early (from 
day 0) during mucociliary differentiation of mTEC at ALI and undergo 
upregulation. The genes encoding ciliary components such as Tekt1 are 
expressed later (from day 2). Therefore, we studied the pattern of 
transcriptional expression of the candidate genes during mucociliary 
differentiation at ALI.  All the genes appeared to upregulate during the 
differentiation of mTECs at the ALI. Some genes were observed to be 
expressed from day 0 and while others were only seen from day 2 or later. 
These PCRs were carried out in January 2015. 
           Consistent with our end-point PCR data, many of these candidate genes 
were shown to be upregulated in the data sets of RNA seq during cell 
differentiation at ALI found by RNA sequencing by Nemajerova et al (2016). 
This data set was generated to find the downstream effects of TP73 in 
multiciliogenesis in mTEC cells, by comparing the transcriptome of WT and 
Tp73 knockout (KO) mTECs at day 0, 4, 7 and 14 of ALI differentiation. In these 
data, all the genes, except Lrrc4b, were shown to be upregulated from day 0 to 
day 14. This increase in expression during the mucociliary differentiation at ALI 
mirrors what has already observed for established ciliary genes such as Foxj1, 
Mcidas and Tekt1. Again, this shows that these genes could be playing a role 




All the genes except Lrrc4b, were also shown to be downregulated in tp73 KO 
mTECs. TP73 is shown as a central transcriptional regulator of 
multiciliogenesis that works upstream of many cilia genes (Nemajerova et al., 
2016a, Marshall et al., 2016) including FOXJ1, the master regulator of motile 
ciliogenesis (Yu et al., 2008, Stubbs et al., 2008). So, it can be expected that 
cilia genes will be downregulated when TP73 is not expressed. Unfortunately, 
they only undertook 2 replicates of the experiment, so I was not able to perform 
statistical analysis to validate the significance of the result.  
By end-point RT-PCR, the expression of the potential candidate genes was 
examined on a panel of whole mouse tissues; kidney, lungs, liver, embryo, 
thymus, spleen, testicle, heart, brain, ovary. Motile cilia can be found in lung, 
embryo, testicle, brain and ovary.  Foxj1 and Tekt1 was shown to have specific 
enriched expression in motile ciliated tissues. Similar pattern of expression was 
observed for Pierce1, RIKEN cDNA 1700013F07 and RIKEN cDNA 
1700001L19, RIKEN cDNA 1700028P14 and Cbe1. The dataset in bioGPS that 
looked at expression of these genes in mouse tissues shows enriched 
expression in testis for most of these genes. In the testis, the sperm harbours 
flagellum and many of the mechanisms in ciliogenesis are conserved in sperm 
flagella formation (Fisch and Dupuis-Williams, 2012).  
Human Protein Atlas described localization patterns for some of my 
ciliary candidates. For the analysis, I used images of staining done in 
multiciliated tissues such as bronchus and fallopian tube. The positive control 
was FOXJ1 as that has a strong nuclear staining in cells with motile cilia and 
lack staining in non-ciliated cells. Staining restricted to ciliated cells was 




cDNA 1700013F07 and RIKEN cDNA 1700001L19. It should be remembered 
that not all proteins are well represented in Protein atlas. Although the presence 
of a particular protein associated with ciliated cells is a useful source to boost 
the confidence in the gene’s role in ciliogenesis, the lack of staining may mean 
only that the antibody is not very reactive.  
Finally, I studied the expression of the candidate genes in distinct cell 
types of E18.8 mouse lung using the data from ‘LungGens’. As expected for a 
ciliary gene, 9 out of 10 candidate genes were specifically expressed in ciliated 
cells. Lrrc4b had comparatively low expression in the cell types studied in 
mouse fetal lung. Interestingly, Spata24 showed low expression in club cells 
and high expression in ciliated cells. Previous studies performed on tissue 
cultures of human respiratory epithelium and lung segments have established 
unequivocally that club cells are one of the primary sources of stem cells in the 
airways. Researchers have shown that club cells can differentiate into ciliated 
cells (Rawlins et al., 2009, Reynolds and Malkinson, 2010, Rokicki et al., 2016). 
The gene ontology (GO) term for biological function for SPATA24 is shown as 
transcriptional regulation. It was also shown as a strong binding partner of 
GEMININ, a coiled coil domain protein belonging to same family of MCIDAS. 
The expression pattern for Mcidas in LungGens is very similar to that of 
Spata24.(https://research.cchmc.org/pbge/lunggens/genequery_E18_p3.html?geneid=mcid
as). So, it can be assumed that Spata24 may also have transcriptional 
regulatory role in ciliogenesis. This is further supported by the pattern of 
expression during the mucociliary differentiation of mNEC at ALI. The peak 





           After comparing all these results, I selected one gene for further 
functional characterisation. This gene had to be novel and should have fulfilled 
most of the criteria, I thought would give it more significance to be a ciliary gene.  
The criteria were as follows 
 The gene should be listed in 5 or more ciliary genomic and proteomic studies 
and at least in 3 species, including zebrafish. 
 The gene should have differential expression like known cilia genes e.g. Foxj1, 
Tekt1, during the mucociliary differentiation of airway epithelial cells at ALI.  
 The gene should have enriched expression in motile ciliated tissues as 
evidenced by the RT-PCR and bioGPS. 
 The gene should have enriched expression in ciliated tissues as evident by 
human protein atlas. 
 The gene should be specifically expressed in ciliated cells as evident by 
LungGens data.  
           I selected PIERCE1 as my candidate gene since it fulfilled all criteria.  I 
decided to study the role of PIERCE1 using an in vitro model; mouse primary 
airway epithelial cell cultured at ALI and an in vivo vertebrate model; zebrafish. 














In the previous chapter, I presented results that lead me to select PIERCE1 for 
further characterisation. This choice was based on data from several ciliary 
genomic and proteomic screens, transcriptional expression during 
differentiation of airway epithelial cells at the ALI, expression in tissues 
containing motile cilia and enriched expression in ciliated cells.  
           Since pierce1 was shown to be induced by Foxj1 in zebrafish by Choksi 
et al (2014) (Choksi et al., 2014c), I hypothesised that Pierce1 has a conserved 
functional role in zebrafish in motile ciliogenesis downstream of Foxj1. 
           Many human ciliopathy causative mutations were identified in a large-
scale mutagenesis screen undertaken in zebrafish (Howe et al., 2013b). Many 
groups have also utilised zebrafish vertebrate organism model to functionally 
characterise roles of novel genes in motile ciliogenesis (Knowles et al., 2013c, 
Narasimhan et al., 2015, Song et al., 2016b). I decided to follow the same 
strategy to functionally characterise the role of Pierce1 in motile ciliogenesis. 
5.1.1 Proposed method for investigating the functional role of Pierce1 in 
zebrafish 
In zebrafish, the most economic and rapid method for performing reverse 
genetic analysis is by utilising modified anti-sense oligonucleotides known as 
morpholinos (MOs), which provide transient gene knockdown by binding to 




Laragy et al., 2012). Most commonly, researchers use two types of MOs. The 
first is a translation blocking MO that targets sequence in the post-spliced 
mRNA in the region from the 5' cap to about 25 bases 3' to the AUG 
translational start site and thus blocks translation of the transcript.  Secondly, 
there is splice blocking MO that targets an exon-intron boundary (splice donor) 
or intron-exon boundary (splice acceptor) that results in disruption of the ORF 
and translation of protein (GeneTools, 2018). I decided to undertake initial 
characterisation of Pierce1 by designing two independent MO; one a translation 
blocking MO and one a splice blocking MO.  
In the past few years, CRISPR/Cas9 has become a favourite gene-
editing tool to make stable zebrafish genetic mutants (Hwang et al., 2013a). I 
also decided to make a genetic mutant for pierce1 in zebrafish as I considered 
it would be a good model to study functional role of Pierce1 in adult fish. It would 
also function as a model to study molecular pathways and protein interactions 
of Pierce1. Furthermore, I also decided to utilise zebrafish expression plasmids 
to study the subcellular localisation of Pierce1 in vivo.  
5.2 Results 
5.2.1 pierce1 is upregulated by Foxj1 
Microarray indicated that pierce1 was upregulated by Foxj1 (5.22 fold up) in 
zebrafish (Choksi et al., 2014c). I initially further validated this result by qRT-
PCR and found that pierce1 was greater than 7-fold upregulated by Foxj1 as 
shown in Figure 5.1. For this experiment, I made the cDNA from embryos from 
the zebrafish transgenic line (hsp70: foxj1) that temporally overexpresses Foxj1 




Foxj1 targets by Choksi et al (2014).  cDNA from hsp70: foxj1 embryos, that 
was not subjected to heat-shock and hence does not overexpress Foxj1, was 
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Figure 5-1. pierce1 is upregulated by Foxj1. 
qPCR results indicate that Foxj1 upregulates pierce1 by >7 folds compared to wild-
type. The embryos that were not subjected to heat shock were the negative control. 
(n=3 independent batches of experiments). The error bars represent standard error of 
the mean (SEM). *-p<0.05 using 1way ANOVA. 
 
5.2.2 Transient knockdown of pierce1 in zebrafish by morpholinos 
 
I injected the 2 independent MOs designed against pierce1, into the animal pole 
of WT zebrafish embryos at the one cell stage. One was a start MO that should 
block translation of the protein by binding to the translation start site of the 
pierce1 transcript.  Secondly, a splice blocking MO was designed that targeted 
the splice junction of exon 1-intron 1 of the pierce1 transcript. Dose titration was 
carried out to determine the optimal dose and I found that the start MO works 
best (i.e. less than 20% mortality at maximum dose) at a concentration of 0.25 
mM and an injection volume of 1 nl. The splice MO works best at a 




To validate the splice MO, primers were designed to amplify a region from exon 
1 to intron 1 of pierce1 as shown in Figure 5.2.2 (a). If the splice MO was able 
to block the splicing, a product would be amplified.  I carried out a RT-PCR on 
the cDNA made form DNase1 treated RNA from morphant embryos at 24 hours 
post fertilisation (hpf), while uninjected WT embryos served as the control. The 
products of the PCR were resolved on a 1.5% agarose gel as shown in Figure 
5.2 (b). As expected, a 766 bp band was detected for pierce1 splice morphants 
and not detected in WT control. This band was gel extracted and cloned into 
pCR II TOPO. After miniprep, the plasmids were sent for sequencing.  The 
sequencing results revealed that in splice morphants, splicing event was 





Figure 5-2. pierce1 splice morpholino blocks splicing of pierce1 transcript. 
 (A) Primers were designed to amplify a product that span from exon 1 to intron 1 of 
pierce1 transcript.  (B) As expected, a band was only detected for pierce1 splice 
morphant.  β-actin was used as the loading control.  
 
5.2.2.1 pierce1 morphants display ciliopathy phenotypes 
 
The embryos were assayed for various phenotypes arising due to loss of 
Pierce1 function. Data for the phenotypes was obtained from analysis of 
morphants as well as controls from three independent trials. In each trial, 50- 
70 embryos for each variable were used.  
5.2.2.2 pierce1 morphant embryos display phenotypes associated with 
motile ciliary defects 
The embryos were examined at 22 hpf, 48 hpf and 72 hpf to look for phenotypes 
associated with ciliary defects such as otolith defects, curved body axis, 
hydrocephalus and pronephric cysts. As shown in Figure 5.3, both morphants 
displayed curved body axis and heart oedema. Splice morphants also 
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Figure 5-3. pierce1 morphants display phenotypes associated with ciliary 
structural defects. 
A) The figure shows embryos at 48 hpf. Both pierce1 morphants showed significant 
curved body axis and heart oedema. Splice morphants also displayed hydrocephalus. 
The WT embryos did not show these phenotypes. B) The phenotypical assay was 
done in 3 independent batches. In each trial, 50- 70 embryos for each variable was 
used. Error bars indicate standard error of mean (SEM) (n=3 independent batches of 
experiments). ***p<0.001 using 2way ANOVA. 
5.2.2.3 pierce1 morphants have laterality defects  
Since the pierce1 morphants showed phenotypes corresponding to ciliary 
phenotypes, I hypothesised the morphants would also have laterality defects 





morphant embryos fixed at 48 hpf were stained with an antibody against myosin 
heavy chain (A4.1025 antibody) to visualize the looping of the heart. In the WT 
zebrafish embryos, the heart is looped to the left. The immunostaining revealed 
that in both splice and start morphants, over 60% had bilateral looping, 15- 20% 
had right side looping and 20-25% with left sided looping as seen in WT. 
Therefore, both splice morphants and start morphants of pierce1 had significant 
alteration in L-R symmetry. 
 
Figure 5-4. pierce1 morphants display laterality defects. 
A) Both pierce1 morphants showed laterality defects as shown by the altered left-right 
sidedness in the heart looping. In both morphants (36 hpf), majority showed bilateral 
heart looping while in WT it was left sided heart looping. B) In each trial, 50- 70 embryos 
for each variable was used. Error bars indicate standard error of mean (SEM) (n=2 





5.2.2.4 pierce1 morphants have cilia motility defects in KV 
 
Since the pierce1 morphants showed laterality defects as shown by altered left-
right sidedness of heart looping in Figure 5.4, I hypothesised that cilia motility 
would be abnormal in KV. Live imaging for studying cilia beating in KV was 
carried out on the morphants and WT embryos at the 10-somite stage (see 
attached video files). It revealed that in both morphants, the ciliary motility in 
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Figure 5-5. pierce1 morphants have cilia motility defects inKV. 
Live imaging was carried out on both start and splice morphants to examine the cilia 
motility. This showed severe KV cilia motility defects in 80%-90% of morphants 
embryos. In WT embryos, we could observe normal KV cilia beating in counter 
clockwise manner in 100% embryos. This data is representative of 2 biological 
replicates. 5-6 embryos were screened in each replicate for different variables. Error 
bars indicate standard error of mean (SEM) (n=2 independent batches of 





5.2.2.5 Analysis of cilia number and length in KV in pierce1 morphants 
 
After studying the morphology of pierce1 morphants, I considered that cilia 
length and number of cilia might be altered in the morphants. To address this 
question, I visualized cilia in the KV of both pierce1 morphants at 10 somites 
by immunolabelling cilia with an antibody against Acetylated Tubulin. As shown 
in Figure 5.6, no gross difference was observed between WT embryos and 
morphant embryos.  The staining was performed in 2 batches of MO injected 




Figure 5-6. pierce1 morphants have normal cilia length and number in KV. 
At 10 somites, Cilia were immunolabelled using an antibody against acetylated α-
tubulin in wild-type and morphant embryos. Cilia length and number were observed by 






5.2.3 Tagged expression vector systems shows cytoplasmic localisation 
of Pierce1  
 
To understand the function of Pierce1, I first wanted to determine where the 
protein is localised in ciliated cells. The best approach to solve this would be by 
using an antibody directed against Pierce1 that could be used to determine the 
subcellular localization by immunohistochemistry. During my study, no 
commercial antibody was available against Pierce1 that would work in 
zebrafish. However, there was an antibody generated by SIGMA against 
human PIERCE1, in which, the epitope shared some conserved amino acid 
residues with the zebrafish protein. However, no signal was detected on 
immunofluorescence (data not shown). Therefore, I decided to clone pierce1 
into two tagged zebrafish expression vectors that would allow me to express 
Pierce1 with a C-terminus GFP tag and an N-terminus Myc (6x) tag. After in 
vitro transcription, I injected mRNA encoding pierce1-gfp and 6xmyc-pierce1 
into 1-cell stage embryos. After double labelling the embryos with anti-
Acetylated Tubulin and either anti-GFP or anti-Myc, both tagged versions of 
Pierce1 were shown to be localized to the cytoplasm as shown in Figure 5.7. 
The negative control was uninjected embryos that were stained with the same 






Figure 5-7. Pierce1 has a cytoplasmic sub-cellular localisation in zebrafish 
embryos. 
pierce1 with a C-terminus GFP tag and an N-terminus Myc (6x) tag was injected into 
1-cell stage embryos. After double labelling the 10 somites embryos with anti-
Acetylated tubulin and either anti-GFP or anti-Myc, both tagged versions of Pierce1 
was shown to be localized to the cytoplasm in KV by confocal imaging. The negative 
control was uninjected embryos that were stained with the same antibodies at the 
same time as the injected embryos as shown in the right hand panels.  
 
          I attempted to rescue the pierce1 morphants by injecting the 6 x Myc-






5.2.4 Creating a pierce1 zebrafish mutant line using CRISPR/Cas9 
Many research groups have utilised antisense MOs to perform targeted 
transient knockdowns in zebrafish embryos to assess the developmental 
functions of genes of interest. However, many groups have now argued that 
this technique is flawed by potential off target effects (Kok et al., 2015, Place 
and Smith, 2017, Eve et al., 2017). On the other hand, some groups still 
support the value of the use of morpholinos with proper controls (Stainier et 
al., 2015, Blum et al., 2015). Despite the controversy, the zebrafish community 
are moving towards making stable genetic mutants as a more reliable approach 
to assess the functional roles of genes of interest. 
           The CRISPR/Cas9 system was utilised to generate a stable mutant line 
deficient for Pierce1. This technique was recently introduced as a new type of 
gene editing tool, even for organisms with a genome difficult to edit like the one 
of zebrafish (Hwang et al., 2013b, Seruggia and Montoliu, 2014). The 
CRISPR/Cas9 system is present in prokaryotes and archaea as part of their 
adaptive immune defence mechanism. Bacteria store fragments of DNA from 
invading viruses, which are then spliced into the bacterial genome region 
containing CRIPSRs (Clustered Regularly Interspaced Short Palindromic 
Repeats). This region is then transcribed to make a guide-RNA that is used to 
guide Cas9 nucleases to viral DNA and cleave it thus            prevent virus 
replication (D’Agostino et al., 2016). 
           The type II CRIPSR/Cas9 system from Streptococcus pyogenes can be 
utilised in vitro by synthesising a guide RNA (gRNA) from the target site of the 




zebrafish embryos. The 20 bp long target site must be immediately upstream a 
Protospacer Adjacent Motif (PAM) 5′-NGG/NCC (Ran et al., 2013, D’Agostino 
et al., 2016).  
5.2.4.1 Validating the guide RNAs (gRNAs) that target pierce1 
In order to find potential target sites from pierce1 for synthesising gRNA, I 
utilised a webtool called ‘CHOPCHOP’ that identifies potential target sites 
without off targets and list them according to their quality (Labun et al., 2016). 
           As shown in Figure 5.7, CHOPCHOP results showed potential target 
sites in pierce1 for gRNAs. The green coloured target sites were predicted to 
be the best quality to achieve expected mutations. Since, pierce1 has a small 
coding region composed of 3 exons, only a few sites were identified. I decided 
to use two approaches; 1) to use a single gRNA that would result in indels 
(insertion/deletion) in the target site, 2) to use double gRNAs to make a deletion 
of the region spanning between the two target sites.  
 
Figure 5-8. pierce1 gRNA target sites identified by CHOPCHOP. 
The results are displayed across the genomic region of pierce1. The target colour 
shows the quality of each sgRNA (green [best] to red [worst]). 
http://chopchop.cbu.uib.no/search.php 
 
           For the sgRNA approach, I chose three target sites found on exon 2 and 




in vitro with PCR amplified coding region of pierce1 from WT zebrafish cDNA. 
As shown in Figure 5.9, only 1 of the 3 gRNAs was able to cleave the PCR 
product. 
 
Figure 5-9. Validation of sgRNAs in vitro. 
sgRNAs that target 3 different target sites of exon 2 on pierce1 gene were added along 
with Cas9 in to PCR amplified pierce1 transcript. As controls, pierce1 transcript was 
incubated with sgRNAs without Cas9 and Cas9 without sgRNAs. Only with sgRNA1, 
Cas9 was shown to cleave the PCR product.  
 
Once validated in vitro, I injected sgRNA1 with Cas9 protein into one cell stage 
zebrafish embryos. At 24 hpf, 8 injected embryos were pooled together for 
gDNA extraction. The region spanning the target site was amplified as shown 
in Figure 5.10.  
There was no difference in band size observed between WT and 
sgRNA1 injected embryos. This was expected because small indels would not 
be visible in the gel. So I gel extracted these bands and cloned into pCR II 





embryos, 1 out of the 5 colonies picked for sequencing had a 12 bp deletion in 
the target site as shown in Figure 5.10. This experiment validated the efficiency 
of this sgRNA1 in vivo.  Once validated, I continued injecting embryos with 
sgRNA1 + Cas9 RNA and sent them to the nursery to grow into adults. 
 
Figure 5-10. Validation of sgRNAs in vivo. 
sgRNA1 was injected into one cell stage WT zebrafish along with Cas9.  8 injected 
embryos were pooled to extract gDNA. The gDNA was used to amplify the region 
spanning the target site using the primers indicated in the Figure.  The products were 
gel extracted and cloned in to pCR II TOPO. Out of the 6 clones sequenced, one had 
a 12 bp deletion at the target site validating the efficiency of the sgRNA in vivo. 
 
           For my second approach with dgRNAs for deleting a large region, I 
chose the green coloured target site in the 5’UTR of pierce1 as shown in Figure 
5.8.  I made a gRNA against this target site. I proposed that the combination of 
the newly made gRNA with the previously used gRNA would result in a deletion 





           The efficiency of the newly made gRNA was also tested in vitro with 
pierce1 cDNA with 5’ and 3’ UTRs cloned into pCR II TOPO. The gRNA was 
tested alone and in combination with previously used gRNA. It was compared 
with the plasmid with just Cas9 (negative control). As shown in Figure 5.11a, 
the gRNAs were shown to cleave the plasmid.  
 
Figure 5-11. Validation of dgRNAs in vitro and in vivo. 
A new gRNA was designed against a target site on 5’UTR. This was validated in vitro 
alone and in combination with sgRNA1 on a plasmid containing 5’UTR-pierce1-3’UTR. 
A) sgRNA5’UTR was shown to cleave the plasmid by itself and in combination with 
sgRNA1. B) sgRNA5’UTR + sgRNA1 (dgRNAs) were injected into one cell stage 
zebrafish embryos along with Cas9. gDNA was extracted from injected embryos and 
PCR was carried out using the primers indicated in the Figure. As shown, deletions 
generated by dgRNAs were found in several embryos validating the dgRNA approach. 
 
           After validation in vitro, the two gRNAs were injected into one cell stage 
zebrafish embryos along with Cas9. As shown in Figure 5.11b, primers were 
designed to amplify from 5’UTR to 3’UTR of pierce1. In the WT embryos, the 
PCR would not be expected to generate a product as it is too large to amplify 
(3824 bp) with the PCR conditions used. With the deletion generated by 




           gDNA was extracted from 15 injected embryos and PCR was carried out 
using these primers. As shown in Figure 5.11b, the expected 903 bp product 
was amplified from some injected embryos along with larger products from few 
embryos. Subsequently, these were gel extracted and cloned into pCR II TOPO 
for sequencing.  
           As expected, the 903 bp product resulted from dgRNA deletion of the 
region spanning between the target sites. Sequencing of the larger products 
revealed that the allele had a partial deletion due to the NHEJ repair mechanism 
existing in the fish embryos (Certo et al., 2011, Cong et al., 2013). So, I 
continued injecting embryos with dgRNAs with Cas9 and these were sent to 
the nursery to grow into adults. 
5.2.4.2 Generating pierce1 mutant zebrafish line from sgRNA/ 
dgRNA+Cas9 injected F0 fish. 
 
Since, injected zebrafish embryos (F0) are mosaics, a screening step was 
required to identify founders with mutations induced in the germline for 
transmission into the next generation. F0 fish were crossed with WT and gDNA 
was extracted from the progeny to check for transmission of mutant alleles. 
With the sgRNA approach, PCR for progeny from a female F0 fish was found 
to amplify a larger product than the expected product from WT. This band was 
gel extracted and sequenced. Sequencing revealed that an allele with a 29-
base pair insertion (c.178_179ins (29 bp)) in the target site of exon 2 of pierce1 
was being transmitted as shown in Figure 5.12. Hence, this F0 female fish was 
outcrossed to raise an F1 generation with carriers, from where I could generate 





Figure 5-12. Transmission of 29 bp insertion in exon 2 from sgRNA1 injected F0. 
A) gDNA from progeny from outcross of sgRNA1 injected F0 female was used to carry 
out PCR to amplify region spanning target region. A larger product in addition to the 
expected product was observed in some embryos. B) These products were gel 
extracted and cloned into pCR II TOPO for sequencing. The results revealed that 
larger product was caused by 29 bp insertion (circles in green) in the target site on 
exon 2 (boxed in blue) resulting in a frameshift. 
 
           Similarly, with the dgRNA approach, a male founder was found that 
transmitted an allele with partial deletion of the intron1 and a 5 base pair 
deletion in the target site in exon 2 (c.176_180del) resulting in a frameshift as 
shown in Figure 5.13. Again, this founder was outcrossed to raise F1 generation 
with heterozygous fishes. These heterozygous fish could be used to generate 







Figure 5-13. Transmission of 5 bp deletion in exon 2 from a male founder injected 
with dgRNA. 
gDNA from progeny from outcross of dgRNA1 injected F0 male was used to 
carry out PCR to amplify region spanning target region. A product of size 1200 
bp was observed in some embryos. These products were gel extracted and 
cloned into pCR II TOPO for sequencing. The results showed that larger 
product was resulted by a partial deletion of the targeted region. This allele had 
a partial deletion of intron 1 and a 5 base pair deletion in exon 2. 
 
           Subsequently, F1 fish for both alleles were fin-clipped to extract gDNA 
and screened by PCR to identify heterozygous fish. To raise homozygous 
mutants, the F1 heterozygous fish were in-crossed to generate F2 generation. 
According to the Mendelian ratio, we expect 25% of F2 fish to be homozygous.  
          gDNA was extracted from progeny of the F1 heterozygous fish in-cross 





using primers spanning the deleted intron region as shown in Figure 5.14 for 
the c.176_180del allele.  
 
Figure 5-14. Location of primers designed to identify homozygous mutants with 
c.176_180del allele. 
           In the c.176_180del mutants, the expected product size of 228bp was 
not amplified in the homozygous but it was amplified in the WT and 
heterozygous embryos as shown in Figure 5.15 b.  
           For c.178_179ins (29 bp) allele, the same primers from Figure 5.10 were 
used.  Product of 2 different sizes was observed in heterozygous whereas only 
the larger product was observed in homozygous embryos (Figure 5.15 a). The 
smaller product was observed in WT.  
           However, for both mutant alleles, we did not see any phenotypical 
difference between F2 zygotic mutants (homozygous) embryos from WT and 
heterozygous embryos. The number of homozygous embryos identified 
corresponded to the expected 25% as per Mendelian ratio indicating embryonic 







Figure 5-15. Identification of F2 homozygous pierce1 mutants for 
c.178_179ins(29 bp) and c.176_180del. 
A) For the c.178_179ins(29 bp) allele, a homozygous embryo was identified by PCR 
that is highlighted by red column by using primers shown in Figure 5-10B. B) For 
c.176_180del allele, homozygous embryos were identified by PCR using the primers 
shown in Figure 5.14. Homozygous embryos are highlighted by red column. 
 
5.2.4.3 Maternal contribution of pierce1 mRNA in zebrafish embryos 
 
Since the zygotic mutants for pierce1 did not show any significant difference 
from WT, I decided to check if pierce1 mRNA is contributed from the maternal 
side into the embryos. I thought that the maternal contribution of WT pierce1 
mRNA from the heterozygous mother into the zygotic mutants would be acting 
as a rescue factor and thus be masking the phenotypes.  
           To check for maternal contribution, I extracted RNA and made cDNA 
from embryos at earlier developmental stages, 1.5 hpf, 3 hpf, 5 hpf, 6 somites, 




was found from earliest developmental stages indicating there is maternal 
contribution of pierce1 mRNA. 
 
Figure 5-16. Maternal contribution of pierce1 in zebrafish embryos. 
cDNA was made from zebrafish embryos at early developmental stages, 1.5 hpf, 3 hpf, 
5 hpf, 6 somites, 10 somites, 18 somites and 24 hpf. PCR for pierce1 and actin (loading 
control) was carried out on these cDNAs. pierce1 transcripts were identified from 
earliest developmental timepoint when the embryonic transcription is not carried out. 
Hence, it was concluded that there is maternal contribution of pierce1. 
 
5.2.4.4 Maternal zygotic mutants for pierce1 
 
Since there is maternal contribution of pierce1 mRNA in zebrafish embryos, I 
in-crossed F2 pierce1 homozygous mutants (zygotic mutants) for both mutant 
alleles to generate maternal zygotic mutants. Zygotic mutants from both alleles 
were able to generate progeny. Therefore, it can be concluded that both 
mutants did not have fertility issues and sperm motility was normal. 
           There was no commercial antibody to confirm that Pierce1 protein was 
not generated in mutants. Therefore, I used cDNA from pooled F3 maternal 




           As shown in Figure 5.17A, a larger PCR product was observed for 
c.178_179ins(29 bp) maternal zygotic mutants compared to WT. These 
products were cloned into pCR II TOPO and sent for sequencing. As shown in 
Figure 5.17B, the sequencing showed that the 29 bp insertion is integrated in 
the pierce1 transcript. 
 
Figure 5-17. Validation of mutation in pierce1 transcripts of c.178_179ins(29 bp) 
maternal zygotic mutants. 
A) pierce1 transcripts amplified by PCR from mutants and WT. Product is larger in 
mutants. B) Sequencing of PCR products showed 29 bp insertion in the pierce1 
transcripts from mutants. 
 
           As shown in Figure 5.18A, no significant size difference was observed 
for PCR products generated by c.176_180del maternal zygotic mutants 
compared to WT. The PCR products were cloned into pCR II TOPO and sent 
for sequencing. As shown in Figure 5.18B, the sequencing showed that the 5 






Figure 5-18. Validation of mutation in pierce1 transcripts of c.176_180del 
maternal zygotic mutants. 
A)  pierce1 transcripts amplified by PCR from mutants and WT. B) Sequencing of PCR 
products showed 5 bp deletion in the pierce1 transcripts from mutants. 
 
           The multi-alignment of Pierce1 orthologues of human, mouse and 
zebrafish highlight the conserved regions (Figure 5.19A). Both mutant 
transcripts were translated in silico using Expasy 
(https://web.expasy.org/translate/). As shown in Figure 5.19B, the mutations 
result in frameshifts and premature stop codons in pierce1 mutant transcripts 
and would be expected to generate truncated proteins. In the truncated proteins 
generated from the mutant transcripts, 70% of the conserved residues would 








Figure 5-19. Conserved amino acid residues are missing in the mutants. 
 A) Multi-alignment of Pierce1 from zebrafish, mouse and human using Clustaw and 
Boxshade. The conserved residues are shaded in black. B) Multi-alignment of Pierce1 
protein sequences generated form WT and mutants’ transcripts. 70% of the amino acid 
residues are lost in the mutants. Species and accession numbers are as follows: 
Zebrafish (Danio rerio, GenBank: NP_001116715.1); Mouse (Mus musculus, 
GenBank: NP_081316.1); Human (Homo sapiens, GenBank: NP_001041730);). 
 
5.2.4.5 Maternal zygotic mutants exhibited mild situs abnormalities  
 
After validating the maternal zygotic mutants, we characterised the 
phenotypes of these maternal zygotic mutants by observing them at 24 hpf, 
48 hpf and 72 hpf. In contrast to the morphants, they did not exhibit curved 
axis, hydrocephalus and heart oedema. Otolith defects and pronephric cyst 
were not observed. A small proportion exhibited situs abnormalities as shown 




embryos with KV cilia with abnormal motility or immotility (see attached video 
files). 
 
Figure 5-20. Maternal zygotic mutants showed mild situs abnormalities. 
In maternal zygotic (mz) mutants from both alleles showed 10-20% embryos with situs 
abnormalities.  The difference between WTs and mutants is significant. In each trial, 
50- 70 embryos for each variable was used. Error bars indicate standard error of mean 




Pierce1 was one of the candidate genes that I chose for further 
characterisation. It had come up in many ciliary genomic and proteomic 
screens. Moreover, orthologues of PIERCE1 are only identified in organisms 
with motile cilia (Mi et al., 2010). It encodes a small protein made up of 167 
amino acids in mouse and 137 amino acids in zebrafish. No known functional 
domains have been identified in this protein and the only identified conserved 




a target of TP53 that was also overexpressed in Rb-/- MEFs (Sung et al., 
2007, Sung et al., 2010).   
           To characterise the functional role of PIERCE1, I used zebrafish for in 
vivo investigation. Zebrafish is an increasingly popular vertebrate whole 
organism model for biomedical research. They have many advantages such 
as large progeny number, small body size, transparent embryos and 
abundance of mammalian orthologues (Malicki et al., 2011, Song et al., 
2016a). 
           Initially, I decided to utilise two independent MOs for transient 
knockdown of pierce1 in zebrafish embryos. Both morphants showed severe 
laterality defects and curved axis, phenotypes usually associated with motile 
cilia defects (Malicki et al., 2011, Song et al., 2016a). Abnormal cilia motility 
was observed in KV of the morphant embryos that might explain the laterality 
defects. Immunolabelling of cilia by Acetyl α-tubulin suggested that there was 
no difference in the cilia morphology in the morphants. In terms of cilia 
structural analysis, immunostaining has limitations. It can only be used to 
study cilia number and length. To study cilia architectural defects, electron 
microscopy would be more beneficial. Such an analysis was not undertaken.  
           During my study, the same group that identified PIERCE1 as a target 
of TP53, reported that mouse null mutants of Pierce1 exhibit severe laterality 
defects. They reported there was no cilia morphology differences in the motile 
cilia of mouse embryonic node. In the pierce1 null embryos, they also found 
loss of asymmetric expression of Cerl2, the earliest flow responding gene, 




These results confirm the findings I had with the MO assays. In addition, using 
live imaging, I concluded that the laterality defects arise due to abnormal 
motility of cilia in the KV.  
To further understand the functional role of Pierce1 in motile 
ciliogenesis, I wanted to study the subcellular localisation Pierce1 in KV. 
Since, no working commercial antibodies were available at the time of my 
study; I decided to use expression of tagged versions of Pierce1 in zebrafish 
embryos to detect the localisation. Two tagged versions were utilised to 
overcome the limitation caused by positioning of the tags; a N-terminus Myc 
tag and a C-terminus GFP tag. Both tagged versions localised to the 
cytoplasm. One limitation of this approach is the relative larger size of tags 
with the small Pierce1 protein can affect the native localisation of the Pierce1 
protein. Hence, to get a more reliable data for the localisation, I would ideally 
wish to use an antibody against Pierce1 that would detect the native protein.  
           I attempted to rescue the morphants using the 6 x Myc-Pierce1 
construct. However, there was no significant difference between rescue and 
morphants. There are two different ways to interpret this result. Firstly, the 
tags are interfering the native function of the protein and secondly the 
morphant phenotypes were caused by off-target effects of the MOs.  
           Although, initially MOs gained a widespread popularity in the zebrafish 
community through their ease of usage and rapid results, problems with their 
application in zebrafish embryos soon emerged. Several research groups 




in perplexing ‘pseudophenotypes’ (Kok et al., 2015, Place and Smith, 2017, 
Eve et al., 2017). 
Kok et al used gene-editing techniques to make zebrafish mutants for 
24 genes suspected to be involved in the vascular development. However, 
mutants for only three of the 24 genes showed phenotypes related to vascular 
development defects. Previous studies had reported phenotypes in the 
morphants for more than half of these genes (Kok et al., 2015).  
The low concordance between mutant and morphant phenotypes has 
made many researchers feel sceptical about the MO assay results (Vogan, 
2015). Hence, MOs might not be reliable enough to use as a standalone tool to 
assess gene function. In addition, MOs are only able to generate a transient 
knock down. Therefore, the phenotypes in adults cannot be characterised. 
To validate the phenotypes induced by the transient knockdown by 
MOs and to assess the phenotypes of the adult fish, I proceeded to generate 
a zebrafish genetic mutant line for pierce1.The small size of the pierce1 ORF 
meant only few choices were available for suitable target sites. I decided to 
use a sgRNA approach to make small indels on exon2 of pierce1 and 
dgRNAs approach that target the 5’UTR and exon 2 of pierce1 that would 
delete the region spanning in between.  
           Using the sgRNA, I identified a founder that transmitted 29 bp insertion 
in the target site of exon2, which would be expected to result in a frame shift 
and a truncated protein. With the dual-guide CRISPR/Cas9 (dgRNA) genome 
editing approach, one founder was identified that transmitted a partial 




result in multiple classes of structural variation mediated by non-homologous 
repair within unique genic segments across a range of sizes (Tai et al., 2016, 
Certo et al., 2011, Cong et al., 2013). In my allele, there was a partial deletion 
of intron 1 and a 5 bp deletion in the target region of exon 2. Therefore, this 
allele was similar to the allele produced by sgRNA approach where the 
frameshift results in a truncated protein.  
The only identified conserved functional domain, known as DUF4990, 
spans from 11-117 amino acids of the Pierce1 protein. Both mutant alleles 
would be expected generate truncated proteins with first 60 amino acids and 
a disruption of the conserved domain.  
The zygotic mutants generated by crossing heterozygous fish did not 
show any phenotypical difference from WT but I found that there was 
maternal contribution of pierce1 mRNA in the embryos. In all animals 
examined, the earliest stages of development depend on maternal gene 
products, which are made during oogenesis and deposited in the egg.  The 
phase of maternal control of embryonic development differs among animals 
and it relies on the onset of zygotic transcription and the stability of the 
maternal gene products (Abrams and Mullins, 2009, Tadros and Lipshitz, 
2009). The initiation of zygotic transcription happens during blastula stage 
(2.25 hpf -5.25 hpf) in zebrafish embryo development (Kane and Kimmel, 
1993, Tadros and Lipshitz, 2009, Langley et al., 2014). My end-point RT-PCR 
detected presence of pierce1 transcripts from 1.5 hpf.  I considered that the 
maternal deposition of WT mRNA from the heterozygous mother would be 




Hence, I proceeded to make maternal zygotic mutants for pierce1 by 
in-crossing zygotic homozygous mutants. Interestingly, the adult zygotic 
mutants were viable and fertile indicating that sperm motility is normal, an 
observation that might be unexpected for a ciliary phenotype. 
           Unexpectedly, in maternal zygotic mutants from both alleles, only 
small majority had situs abnormalities. Live imaging showed small number of 
abnormal/ immotile cilia in KV of the mutants and the proportion varied 
between different embryos.  Since, the mutants from both mutant lines (two 
independent alleles) show few embryos with laterality defects, the laterality 
defects observed are less likely due to off-target defects. The existence of 
pierce1 null mouse mutants that exhibit severe laterality defects like pierce1 
knockdown zebrafish embryos (i.e. morphants) suggest that a compensatory 
mechanism existing in the zebrafish knockouts (i.e. mutants) that might be 
masking the mutant phenotype.  
           Phenotypic differences between knockdowns (e.g., antisense-treated 
animals) and knockouts (i.e., mutants) have been reported in a number of 
recent studies in model systems including mouse (White et al., 2013), 
zebrafish (Kok et al., 2015)  and Arabidopsis (Bouche and Bouchez, 2001). 
           Although the off-target effects of the anti-sense reagents can be a 
reason for these differences, recent studies in zebrafish have given genetic 
compensation as an alternative explanation. This included a study by Andrea 
Rossi and colleagues (2015). Knockdown of egfl7, an endothelial 
extracellular-matrix (ECM) gene, in zebrafish lead to severe vascular defects 




upregulation of other ECM proteins, specifically Emilins, which might explain 
this discrepancy partially in egfl7 mutants but not in the MO embryos. 
Furthermore, they reported minor or no vascular defects upon egfl7 MO 
injections into egfl7 mutants, suggesting that the phenotypic differences are 
not due to MO toxicity (Rossi et al., 2015). 
           In 2017, Anderson et al have given a second explanation where they 
challenged the assumption that complete loss of function (null) phenotypes 
can always be made by splice site, frameshift, and nonsense mutations. They 
demonstrated the emergence of transcript variants with restored ORF with 
alternative mRNA splicing and use of cryptic splice sites in homozygous 
mutants. Hence, these variants have the potential to translate into at least 
partially functional proteins (Anderson et al., 2017). However, this 
phenomenon can be tested by reverse transcription PCR and sequence 
analysis on homozygous mutant embryos.  
           I amplified the pierce1 transcript from both mutant lines and sent the 
resultant products for sequencing. My data revealed the mutated regions 
were still intact in the transcript and would result in frameshift and 
consequently truncated protein. So, I conclude that frame-restoring mRNAs 
are not found in the pierce1 mutants.  It can also be argued that, through 
mechanisms such as ribosomal frameshifting and nonsense read through, 
mRNAs can be translated into full-length proteins. This is difficult to test 
without a working antibody. Anderson et al provided guidelines to tackle this 
problem including targeting the functional domain of the protein (Anderson et 




should have been disrupted in the truncated protein generated by the 
mutants.  
           Dosage compensation was first observed for X-linked genes in 
Drosophila by Muller in 1932 ((MULLER, 1932). Subsequently, in many 
model organisms, genetic compensation has been reported i.e. mouse (White 
et al., 2013), zebrafish ((Kok et al., 2015) and Arabidopsis (Bouche and 
Bouchez, 2001). Furthermore, a comprehensive study of 874 genes in over 
500,000 human genomes identified 13 individuals harbouring severe 
disease-causing mutations in 8 different genes, with no reported clinical 
manifestation of the disease (Chen et al., 2016). Another study on British 
individuals with Pakistani heritage also reported no significant relationship 
between genotype and disease manifestations (Narasimhan et al., 2016).  
Similar findings were reported from a study on individuals from Iceland (Sulem 
et al., 2015).  
Molecular insight into the mechanisms behind genetic compensation 
is limited. Several mechanisms have been proposed to work behind this 
phenomenon recently by El-brolosy and Stanier. This include epigenetic 
changes, mRNA surveillance pathways, ncRNAs, uORFs, RBPs, and 
miRNAs (El-Brolosy and Stainier, 2017). 
In conclusion, Pierce1 is conserved only in organisms with motile cilia 
and it has been identified in many ciliary genomic and proteomic screens. 
Choksi et al and my own experiments have shown that pierce1 functions 
downstream of Foxj1, the master regulator of motile ciliogenesis (Choksi et 




with ciliary defects including severe situs abnormalities. Further analysis 
showed abnormal ciliary motility in KV in the morphants. This was in 
agreement with the results from mouse null mutants of pierce1 (Sung et al., 
2016). However, pierce1 knockout in zebrafish only showed mild situs 
abnormalities. This could be due to genetic compensation mechanisms that 
mask the mutant phenotype. Many studies have shown difference between 
knockdowns and knockouts for several genes. 
Future work should focus on validating that the mild phenotype in 
mutants is due to genetic compensatory mechanisms. This could be validated 
by injecting MOs into the mutants. If there were genetic compensation in the 
mutants, the mutants would not show severe phenotype as opposed to the 
WT embryos. It could also seek to characterise the compensatory 
mechanisms including any upregulation in other genes in the mutants.  Ideally 
the use of an antibody for the protein would help to identify the native protein 
localisation as this is more reliable than tagged protein expression. This is 





Chapter 6 :  Localisation of PIERCE1 to multiciliated cells may 
give clues to its function. 
 
6.1 Preface 
PIERCE1 is a novel gene that appears to be important for motile cilia function. 
The gene was identified in many high throughput genomic screens for ciliary 
genes as outlined in chapter 4 (Geremek et al., 2011, Hoh et al., 2012, Choksi 
et al., 2014b, Treutlein et al., 2014b, Nemajerova et al., 2016a). In addition, 
mouse Pierce1 null mutant embryos exhibit severe laterality defects consistent 
with ciliary defects (Sung et al., 2016). Furthermore, knockdown/knockout of 
Pierce1 in zebrafish embryos outlined in chapter 5 also showed laterality 
defects associated with motility defects of cilia in KV.  
Since I have only established that PIERCE1 is required for cilia motility, 
the next step is to understand the biochemical pathway for its function. To 
understand how PIERCE1 is involved in cilia motility, I have to identify the 
native localisation of PIERCE1 in ciliated cells.  Although, I used tagged 
expression vectors in zebrafish embryos to understand the subcellular 
localisation of Pierce1, this method has many limitations e.g. expression tags 
can affect native localisation of the protein.  
           Fortunately, our collaborator, Dr Dominic Norris (MRC, Harwell, Oxford), 
gifted us a custom-made polyclonal antibody against full-length mouse 
PIERCE1 protein raised in rabbit. In this chapter, I outline how we used this 
antibody in mNEC cultured at the ALI to deduce the expression and localisation 




the results from Yeast 2-Hybrid assay carried out with human PIERCE1 on 
human lung and testis cDNA to find possible interactors. 
6.2 Results 
6.2.1 Validating PIERCE1 antibody on testis cell lysate by Western blot 
To validate the PIERCE1 antibody, we tested it on mouse testis cell lysates 
(200 mg tissue lysed in 2 ml SDS lysis buffer) by western blot as the gene is 
highly expressed in testes (Figure 4.2 and 4.3). 
           As shown in Figure 6.1, different amount of testis tissue lysate (5 µl to 
30 µl) were loaded on to the gel with SDS lysis buffer as negative control lane. 
A single band with an apparent molecular mass of just above 20 kDA was 
detected in all lanes with increasing band densities correlated with increased 
amount of cell lysate loaded. The predicted molecular mass of the PIERCE1 






Figure 6-1. Western blot of PIERCE1 in mouse testis tissue lysate. 
Increasing amounts of testis tissue lysate (5 µl to 30 µl) was loaded with SDS 





6.2.2 Localisation of PIERCE1 in differentiated mouse airway epithelial 
cells cultured at the ALI 
Next, I wanted to test whether the PIERCE1 antibody could be used to identify 
the localisation of native PIERCE1 protein in differentiated mNEC cultured at 
the ALI.  
6.2.2.1 PIERCE1 is specifically expressed in ciliated cells 
Day 0 and day 14 differentiated mNEC cells were co-stained with an antibody 
to FOXJ1 that allowed us to visualise the ciliated cells alongside PIERCE1. As 
shown in Figure 6.2, on day 0 of culture, staining for PIERCE1 and FOXJ1 
was absent. At ALI day 14, ciliated cells were found in the cultures, indicated 
by the staining of FOXJ1 and PIERCE1 was also found to be specifically 







Figure 6-2. PIERCE1 in localised to ciliated cells in ALI mNECs at day 14. 
Cells were stained with antibodies against FOXJ1 (cilia specific) and PIERCE1. 
Immunofluorescence confocal images show A) day 0 and day 14 cultures (40x) B) 40x  
magnification cross section z-stack confocal image of d14 cultures. . Scale bars: 50 







6.2.4.2 PIERCE1 is localised in the cytoplasm of ciliated cells and does 
not localise to the cilia axoneme 
Cells were also co-stained with ACETYL α-TUBULIN that allows visualisation 
of the cilia axoneme, and PIERCE1. These cells were then imaged using 
confocal microscopy to make z-stack images to analyse the localisation of 
PIERCE1. This technique allows the visualisation of different focal planes in the 
multi-layered mNEC culture by taking z-stack images though the depth of the 
cells as shown Figure 6.3. 
 
Figure 6-3. Schematic diagram indicating the z-stacks created by the confocal 
laser scanning microscope from the ALI cultured mNEC samples. 
           As shown in Figure 6.4, using this technique, I was able to observe that, 
in the differentiated mNEC, PIERCE1 is localised in the cytoplasm of ciliated 





Figure 6-4. PIERCE1 does not localize to cilia axoneme and is localized in the 
cytoplasm. 
Immunofluorescence confocal (40x) image is representative of 3 independent batches 
of mNEC cultures. At ALI day 14, mNEC were stained with antiobodies against 
ACETYL α-TUBULIN targeting cilia axoneme and PIERCE1. A) Confocal cross-
section z-stack image.  B) Single z-stack slices from apical surface of the apical (1) to 







6.2.3 PIERCE1 is upregulated in mNEC treated with DAPT 
 
In chapter 3, I had shown that MCCs in the mNEC culture at ALI can be 
increased by DAPT treatment. Therefore, I hypothesized that PIERCE1 
expression would also be upregulated in mNECs treated with DAPT. To test 
this, transcriptional and protein expression of Pierce1 and Foxj1 was studied in 
differentiated mNEC treated with DAPT using real-time PCR and 
immunofluorescence microscopy. 
           As shown in Figure 6.5A, transcriptional expression of Foxj1 and Pierce1 
was significantly increased by around 2-fold in DAPT treated samples. I could 
show an increased number of ciliated cells (FOXJ1+ve) in DAPT treated mNECs 
(Figure 3-8).  PIERCE1 is also found in FOXJ1+ve cells. Therefore, PIERCE1 
may be upregulated in DAPT treated mNEC and PIERCE1 seems to be 





Figure 6-5. PIERCE1 is upregulated in DAPT treated mNEC. 
A. Real-time PCR results of Foxj1 and Pierce1 expression DAPT treated mNEC 
(Scale=50 μm). The data is representative of 3 batches of cells. Error bars indicate 
standard error of mean (SEM) (n=3 independent batches of experiments). **-p<0.01 











6.2.5 Determining the interactors of PIERCE1 
To further understand the molecular functions of PIERCE1, it is essential 
to uncover the protein partners that it interacts. To do this an unbiased 
approach was used to identify the interactors of PIERCE1. The yeast two-
hybrid system is an in vivo method widely used to examine the existence of 
protein-protein interactions or identify new interacting candidates of a known 
protein (Chien et al., 1991).  A yeast two-hybrid screen was performed using 
full-length human Pierce1 (1-136 aa), as a bait fusion and screening human 
lung and testis libraries. A commercial company, Hybrigenics 
(https://www.hybrigenics-services.com/), carried out the screen on our 
behalf. Although I did not perform this study it is directly relevant to the 
work in my thesis. 
           Interestingly, the screens done on both libraries yielded many hits. 
However, only one candidate came up on both screens (lung and testis) 
and came up in the category of the highest confidence level. This protein 
was PIAS2, a E3-type small ubiquitin-like modifier (SUMO) ligase. From the 
human lung library, two independent clones for PIAS2 was identified with 
one clone spanning -136…600 nt and the second spanning -115...1167 nt.  
From the human testis library, two independent clones for PIAS2 were 
identified with one clone spanning -61…539 nt and the second spanning -
59...544 nt. This indicated that PIERCE1 may interact with region spanning 
from 20 aa- 390 aa of PIAS2. Other hits were placed in the categories of 
moderate or below confidence. They did not overlap in two screens. The 






I previously suggested that PIERCE1 is a novel gene that is involved in the 
function of motile cilia. It was identified in many high throughput genomic and 
proteomic screens for ciliary genes (Geremek et al., 2011, Hoh et al., 2012, 
Choksi et al., 2014b, Treutlein et al., 2014b, Nemajerova et al., 2016a).  Sung 
et al (2016) reported that mouse null embryos of Pierce1 exhibited severe 
laterality defects commonly seen in patients with ciliopathies (Sung et al., 
2016). To investigate the function of PIERCE1 in vivo, I used zebrafish 
embryos as my in vivo model as described in Chapter 5. The knockdown of 
Pierce1 in zebrafish embryos resulted in phenotypes consistent with motile 
cilia defects and with live imaging, I was able to establish that cilia motility 
was aberrant in these embryos. 
           Further investigation regarding the biochemical, molecular, and 
genetic mechanisms by which PIERCE1 interacts with other known factors is 
required to elucidate the precise role of PIERCE1 during motile ciliogenesis. 
As a starting point, I decided to study the localisation of PIERCE1 in ciliated 
cells.  
In Chapter 3, I validated primary mouse airway epithelial cell culture 
as a good in vitro model to investigate the factors associated with 
ciliogenesis. I decided to use a custom made polyclonal antibody raised 
against full length mouse PIERCE1 protein, on differentiated ALI cultured 
airway epithelial cells to understand its’ localisation. Prior to using the 
antibody for microscopy, I tested it on mouse testis tissue lysate by western 




Human Protein Atlas, showed that PIERCE1 is highly expressed in testis. 
Sperm harbours flagella for locomotion. The structure and function of cilia 
and flagella are very well conserved across evolution (Ibañez-Tallon et al., 
2003). I did not quantitate protein levels for this experiment, but I reasoned 
that since my purpose was only focused on detecting the protein, this method 
was sufficient. As expected, PIERCE1 was detected by the antibody on the 
western blot. A very clear band with a size of around 20 kDA was visible 
across the blot. It is difficult to prove that this is PIERCE1 but as it was close 
to the predicted size for mouse PIERCE1 protein it seems like a reasonable 
assumption. I was not able to compete this binding as I did not have access 
to any recombinant protein.  
When I used this antibody on undifferentiated and differentiated mNEC 
cultured at ALI, PIERCE1 (like FOXJ1) was not detected in undifferentiated 
mNECs. In contrast, at day 14, PIERCE1 was found to be specifically 
localised in ciliated cells (FOXJ1+ cells). It had a cytoplasmic localisation 
while FOXJ1 was localised in nucleus. These data were consistent with the 
data from chapter 5, where I showed that tagged proteins in zebrafish 
embryos also localised to the cytoplasm. This localisation data confirms that 
the protein is not found in the cilia axoneme, but my functional data suggest 
that it is required for normal cilia motility. Further support for the localisation 
of the protein in ciliated cells comes from the DAPT treatment data which 
showed that Pierce1 increased along with ciliated cell numbers.  
           Having established that PIERCE1 is a cytoplasmic protein found in 
ciliated cells and is required for cilia motility, I looked in the literature for other 




cilia motility. Axonemal dynein arms are large sophisticated devices that fuel 
cilia motility (Gibbons and Rowe, 1965, Ishikawa, 2017). In 1988, Fawkes et al 
performed studies on Chlamydomonas to show that Dynein subunits are pre-
assembled in the cytoplasm and then exported into the axoneme, where they 
are docked onto peripheral microtubules. The underlying mechanisms for this 
were   not clearly understood (Fowkes et al., 1998). In the following years, 
human genetics and model organisms have contributed major insights into the 
complex process of axonemal dynein arm assembly and how they are 
transported into cilia/flagellum by dynein axonemal assembly factors (DNAAFs) 
which are themselves largely cytoplasmic. Many of these proteins were 
identified by screening for causative mutations in PCD patients (Loges et al., 
2009, Omran et al., 2008, Mitchison et al., 2012, Tarkar et al., 2013). Multiple 
PCD genes such as LRRC50/DNAAF1 (Duquesnoy et al., 2009, Loges et al., 
2009), KTU/DNAAF2 (Omran et al., 2008), PF22/DNAAF3  (Mitchison et al., 
2012), DYX1C1/DNAAF4  (Tarkar et al., 2013),  HEATR2/DNAAF5 (Horani et 
al., 2012, Diggle et al., 2014), LRRC6 (Kott et al., 2012, Horani et al., 2013a), 
ZMYND10 (Moore et al., 2013, Zariwala et al., 2013, Mali et al., 2018), SPAG1 
(Knowles et al., 2013d), C21ORF59 (Austin-Tse et al., 2013)  and PIH1D3 (Paff 
et al., 2017, Olcese et al., 2017), have been shown to be involved in the 
cytoplasmic assembly of dynein arm subunits and loss of these factors lead to 
loss of both ODAs and IDAs. Although, the specific functions of these proteins 
are not clear, by analysis of protein sequence and interactions, some of them 
seem to interact with ubiquitous chaperone, HSP90 (zur Lage et al., 2018). So, 
it indicates these cytoplasmic factors may facilitate the proper folding of dynein 




Since PIERCE1 is localised to the cytoplasm and its loss results in cilia motility 
defects, it can be hypothesised that PIERCE1 may be a cytoplasmic factor 
involved in the assembly of dynein arms. Since I did not study the axonemal 
structure of cilia in zebrafish knockdown experiment in detail e.g. by TEM, we 
do not know whether there was a loss of ODA and IDA in the cilia axoneme. 
Until the structure of motile cilia formed in the absence of PIERCE1 is 
investigated, it will not be possible to draw a conclusion regarding the 
involvement of PIERCE1 in dynein arms assembly.  
           To gain further insights into the molecular function of PIERCE1, a Yeast 
Two-Hybrid assay with LexA bait fusion was very recently carried out to identify 
the interacting partners of PIERCE1. This was undertaken using human lung 
and testis cDNA libraries independently. These tissues were chosen as they 
contain abundant ciliated cells. Protein inhibitor of activated STAT2 (PIAS2) 
was the only candidate that came up on both screens (lung and testis) and 
came up in the category with the highest confidence level. PIAS2 is an E3-type 
small ubiquitin-like modifier (SUMO) ligase (Palvimo, 2007, Rytinki et al., 2009). 
Many additional candidates came up in each screen with a lower level of 
confidence.  In future, co-immunoprecipitation and mass spectroscopy studies 
will be carried out to validate the interaction and to look for more interacting 
partners.    
           Protein inhibitor of activated signal transducer and activator of 
transcription 2 (PIAS2) belongs to the PIAS protein family (Moilanen et al., 
1999, Kotaja et al., 2002). PIAS proteins are shown to be inhibitors of activated 
STAT only and modulate and interact with several other proteins, including AR 




           PIAS2 is highly expressed in the testis (Yan et al., 2003).  PIAS proteins 
also acts as E3 ligases involved in the process of sumoylation (Palvimo, 2007). 
In addition, PIAS2 was shown to be upregulated during  mucociliary 
differentiation of mouse tracheal epithelial cells as it is in the RNA sequencing 
data set generated by Nemajeravo et al (Nemajerova et al., 2016a).  
Interestingly both PIERCE1 and PIAS2 were identified in whole-genome gene 
expression profiling of bronchial biopsies from PCD patients and were both 
placed into the cluster enriched for cilia genes. (Geremek et al., 2011). These 
findings raise a possibility that PIERCE1 and PIAS2 might be involved in the 
sumoylation of factors associated with cytoplasmic assembly of dynein arms. 
Sumoylation is a protein modification process facilitated by E1-activating 
enzyme, E2-conjugating enzyme and E3 ligating proteins (Wilkinson and 
Henley, 2010, Flotho and Melchior, 2013). Sumoylation commonly results in 
change in the molecular interactions of the sumoylated proteins, which 
ultimately result in changes in protein activity, localization or stability (Flotho 
and Melchior, 2013, Bi et al., 2014). 
           Sumoylation has been found to be important in ciliogenesis in different 
contexts by several groups (McIntyre et al., 2015, Li et al., 2012b). In motile 
ciliogenesis, the current understanding about the molecular and biochemical 
pathways involved in the cytoplasmic assembly of dynein arms remains vague.  
The components of the Ruvbl1-Ruvbl2-Tah1-Pih1 (R2TP) complexes, Pontin 
(Ruvbl1) and Reptin (Ruvbl2, that normally act as co-chaperones for the 
assembly of multiple macromolecular protein complexes are also known to be 
important for the cytoplasmic assembly of dynein arms (Te et al., 2007, 




and Reptin show cilia motility defects along with reduction in the number of 
outer and inner dynein arms (Zhao et al., 2013b, Li et al., 2017). Reptin was 
also shown to interact with Lrrc6, one of the cytoplasmic Dynein assembly 
factor(Zhao et al., 2013b). Pontin was also shown to be required for the 
stabilization of axonemal dynein intermediate chain 1 (DNAI1) and DNAI2, one 
of the initial steps in axonemal dynein arm assembly (Li et al., 2017, zur Lage 
et al., 2018).   
           In the canonical pathway, sumoylation was shown to be required for 
activity of Reptin as part of R2TP complex in cell cycle pathway (Kim et al., 
2006). Although it’s not clear how Reptin and Pontin functions as part of the 
cytoplasmic dynein assembly in motile ciliogenesis, it is possible that 
sumoylation may be required to regulate their activities. This is just one of the 
many possible examples where sumoylation may play a role in dynein arms 
assembly in motile ciliogenesis. Since, the current understanding regarding the 
cytoplasmic assembly of dynein arms is ambiguous, it can only be assumed 
that the modification process of sumoylation may be important for some factors 
involved.  
           In conclusion, I suggest that PIERCE1 is involved in the pre-assembly 
of dynein arms based on its cytoplasmic localization and consequences upon 
loss of function. However, the specific functions of this protein and its 
relationships with cytoplasmic dynein assembly factors remains to be 
understood. The Y2H assay carried out with the full-length Human Pierce1 
(1-136 aa) protein identified PIAS2, as a possible interacting partner of 
PIERCE1.  With this finding, I hypothesise that PIERCE1 and PIAS2 may 








Chapter 7 :  Discussion 
 
As I described in chapter 1, there are many gaps left in the current 
understanding of cilia formation and function. Therefore, many components and 
pathways that make up the cilium and required for its motility are still not known. 
In order to address this, many groups have conducted large scale proteomic, 
genomic and transcriptomic screens that have identified a large number of 
candidates that may have a role in motile ciliogenesis (Ross et al., 2007, Hoh 
et al., 2012, Choksi et al., 2014b, Choksi et al., 2014c, Stauber et al., 2017) . 
However, further characterisation of these candidates is required to understand 
its role and importance in ciliogenesis.  
           My aim in this thesis was to select putative genes from large scale 
screens I mentioned in the last paragraph based on the number of studies that 
have identified the gene as a ciliary gene, in silico analysis and expression 
profile in differentiating in vitro cultured mouse primary airway epithelial cells.  
Once a gene was selected, I aimed to carry out further characterisation of the 
genes using my in vitro model – mouse primary airway epithelial cells cultured 
at ALI and an in vivo model- zebrafish embryos.  
           In this closing chapter, I will summarise all the significant findings from 
the thesis and discuss how close I managed to get to my initial aims. I will also 






7.1 Establishment of in vitro culture of mouse primary airway 
epithelial cells as a model for studying motile ciliogenesis 
 
First step was to establish the in vitro model, mouse primary airway epithelial 
cell culture at ALI. I successfully managed to isolate cells from mouse trachea 
and nasal cavity and to grow and differentiate them on ALI following the 
protocols adapted from other groups (You et al., 2002, Antunes et al., 2007a, 
Vladar and Brody, 2013) . The differentiation of mTEC and mNEC at the ALI 
was first validated by studying the expression of markers of basal cells, ciliated 
cells and secretory by end-point RT-PCR, western blot and 
immunocytochemistry. Once I validated that the differentiation had occurred, 
the expression pattern of genes required for ciliogenesis as the cells 
differentiate at ALI was examined using end-point RT-PCR. An increase in 
expression was observed, consistent with studies by other groups (Vladar and 
Brody, 2013, Nemajerova et al., 2016a). Since end-point RT-PCR is only semi-
quantitative, it is difficult to deduce further information about the pattern of 
expression. In the future, I will move on to real time PCR that would allow me 
to understand the expression pattern of cilia specific genes during the 
differentiation of airway epithelial cells.  
As reviewed by Vladar et al and shown by many groups, ciliogenesis in 
mTEC grown at ALI can be modulated by drug treatment (Pan et al., 2007b, 
Vladar et al., 2012, Vladar and Brody, 2013, Burke et al., 2014). I decided to 
test this aspect on mNEC by DAPT (a Notch inhibitor) treatment. Consistent 
with results from several groups on mTEC cultured at ALI, I saw increase in 
MCCs in mNEC culture (Stubbs et al., 2012, Tan et al., 2013b, Villa et al., 




of FOXJ1+ve cells in the culture. I realised that more reliable way would be to do 
a real-time PCR to study the mRNA expression levels of Foxj1. This was 
explored in chapter 6.  The increase in MCCs in mNEC, like reported in mTECs 
by other groups, was expected since molecular pathway of MCC formation is 
conserved even though the cells are from different niches (Brooks and 
Wallingford, 2014b, Meunier and Azimzadeh, 2016). It showed mNECs can be 
used like mTECs as a model to understand MCC formation. I also attempted to 
optimise gene modulation in these cells by siRNA transfection. This was not 
successful because of limitations such as low transfection efficiency, batch 
variation, difficulty in growing FACS sorted cell population of interest since 
primary cells loss their proliferative potential once they are passaged. Recently, 
different groups have reported various ways of overcoming these issues in this 
models such as treating the cells with SMAD signalling inhibitors that would 
consequently increase the proliferative potential of the cells (Mou et al., 2016, 
Eenjes et al., 2018a, Levardon et al., 2018).  However, in the interest of time, I 
did not pursue the initial plan to carry out gene modulation in this cell culture 
model.  
           In addition, recent advances in techniques like single-cell profiling can 
also be useful to explore using this in vitro model to understand the molecular 
and cellular biology of lung epithelium. This was demonstrated recently by 
Plasschaert et al (2018) who carried out single-cell profiling of human bronchial 
epithelial cells grown at ALI and isolated mTECs to acquire a complete map of 
distinct cell types in airway epithelium. They made a novel discovery of a new 
cell type known as ‘pulmonary ionocyte’ that express CFTR, a gene mutated in 




           The significant contribution from this work for my research was the 
validation of differentiation of MCCs in this culture and the capability of 
modulating multiciliogenesis in the culture.  
7.2 Pierce1 was selected for further characterisation from a list of 
10 randomly selected putative ciliary genes 
 
From three recent studies that screened for novel ciliary genes at the time of 
my research (Ross et al., 2007, Hoh et al., 2012, Choksi et al., 2014c), I 
selected 10 uncharacterised genes including Pierce1 that might have had a role 
in ciliogenesis. Initially, the expression pattern of Pierce1 during the 
differentiation of mNECs at ALI was studied. Pierce1 showed increased 
expression during differentiation like other established ciliary genes. I used end-
point RT-PCR here. But recently Nemajeravo et al carried-out RNA seq at 
different time points of mTEC differentiation at ALI. Consistent with my findings 
from mNEC, they also showed Pierce1 was upregulated during the 
differentiation of mTEC like many other cilia genes (Nemajerova et al., 2016a).   
           Secondly, the transcriptional expression of candidate genes was 
analysed in different whole mouse tissues. Interestingly, Pierce1 showed 
enriched expression in motile ciliated tissues denoted by higher band densities. 
Again, endpoint PCR used here is semi-quantitative, hence a more accurate 
representation can be made by real time PCR. This distribution of enriched 
expression in tissue harbouring motile cilia for Pierce1 was also shown by 
datasets from bioGPS (Wu et al., 2009)  
(http://biogps.org/#goto=genereport&id=69327).  In addition, the Human 




associated with motile ciliated cells, although the sub-cellular localisation of the 
protein was not clear (https://www.proteinatlas.org/ENSG00000160345-
C9orf116/tissue). However, these datasets do not represent all proteins 
accurately and therefore the data cannot be relied on blindly. Furthermore, the 
expression in distinct cell types of E18.8 mouse lung using the data from 
‘LungGens’ (Du et al., 2015) showed that Pierce1 is specifically expressed in 
ciliated cells. Although none of these data can be used as a standalone tool to 
establish the functional role of the gene in ciliogenesis, these can be used in 
combination to make a rational prediction.  
           Using Cildb, a knowledge database that incorporates ciliary data from 
various sources and links orthology relationships among 44 species (44 
eukaryotes and 3 bacteria) to high throughput ciliary studies (Arnaiz et al., 
2014), I was also able to find other screens done in mouse, human and 
zebrafish that have identified PIERCE1 as a potential ciliary gene (Ross et al., 
2007, Geremek et al., 2011, Geremek et al., 2014, Hoh et al., 2012, Treutlein 
et al., 2014a, Choksi et al., 2014b, Stauber et al., 2017). Combining all these 
findings, PIERCE1 was selected as a strong candidate for further 
characterisation. 
As I mentioned before, recently, Plasschaert et al (2018) had carried out 
single-cell profiling of mTECs and HBECs to obtain a comprehensive map of 
distinct cell types present in proximal airways (Plasschaert et al., 2018). The 
single-cell profiling is a very useful technique as it will allow to analyse the 
difference of individual cells/cell types and can reveal the cell-type specific 




my selection of ciliary gene candidates now, I would have incorporated this data 
as well to select good candidates for further characterisation.  
Nevertheless, using the dataset from Plasschaert et al (2018) that is 
available from NCBI GEO under accession number GSE102580, I studied the 
expression on PIERCE1 in human and mouse proximal airway epithelial cells. 
The data can be viewed using a computational tool, SPRING , that allows an 
interactive visualization of single-cell profiling data and allows to investigate 
unrestricted gene topology (Weinreb et al., 2018). As Shown in Figure 7.1, in 
mTEC, Pierce1 expression is specifically enriched in the ciliated cells as shown 






Figure 7-1. Single-cell profiling of mTEC shows enriched expression of Pierce1 
in ciliated cells. 
Plasschaert et al (2018) carried out single cell profiling of mTEC to obtain a 
comprehensive map of all cell types in mouse proximal airway epithelium and revealed 
novel gene signatures in the distinct cell types. A) SPRING plots of mTEC (n = 3 mice) 
showing distinct cell type clusters (colour coded) present in the proximal airways. B) 
SPRING plot showing the distribution of Pierce1 expression (green colour shaded) in 
distinct airway epithelial cell clusters. It shows enriched expression in ciliated cells 




           Interestingly (and reassuringly), the ciliated cell enriched expression for 
PIERCE1 was also conserved in human bronchial epithelial cell (HBEC) as 
shown by Figure 7.2 (Plasschaert et al., 2018).  
 
Figure 7-2. Single-cell profiling of HBECs shows enriched expression of 
PIERCE1 in ciliated cells. 
Plasschaert et al (2018) carried out single cell profiling of mTEC to obtain a 
comprehensive map of all cell types in human proximal airway epithelium and also 
revealed novel gene signatures in the distinct cell types. A) SPRING plots of HBECs 
(n = 3 donors, 2,970 cells) showing distinct cell type clusters (colour coded) present in 
the proximal airways. B) SPRING plot showing the distribution of PIERCE1 expression 
(green colour shaded) in distinct airway epithelial cell clusters. It shows enriched 





7.3 pierce1 zebrafish morphants showed severe situs abnormalities 
and curved axis associated with cilia defects. 
 
To characterise the functional role of PIERCE1, I used zebrafish for in vivo 
investigation. Zebrafish is a great model for studying motile ciliogenesis as  it 
possess all kind of motile cilia as found in humans (Malicki et al., 2011). Two 
independent morpholinos were used to transiently knockdown pierce1 in 
zebrafish embryos. Both morphants showed severe laterality defects and 
curved axis usually associated with motile cilia defects. The laterality defects 
were consistent with the finding on Pierce1 mouse null embryos (Sung et al., 
2016). Abnormal cilia motility was observed in KV of the morphant embryos that 
explained the occurrence of laterality defects. Immunolabelling the cilia by 
Acetyl α-tubulin antibodies showed that there was no difference in the cilia 
morphology in morphants by immunofluorescence. In terms of cilia structural 
analysis, immunostaining has limitations. It can only be used to study cilia 
number and length. To study cilia architectural defects, electron microscopy 
would be more beneficial. 
            I was able to validate the splice blocking morpholino by RT-PCR and 
sequencing which showed that the targeted exon/intron boundary was retained 
in the morphants. However, to my disappointment, the rescue of the morphants 
by injection of the 6 x Myc-Pierce1 failed. There are different ways to interpret 
this result. Firstly: the tags are interfering with the native function of the protein 
and secondly: morphant phenotypes were caused by the off-target effects of 
the morpholinos. But this also meant that I could not validate whether the 
phenotypes of morphants were not due to off-target effects. Since, the reliability 




2011, Schulte-Merker and Stainier, 2014), I decided not to use the morpholino 
assay results as a standalone source to functionally establish Pierce1 as a 
ciliary gene. The morpholino assay also does not allow to assess for adult 
phenotypes e.g. male fertility.  
7.4 Maternal zygotic zebrafish mutants of pierce1 showed mild situs 
abnormalities 
 
To validate the phenotypes caused by the transient knockdown by morpholinos 
and to assess the phenotypes of the adult fishes, I proceeded to generate a 
zebrafish genetic mutant line for pierce1. 
Using CRIPSR/ Cas9 gene editing technique (Hsu et al., 2014), I 
generated two mutant alleles in zebrafish, both targeting the exon 2. The only 
identified conserved functional domain in PIERCE1, known as DUF4990, span 
from 11-117 amino acids of the zebrafish Pierce1 protein. Both mutant alleles 
would be expected to generate truncated proteins with first 60 amino acids and 
disrupted conserved domain. The zygotic mutants generated by crossing 
heterozygous fishes did not show any phenotypical difference from WT. Since 
I found maternal contribution of pierce1 mRNA in the zebrafish embryos, I 
proposed that the maternal deposition of WT mRNA from heterozygous mother 
would be compensating for the mutant phenotype. 
I next made maternal zygotic mutants for pierce1 by in-crossing zygotic 
homozygous mutants. Interestingly, adult zygotic mutants were viable and 
fertile indicating that sperm motility is normal. In maternal zygotic mutants from 
both alleles, small majority had situs abnormalities. The live imaging showed 




Pierce1 null mouse mutants that exhibit severe laterality defects (Sung et al., 
2016) like pierce1 zebrafish morphants suggest that a compensatory 
mechanism exists in the zebrafish knockouts (i.e. mutants) that might be 
masking the mutant phenotype. However, it is interesting to note that the 
maternal contribution of pierce1 mRNA did not reflect on the splice morpholino 
results since maternally contributed mRNA is already spliced. This may be due 
to the fact that the morpholino is faster in its action in knocking down the Pierce1 
activity whereas creating the genetic mutant take generations. The zebrafish 
might have developed compensatory mechanisms to recompensate the loss of 
Pierce1 functional role. This compensatory mechanisms in combination with 
maternal contribution was more effective in rescuing the loss of Pierce1 
phenotype. In addition, many groups have reported the same phenomenon 
where phenotypes exhibited by knockdown experiments does not get 
recapitulated in the knockouts (White et al., 2013, Kok et al., 2015, Bouche 
and Bouchez, 2001). Future work would focus on validating that the milder 
phenotype in mutants is due to genetic compensatory mechanisms. This could 
be validated by injecting morpholino into the mutants. If there is genetic 
compensation in the mutants, the mutants would not show severe phenotype 
as opposed to the WT embryos. We would also seek to characterise the 
compensatory mechanisms including any upregulation in other genes in the 
mutants. 
In addition, I also attempted to study the subcellular localisation of 
Pierce1 in zebrafish embryos. At the time of research, working antibodies 
against Pierce1 was not available hence I used expression of tagged versions 




were utilised to overcome the limitation caused by positioning of the tags; a N-
terminus Myc tag and a C-terminus GFP tag. Both tagged versions were 
localised into the cytoplasm. One limitation of this approach is that the relative 
larger size of tags with the small Pierce1 protein can affect the native 
localisation of the Pierce1 protein. Hence, an antibody against Pierce1 that 




7.5 PIERCE1 has specific expression in multiciliated cells in mouse 
airway epithelial cells and has a cytoplasmic subcellular localization 
 
So far, I focused on understanding the implications on ciliogenesis when there 
is absence of PIERCE1. This allowed me to understand what aspect of 
ciliogenesis require PIERCE1. The findings point towards ciliary motility. So I 
asked myself how PIERCE1 regulates ciliary motility. To answer this question, 
we needed to know where PIERCE1 localises in a ciliated cell. Does it localise 
to the axoneme?  We used a custom made polyclonal antibody that was 
designed against full length mouse Pierce1 protein. This antibody was first 
validated on western blot on mouse testis cell lysate that detected a protein with 
predicted size of mouse PIERCE1.  Subsequently, the antibody was used to 
carry out immunohistochemistry on differentiated ALI cultured airway epithelial 
cells and I observed that PIERCE1 was specifically expressed in ciliated cells 
as predicted from the datasets like bioGPS, Human Protein Atlas and 
LungGens. Moreover, the recent single-cell profiling data by Plasschaert et al 
(2018) also showed enriched expression in ciliated cells (Plasschaert et al., 
2018).  
           Furthermore, I have shown that it has a cytoplasmic localisation and the 
protein did not localise to the axoneme. In the literature, many cytoplasmic 
proteins, mostly dynein assembly factors, have been found to be required for 
cilia motility e.g. HEATR2, LRRC50, KTU etc. Absence of these proteins result 
in abnormal or complete loss of cilia motility due to loss of dynein arms 
(Duquesnoy et al., 2009, Loges et al., 2009, Omran et al., 2008) (Horani et al., 




play a similar role. To validate this, we will need to go back to the zebrafish 
morphants or the mouse null mutants of pierce1 and analyse the motile cilia 
architecture using TEM to study the axonemal dynein arms. In the future we 
will also try to get working antibodies of Pierce1 for human and zebrafish to 
explore the conservation of the pattern of expression and localisation in ciliated 
tissues.  
7.6 C15ORF65, a paralog of PIERCE1 
 
The milder phenotype observed in pierce1 zebrafish mutants prompted me to 
investigate the potential existence of gene redundancy through paralogous 
genes. Using a web database, KEGG sequence similarity data base (SSDB) 
(Kanehisa et al., 2016), I was able to identify C15ORF65 as a paralog of 
PIERCE1. C15ORF65 is also a poorly characterised protein like PIERCE1.  
Both proteins share the unknown domain of function, DUF4490. Interestingly, 
Ccpg1os (Cell cycle progression 1, opposite strand), mouse orthologue of 
C15ORF65 was also shown to have increased expression like Pierce1 during 






Figure 7-3. Expression of Pierce1 and Ccpg1os in ALI cultured WT mTEC vs Tp73 
KO mTEC. 
Nemajerova et al (2016) acquired RNA seq reads from 3 independent cultures for WT 
and 2 independent cultured of Tp73-/- mTEC. Error bars represent standard error of 
the mean. 
 
           Analysis of the Biology Gene Portal System (BioGPS) (Wu et al., 2009) 
microarray data set (expression in different mouse tissues, Dataset: GeneAtlas 
GNF1M, gcrma), suggests that Ccpg1os is abundantly expressed in testis like 





Figure 7-4. Ccpg1os expression on mouse tissues based on the BioGPS 
database. 
(Dataset: GeneAtlas GNF1M, gcrma; Probeset: gnf1m04869_a_at)    
 
LungGens single cell RNA seq of mouse (E18.5) fetal lung (Du et al., 2015) 





Figure 7-5. Expression of Ccpg1os in 9 distinct cell types of E18.5 fetal mouse 
lung. 
The graphs were plotted from the average mean expression data acquired from the 
LungGENS.   The data was collected from contains cells sequenced from E18.5 mouse 
lung, processed using Fluidigm C1 microfluidics technology. The count of samples for 
each cell types are as follows: Epi-AT1-7, Epi-AT1-9, Ciliated cells-2, Club cells- 2, 
Endothelial cells- 18, Myeloid/ Immune cells-8, Lipofibroblast-8, Matrix fibroblast- 9 and 
myofibroblast-9. 
 
           These results point towards a possible role for C15ORF65 in motile cilia 
formation. Based on the conserved sequence similarity and expression pattern 
with PIERCE1, C15ORF65 could play a similar function. So, it would be useful 
to explore the functional role of this novel candidate. It would also be useful to 
study the expression levels of c15orf65 in pierce1 zebrafish mutants to 




7.7 PIAS2 is a potential binding partner of PIERCE1 
 
To gain further insights into the molecular function of PIERCE1, a Y2H assay 
was carried out to identify the interacting partners of PIERCE1 using human 
lung and testis cDNA libraries independently. Protein inhibitor of activated 
STAT2 (PIAS2) was the only candidate that came up on both screens (lung and 
testis) and came up in the category of the highest confidence level. PIAS2 is 
an E3-type small ubiquitin-like modifier (SUMO) ligase (Palvimo, 2007, Rytinki 
et al., 2009). In future, co-immunoprecipitation and mass spectroscopy studies 
can be carried out to validate this interaction and look for more interacting 
partners.  PIAS2 was identified in some ciliary screens and is also upregulated 
during differentiation of mTEC at ALI (Geremek et al., 2011, Nemajerova et al., 
2016a). These findings raise a possibility that PIERCE1 and PIAS2 might be 
involved in the sumoylation of factors associated with cytoplasmic assembly of 
Dynein arms. Sumoylation is found to be important in ciliogenesis in different 
contexts by several groups (McIntyre et al., 2015, Li et al., 2012b). The current 
understanding regarding the cytoplasmic assembly of dynein arms is 
ambiguous so in future, I will explore the role of sumoylation in cytoplasmic 
assembly of dynein arms. 
7.7 Proposed role of PIERCE1 in motile ciliogenesis 
 
Overall, it appears that PIERCE1 may be involved in the pre-assembly of 
dynein arms based on its cytoplasmic localization and loss of ciliary motility 
upon loss of expression. However, the specific functions of these proteins and 
their relationships with other cytoplasmic dynein assembly factors are not well 




aa) protein, on human lung and testis library found PIAS2, as a possible 
interacting partner of PIERCE1.  With this finding, we hypothesise that 
PIERCE1 and PIAS2 may be involved in the sumoylation of cytoplasmic 
Dynein assembly factors.  A schematic diagram is shown in Figure 7.3 to 






Figure 7-6. Schematic diagram showing the proposed role of PIERCE1. 
We hypothesise that PIERCE1 play a role in cytoplasmic assembly of Dynein arms 
through an E3-type small ubiquitin-like modifier, PIAS2.  There are many known 
cytoplasmic factors that are associated the dynein arms assembly. The absence of 
these factors results in loss of dynein arms and hence abnormal cilia motility. The 
molecular pathway these factors act through is still not clear. Likewise, mouse mutants 
of PIERCE1 and zebrafish pierce1 morphants had abnormal cilia motility and is 
localised in the cytoplasm of ciliated cells. Through Y2H assay, it was shown that 














7.8 PIERCE1 and human diseases? 
 
To my knowledge, mutations in human PIERCE1 have not yet been identified. 
Since Pierce1 null mouse embryos and zebrafish morphants show situs 
abnormalities, it is possible that PIERCE1 mutation would be associated with 
heterotaxy and congenital heart disease. Su et al did not report anything on the 
status of respiratory functions or male fertility in the adult mice (Sung et al., 
2016). Therefore, in future, it would be useful to explore the adult mouse mutant 
to understand more about the disease phenotypes associated with absence of 
Pierce1. In the meantime, I would also consult ciliopathy disease cohorts to 
identify and investigate on any association of PIERCE1 mutation with ciliopathy 
patients.  
7.9 Future directions 
 
The following are some of the areas that can be explored to enhance the 
contributions from my work. 
1. To boost the usefulness of the primary airway epithelial cells cultured at ALI by 
focusing on formulating how to passage cells without loss of differentiation 
potential and adapting this culture system for gene modulation techniques like 
CRISPR and high-throughput screening. 
2. Pierce1 was only one of many uncharacterised genes that may have an 
important role in motile ciliogenesis. It would be also useful to follow up on other 
candidates and their role in ciliogenesis.  
3. To explore why there is variance in the results from Pierce1 knockdown and 




4. To test whether loss of PIERCE1 affect localisation of other ciliary components 
such as dynein arms in zebrafish morphants or mouse Pierce1 mutants. 
5. To validate the interaction of PIERCE1 and PIAS2 by co-immunoprecipitation. 
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 Appendix 1 
 
Table 1: Preparation of mTEC-plus media 
Components For 250 ml Media For 50 ml Media 
Insulin (10 µg /ml) 1250 µl 250 µl 
Transferrin (5 µg /ml) 250 µl 50 µl 
CT (0.1 µg/ml.) 250 µl 50 µl 
EGF (25 ng/ml.) 1250 µl 250 µl 
BPE  (30µg/ml) 7.5 mg 1.5 mg 
FBS 12.5 ml 2.5 ml 
     DMEM/F12 media +10% 
Pen/Strep) 
233.5 ml 46.7 ml 
   RA-B ((10,000×), (5 × 10−4 M) * 
(Use 1µl/10ml) 
2  25 µl (Add just before 
use) 
    5 µl (Add just before 
use) 
 Table 2: Preparation of mTEC-SF media 
Components For 250 ml Media For 50 ml Media 
Insulin (5µg/ml) 625 µl 125 µl 
Transferrin (5µg/ml) 250 µl 50 µl 
CT (0.025µg/ml) 62.5 µl 12.5 µl 
EGF (5ng/ml) 250 µl 50 µl 
BPE (30µg/ml) 7.5 mg 1.5 mg (100 µl) 
BSA (1mg/ml) 2.5 ml 500 µl 
     DMEM/F12 media +10% 
Pen/Strep) 
248.7 ml 49.1 ml 
RA-B (10,000x) 
(Use 1µl/10ml) 
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2.1 Buffers used in Western blotting 
 




       20% SDS 
solution 
50mls 
Water M  Up to 1000ml 
 















Sodium chloride 97.3g 











Sodium chloride 97.3g 
Tween-20 5ml 









Water Up to 500ml 
 
 
2x SDS Lysis Buffer 
 
1M DTT 1ml 
20% SDS solution 1ml 
Glycerol 2ml 















2.2 Buffers in Agarose Gel Electrophoresis 
50X TAE buffer 
Tris free base     242 g 
Disodium EDTA    18.61 g 
Glacial Acetic Acid     57.1 ml 









 Appendix 3 
 
Table 1: RT-PCR primers ordered for mouse genes 
Genes Primers (Fwd-Forward, Rev-Reverse) 
Oaz1 Fwd- ACAGAGGAGCCGACGTCTAA 
Rev-  CCAAGAAAGCTGAAGGTTC 
Mtekt1 Fwd- CAGTGCGAAGTGGTAGACG 
Rev- TTCACCTGGATTTCCTCCTG 
Bpifa1 Fwd- GGTGCACAACATTGCTGAAT 
Rev- CAAGAGGCAGGAGACTGAG 
Krt5 Fwd- ACCTTCGAAACACCAAGCAC 
Rev- TGACTGGTCCAACTCCTTCC 
Foxj1 Fwd- GGCCACCAAGATCACTCTGTA 
Rev- TGTTCAAAAGGACAGGTTGTGG 
 
Mcidas Fwd- CCCCTGACCAACAGTGACTT 
Rev- TTAGGGTCACGATTGTGCAG 
 
Myb Fwd- CAGGAATCGGATGAATCTGG 
Rev- CGTGCTCAGGCTGTTCTCTG 




Cbe1 Fwd- GGATGGAGTCAGTTCGAGGA 
Rev- TGGCCTGGTCAAAGCTTTAC 
Pierce1 Fwd- GGGTGGTTTCATGGCTACG 
Rev- ACATTCCAAAAAGCTGCGTGT 
Riken Cdna 1700013f07  Fwd- GTGGGCTTCTAAGAAATCGCTG 
Rev- GCCACCATCATTTTTCCGGG 
Riken Cdna 1700001l19 (C5orf49 
Homolog) 
Fwd- GCA GAAGCC ACC TAA CCT GA 






Riken Cdna 4833427g06 
(C11orf88 Homolog) 
Fwd- GAA AGC TCC TGA GTC ACC A 
Rev- CAT CTC GCG TTT TGG CCT TT 
Lrrc4b Fwd- GGA ACA GGC TGG AGG AAC AA 
Rev- TGG ATA TCA GAC ACA TCC AGC 
AGT 
Riken Cdna 1700028p14 (C9orf35 
Homolog) 
Fwd- CGG AGC CAG TGT TGG TGT AT 
Rev- TTC TCG GAT CTG GTG GGG AT 
Maats1 Fwd- TGA AAT GGA GAA CCG CCG AA 
Rev- TCC ATG ATG CTT TAT TTG TGA TGG A 
Erich2   Fwd- AGT GTG GTG ACT GTT GGT CC 
Rev- TTC AAC GTG TTC TCC AGG GG 
Spata24 Fwd- CAG TGT GTC TCG CCT TCG AT 













Gene Fwd Primer Rev Primer 
Pierce1 GTGGTTTCATGGCTACGGGA AAAAGCTGCGTGTTGTCTGG 
Foxj1 TGGATCACGGACAACTTCTG TCTTGAAGGCCCCACTGA 
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Table 1: RT-PCR primers ordered for zebrafish work 
Purpose Fwd Rev 










5’UTR -pierce1- 3’UTR 
(checking dgRNA 











actin (loading control 







(For amplifying full 
pierce1 protein coding 
region, and cloning 








BamH1 -pierce1 full 
coding region-EcoR1 












Table 2: RT-qPCR primers ordered for zebrafish 
 
 
Table 3: Oligo sequences used in the synthesis of the gRNA sequences used 
to target the pierce1 locus for Cas9-mediated genomic editing 






5’UTR  Fwd 
GAAATTAATACGACTCACTATAGTGTTGAGGCATTATC
C GTGGTTTTAGAGCTAGAAATAGC 





Gene Fwd Primer Rev Primer 












Figure.1;.Sequence alignment of PIERCE1 orthologues. Sequences were 
aligned using Clustal X and shaded by BOXSHADE. Shaded residues indicate 
≥80%. Species and accession numbers are as follows: Zebrafish (Danio rerio, 
GenBank: NP_001116715.1); Frog (Xenopus laevis, GenBank: XP_018088076.1); 
Mouse (Mus musculus, GenBank: NP_081316.1); Human (Homo sapiens, 







Figure.2.; Sequence alignment of C1ORF194 orthologs. Sequences were 
aligned using Clustal X and shaded by BOXSHADE. Shaded residues indicate 
≥80%. Species and accession numbers are as follows: Mouse (Mus musculus, 
GenBank: NP_083590.1); Human (Homo sapiens, GenBank: NP_001116433.1); 
Chimpanzee (Pan troglodytes GenBank: PNI54343.1) Zebrafish (Danio rerio, 










Figure.3. Sequence alignment of C5ORF49 orthologs. Sequences were aligned 
using Clustal X and shaded by BOXSHADE. Shaded residues indicate ≥80%. 
Species and accession numbers are as follows: Mouse (Mus musculus, GenBank: 
XP_001144715.1); Human (Homo sapiens, GenBank: NP_001083053.1); 
Chimpanzee (Pan troglodytes GenBank: XP_001144715.1) Zebrafish (Danio rerio, 








Figure 4.; Sequence alignment of C11ORF88 orthologs. Sequences were 
aligned using Clustal X and shaded by BOXSHADE. Shaded residues indicate 
≥80%. Species and accession numbers are as follows: Mouse (Mus musculus, 
GenBank: NP_808370.1); Human (Homo sapiens, GenBank: NP_997313.2); 
Chimpanzee (Pan troglodytes GenBank: PNI40766.1) Zebrafish (Danio rerio, 







Figure.1;.Sequence alignment of PIERCE1 orthologues. Sequences were 
aligned using Clustal X and shaded by BOXSHADE. Shaded residues indicate 
≥80%. Species and accession numbers are as follows: Zebrafish (Danio rerio, 
GenBank: NP_001116715.1); Frog (Xenopus laevis, GenBank: XP_018088076.1); 
Mouse (Mus musculus, GenBank: NP_081316.1); Human (Homo sapiens, 







Figure.2.; Sequence alignment of C1ORF194 orthologs. Sequences were 
aligned using Clustal X and shaded by BOXSHADE. Shaded residues indicate 
≥80%. Species and accession numbers are as follows: Mouse (Mus musculus, 
GenBank: NP_083590.1); Human (Homo sapiens, GenBank: NP_001116433.1); 
Chimpanzee (Pan troglodytes GenBank: PNI54343.1) Zebrafish (Danio rerio, 










Figure.3. Sequence alignment of C5ORF49 orthologs. Sequences were aligned 
using Clustal X and shaded by BOXSHADE. Shaded residues indicate ≥80%. 
Species and accession numbers are as follows: Mouse (Mus musculus, GenBank: 
XP_001144715.1); Human (Homo sapiens, GenBank: NP_001083053.1); 
Chimpanzee (Pan troglodytes GenBank: XP_001144715.1) Zebrafish (Danio rerio, 









Figure 4.; Sequence alignment of C11ORF88 orthologs. Sequences were 
aligned using Clustal X and shaded by BOXSHADE. Shaded residues indicate 
≥80%. Species and accession numbers are as follows: Mouse (Mus musculus, 
GenBank: NP_808370.1); Human (Homo sapiens, GenBank: NP_997313.2); 
Chimpanzee (Pan troglodytes GenBank: PNI40766.1) Zebrafish (Danio rerio, 











Zebrafish     1 MRITTVTSLPSPSPLLLLL--------VQLLLRLLLP---G----------QEAVGAA 
Frog          1 -MVTH----LCTCRILGLKLIRMIWKQ-VLILLWVTAL---------------ALGGPSP 
Human         1 --MARAR--GSPCP--PLPPGRMSWPHGALLFLWLFSPPLGAGGGGVAVTSAAGGGSPPA 
Chimpanzee    1 --MARAR--GSPCP--PLPPGRMSWPHGALLFLWLFSPPLGAGGGGVAVTSAAGGGSPPA 
Mouse         1 MAQAHIR--GSPCP--LLPPGRMSWPHGALLLLWLFSPPLRAGGGGVAVTSAAGGGSPPA 
consensus     1   . .     ....   *   .. .    .. *..  .    .          . . . . 
 
 
Zebrafish    38 STCPAVCSCSNQASRVICARQHLEEVPDNISNNTRYLNLQENTIQVIKSDTFKHLRHLEI 
Frog         40 TSCPAPCTCSNQASRVACTRRELVEVPESISVNTRYLNLQENNIQVIKTDTFKHLRHLEI 
Human        55 TSCPVACSCSNQASRVICTRRDLAEVPASIPVNTRYLNLQENGIQVIRTDTFKHLRHLEI 
Chimpanzee   55 TSCPVACSCSNQASRVICTRRDLAEVPASIPVNTRYLNLQENGIQVIRTDTFKHLRHLEI 
Mouse        57 TSCPAACSCSNQASRVICTRRELAEVPASIPVNTRYLNLQENSIQVIRTDTFKHLRHLEI 
consensus    61 ..**  *.********.*.*..* *** .* .********** ****..*********** 
 
 
Zebrafish    98 LQLSKNQIRQIEVGAFNGLPNLNTLELFDNRLTLVPSQAFEYLSKLRELWLRNNPIETLP 
Frog        100 LQLSKNVIRNIEVGAFNGLPNLSTLELFDNRLTTVPTQAFEYLSKLRELWLRNNPIESIP 
Human       115 LQLSKNLVRKIEVGAFNGLPSLNTLELFDNRLTTVPTQAFEYLSKLRELWLRNNPIESIP 
Chimpanzee  115 LQLSKNLVRKIEVGAFNGLPSLNTLELFDNRLTTVPTQAFEYLSKLRELWLRNNPIESIP 
Mouse       117 LQLSKNLVRKIEVGAFNGLPSLNTLELFDNRLTTVPTQAFEYLSKLRELWLRNNPIESIP 
consensus   121 ******..* ********** *.**********.**.********************..* 
 
 
Zebrafish   158 GYAFHRVPSLRRLDLGELKKLDYISDAAFVGLINLRYLNLGMCGLKDIPNLTPLVRLEEL 
Frog        160 SYAFNRVPSLRRLDLGELKKLEYISEAAFEGLVNLRYLNLGMCNLKDIPNLTALVRLEEL 
Human       175 SYAFNRVPSLRRLDLGELKRLEYISEAAFEGLVNLRYLNLGMCNLKDIPNLTALVRLEEL 
Chimpanzee  175 SYAFNRVPSLRRLDLGELKRLEYISEAAFEGLVNLRYLNLGMCNLKDIPNLTALVRLEEL 
Mouse       177 SYAFNRVPSLRRLDLGELKRLEYISEAAFEGLVNLRYLNLGMCNLKDIPNLTALVRLEEL 
consensus   181 .***.**************.*.***.***.**.**********.********.******* 
 
 
Zebrafish   218 ELSGNRLEIIRPGSFQGLESLRKLWLMHSQMSVIERNAFDDLKNLEELNLSHNSLHSLPH 
Frog        220 ELSGNRLEMIRPGSFQGLTSLRKLWLMHAHVAIIERNAFDDLKSLEELNLSHNNLMSLPH 
Human       235 ELSGNRLDLIRPGSFQGLTSLRKLWLMHAQVATIERNAFDDLKSLEELNLSHNNLMSLPH 
Chimpanzee  235 ELSGNRLDLIRPGSFQGLTSLRKLWLMHAQVATIERNAFDDLKSLEELNLSHNNLMSLPH 
Mouse       237 ELSGNRLDLIRPGSFQGLTSLRKLWLMHAQVATIERNAFDDLKSLEELNLSHNNLMSLPH 
consensus   241 *******..*********.*********.... **********.*********.*.**** 
 
 
Zebrafish   278 DLFTPLQKLERVHLNHNPWVCNCDVLWLSWWLKETVPSNTTCCARCHAPPYLKGKYIGEL 
Frog        280 DLFTPLHRLERVHLNHNPWHCNCDVLWLSWWLKETVPNNTTCCARCHSPPNLKMRYIGEL 
Human       295 DLFTPLHRLERVHLNHNPWHCNCDVLWLSWWLKETVPSNTTCCARCHAPAGLKGRYIGEL 
Chimpanzee  295 DLFTPLHRLERVHLNHNPWHCNCDVLWLSWWLKETVPSNTTCCARCHAPAGLKGRYIGEL 
Mouse       297 DLFTPLHRLERVHLNHNPWHCNCDVLWLSWWLKETVPSNTTCCARCHAPAGLKGRYIGEL 
consensus   301 ******..***********.*****************.*********.*  **..***** 
 
 
Zebrafish   338 DQSHFTCYAPVIVEPPTDLNVTEGMAAELKCRTGTSMTSVNWITPNGTLMTHGSYRVRIS 
Frog        340 DQSHFTCYAPVIVEPPTDLNVTEGMAAELKCRSGTSMTSVNWLTPNGTLMTHGSYRVRIS 
Human       355 DQSHFTCYAPVIVEPPTDLNVTEGMAAELKCRTGTSMTSVNWLTPNGTLMTHGSYRVRIS 
Chimpanzee  355 DQSHFTCYAPVIVEPPTDLNVTEGMAAELKCRTGTSMTSVNWLTPNGTLMTHGSYRVRIS 
Mouse       357 DQSHFTCYAPVIVEPPTDLNVTEGMAAELKCRTGTSMTSVNWLTPNGTLMTHGSYRVRIS 
consensus   361 ********************************.*********.***************** 
 
 
Zebrafish   398 VLHDGTLNFTNVTLRDTGQYTCMVTNSAGNTTATAVLNVTAAD----------------- 
Frog        400 VLHDGTLNFTNVTVQDTGQYTCMVTNSAGNTTASATLNVSAVTD---------------- 
Human       415 VLHDGTLNFTNVTVQDTGQYTCMVTNSAGNTTASATLNVSAVDPVAAGGTGSGGGGPGGS 
Chimpanzee  415 VLHDGTLNFTNVTVQDTGQYTCMVTNSAGNTTASATLNVSAVDPVAAGGTGSGGGGPGGS 
Mouse       417 VLHDGTLNFTNVTVQDTGQYTCMVTNSAGNTTASATLNVSAVDPVAAGGPG--GGGPGGG 






Zebrafish   441 -----VSVNYTYFTTVTVETVETTGEEDSALRTFNETFIHIPGPTPSGHLWHEVVPTTAS 
Frog        444 ----PSTTDYTYFTTVTVETLDVEETK---------PTDKEPGPTPTV-RWGITY----- 
Human       475 GGVGGGSGGYTYFTTVTVETLETQPGEEALQP--RGTEKEPPGPTTDG-VWGGGRPGDAA 
Chimpanzee  475 GGVGGGSGGYTYFTTVTVETLETQPGEEALQP--RGTEKEPPGPTTDG-VWGGGRPGDAA 
Mouse       475 GG-AGGAGGYTYFTTVTVETLETQPGEEAQQP--RGTEKEPPGPTTDG-AWGGGRPD-AA 
consensus   481       .  ***********...   ..        .    ****  .  *.   .  .  
 
 
Zebrafish   496 SL----SIFGSSSSPRATKPTFTVPISEPS--YPSGLDDVMKTTKIIIGCFVAITFMAAV 
Frog        485 -----STTSLTPRSTRSTEKTFTIPITDMTGNIMKDLDDVMKTTKIIIGCFVAITFMAAV 
Human       532 GPASSSTTAPAPRSSRPTEKAFTVPITDVTENALKDLDDVMKTTKIIIGCFVAITFMAAV 
Chimpanzee  532 GPASSSTTAPAPRSSRPTEKAFTVPITDVTENALKDLDDVMKTTKIIIGCFVAITFMAAV 
Mouse       530 APASASTTAPAPRSSRPTEKAFTVPITDVTENALKDLDDVMKTTKIIIGCFVAITFMAAV 
consensus   541      ...   ..*.* *.. **.**.... . ...************************ 
 
 
Zebrafish   550 MLVVFYKLRKQHQLHKHHGPARAIEIINVEDEIGAGTGLRGSGISGGSTVPQIGSGGGGQ 
Frog        540 MLIAFYKLRKQHQLHKHHGPTRTIEIINVEDEIPATA--------------------PGD 
Human       592 MLVAFYKLRKQHQLHKHHGPTRTVEIINVEDELPAASAVSVAAAA---AVA-SGGGVGGD 
Chimpanzee  592 MLVAFYKLRKQHQLHKHHGPTRTVEIINVEDELPAASAVSVAAAA---AVA-SGGGVGGD 
Mouse       590 MLVAFYKLRKQHQLHKHHGPTRTVEIINVEDELPAASAVSVAAAA---AVA-GGAGVGGD 
consensus   601 **..****************.*..********..*....   .      .   . . .*. 
 
 
Zebrafish   610 SLRLHHPEIVNLPNLARADHLNHY-YKPHHFNNNMMGLGLGGGLNNNNNPSPCSQVQTPI 
Frog        580 -N------HMALPAIEH-DHLNHY----TAFKAHYNNNTGTLN----------------- 
Human       648 -S------HLALPALER-DHLNHHHYVAAAFKAHYSSNPSGGG----------------- 
Chimpanzee  648 -S------HLALPALER-DHLNHHHYVAAAFKAHYSSNPSGGG----------------- 
Mouse       646 -S------HLALPALER-DHLNHHHYVAAAFKAHYGGNP-GGG----------------- 
consensus   661         ...**.... *****  .   .*....  .  ...                  
 
 
Zebrafish   669 SCTQVPVSAGSTSCSIPSPMPLPTLGIHGSLKGLMGKGQNPQIEPLLFKSGSKENVQETQ 
Frog        611 -------------C-----------------A--KNPMLNSIHEPLLFKSSSKENVQETQ 
Human       683 -------------C-----------------GGKGPPGLNSIHEPLLFKSGSKENVQETQ 
Chimpanzee  683 -------------C-----------------GGKGPPGLNSIHEPLLFKSGSKENVQETQ 
Mouse       680 -------------C-----------------GAKG-PGLNSIHEPLLFKSGSKENVQETQ 
consensus   721              *                 ..   ...*...*******.********* 
 
 
Zebrafish   729 I 
Frog        639 I 
Human       713 I 
Chimpanzee  713 I 
Mouse       709 I 
consensus   781 * 
 
 
Figure 5. Sequence alignment of LRRC4B orthologues. Sequences were aligned 
using Clustal X and shaded by BOXSHADE. Shaded residues indicate ≥80%. 
Species and accession numbers are as follows:  Zebrafish (Danio rerio, GenBank: 
XP_684717.3); Frog (Xenopus laevis GenBank: OCT56939.1) Human (Homo 
sapiens, GenBank: NP_001073926.1); Chimpanzee (Pan troglodytes, Uniprot: 










Figure 6.; Sequence alignment of C9ORF135 orthologues. Sequences were 
aligned using Clustal X and shaded by BOXSHADE. Shaded residues indicate 
≥80%. Species and accession numbers are as follows: Mouse (Mus musculus, 
GenBank: EDL41604.1), Human (Homo sapiens, GenBank: NP_001010940.1); 
Chimpanzee (Pan troglodytes, XP_520445.3); Frog (Xenopus laevis GenBank: 




Zebrafish     1 MS------------VSVTRTFDKKNEGNKGFRQQRTYDYLYDPVYTLSADVDHGRENIRA 
Frog          1 -------------MRIMSETVTHRPGPGARYRPNRAYDFLYDPLYTLSSEKDHAHASFRA 
Mouse         1 MSQTVTIQEPRPNDQRIPYQCREVRRA-KGGFANRTYDYLYDPLFIVSSERDHAQANIQA 
Human         1 MSHAVTIEEPQAQPQVSQTRYRERSRAGSHISSNRAYDFLYDPLFIVSSEKDHTQANIQA 
Chimpanzee    1 MSHAVTIEEPQAQPQVSQTRYRERSRAGSHISSNRAYDFLYDPLFIVSSEKDHTQANIQA 
consensus     1 ..                     .  .      .* **.****.. .*...**  ... * 
 
 
Zebrafish    49 QASLDRMRRVPEFNSMISDLPHHPQYSLRLEATDPVPGFIDRRWRGYAEQRRQALQQLTG 
Frog         48 QLSHDRMQKVPVYPTMFSELVHKPRYSLRLQLKDPVPQFMDRRWRGRAEQRLNALKQLAQ 
Mouse        60 TLIRSRLKKVPNFRSMFSNLFHHPRYSMYWSKTDPVPLHVTREWRGQEAKHKEVLRLQAA 
Human        61 TLIRSRLRKVPRFKTMFSNLIHYPRYSLYWSKSDPVPPFISREWKGHKEKHREALRQLTT 
Chimpanzee   61 TLIRSRLRKVPRFKTMFSNLIHYPRYSLYWSKSDPVPPFISREWKGHKEKHREALQQLTT 
consensus    61  . . *...** . .*.* * * *.**.    .**** .. * *.*  . .. .* ..   
 
 
Zebrafish   109 IVSGAV--THAPNPANVTGVDRWKFFKRPLIPFAQQIPPDVVFALPKSDLLSSD-GDDKR 
Frog        108 SQVPTLPPQELGATGGVSGRDRYKYFERPLVPFVQQVPPNVLLAISRADLSPAP----DR 
Mouse       120 MDTSFQMPKEKDEDPDVSGKNRYKFFDRPFLPFLQQMPLNVVLSPVKTQPLLLTPESSKY 
Human       121 TDASFQMPKEVYEDPEVTGKNRYKYFERPFLPFFQQMPFNVVYAVSKAEPYTFPPTSTKH 
Chimpanzee  121 TDASFQMPKEVYEDPEVTGKNRYKYFERPFLPFFQQMPFNVVYAVSKAEPYTFPPTSTKH 
consensus   121        . .      *.*. *.*.*.** .** **.* .*. .. . .         .. 
 
 
Zebrafish   166 SPTPFQRSVAVQTDYRESETQTDPYSPSYLLRPGTTSPELLTLATLTWGHGLPAGLAEVE 
Frog        164 PATPLVRTVAIQTDYRDSEAQTDPYSPEYVACSG-SVPELLTLANLTWGRGLPAGLAEVE 
Mouse       180 AIIPTKSTVATQTDYRDADVQTDPYSPEYVVCQD-TIPELLTLANLTWGRGLPAGQAEVE 
Human       181 LSIPSKSTVGTQTDYRDADVQTDPYSAEYVVCQD-SIPELLTLATLTWGRGLPAGQAEVE 
Chimpanzee  181 LSIPSKSTVGTQTDYRDADVQTDPYSPEYVVCQD-SIPELLTLATLTWGRGLPAGQAEVE 
consensus   181    *   .*. *****. . ******..*...   ..******* ****.***** **** 
 
 
Zebrafish   226 MIKRARIKRAWEATLPPLNDLSQLDKRRRMMEEMERKEWAFREQEIEKLQETRLTLLLQL 
Frog        223 MIERAREKRAWEATLPPLSDVSQLEKRRKMLDEQERKEWAFREKEIEKLQEARLEVLRKL 
Mouse       239 IIERAREKRAWEATLPPLNDSVQAEKRRKMMNAMERKEWAFREGEIEKLQELRLEVLKQL 
Human       240 MIERAREKRAWEASLPALSDTSQFEKRRKMMNEMERKEWAFREQEIEKLQEIRLEVLKEL 
Chimpanzee  240 MIERAREKRAWEATLPALSDTSQFEKRRKMMNEMERKEWAFREQEIEKLQEIRLEVLKEL 
consensus   241 .*.***.******.** * * .* .***.*. ..********* ******* **..*. * 
 
 
Zebrafish   286 LRQREEEQEEVKMERLDASFSQRQNEKEARLKKIRSDYIIAMRKLLAKRKNVEGNLEKRD 
Frog        283 LQKREEKQKEIDTKRLDSHWSKRQAEKEERIKQIRKKHITAIRKLTGKMNNVEGKLERRN 
Mouse       299 LKRREEDQNELNMRHLNDQWYKLQEAKEAKVAQIRHKHVSDIRKLMGKGKNIEGKLQRRD 
Human       300 LRKREENQNEVNMKHLNARWSKLQEGKEAK------------------------------ 
Chimpanzee  300 LRKREENQNEVNMKHLNARWSKLQEGKEAKMAKIQRTHVSTIRKLVGKRKNIEGKLERRN 
consensus   301 *..*** * *. ...*   ... *  **...  .    .  .... ..  .... . ..  
 
 
Zebrafish   346 IIKDYSDYGSQMYAPLARTGQTPDRNSNRSTVKSHFLSTYQGLLELEASLSPSVTLPQIK 
Frog        343 IIKEFNDFASQTYAPLSRIGYFPDRLAEQYLVKSPFLNSYQGLLELEANLPDFVTQPRVK 
Mouse       359 IISDYSNFASQVYGPLSRLGRFPDNNSEDFVVRNHYLNTYEGLVELESSLPDFVTQPRIK 
Human       330 ------------------------------------------------------------ 
Chimpanzee  360 IIKDYSDYASQVYGPLSRLGCFPDNNSEDFVVKNYYLNTYEGLVELESCLPDFVTQPRIR 
consensus   361 .. ..  .... .... . .  ..       ..  .. .. ......  .   .. . .. 
 
 
Zebrafish   406 VPKPKV---TKGFISRSARRDLELMKTHQALKEEKVC-RVEKKPLRFLFKKEKPVPRPPT 
Frog        403 VPKVRT-TTRSGFLKRTAVLDRELEQVHSALLANKTKTQASKKPLRFLEKIEKPAPRPET 
Mouse       419 PPKPQIITTKAGFLKRTARMDYELAEVHKALVDKKNKGLEGTKSLRFLQKNPISQARLPT 
Human       330 ------------------------------------------------------------ 
Chimpanzee  420 APKPKVITTKAGFLKRTARLDYELAEVHKALLDKKNKVLEAKKPPRFLQRNPIPQPRLPT 
consensus   421  ..        ... ...  . ..   . ..   .       .  ... .      .  . 
 
 
Zebrafish   462 PTVEKPPEGDEERELAIIFLQKLLRGRSTQNQMFEEKERWLELIQELRTTHALQKEEQDK 
Frog        462 PRVQDPPEGDEEKELAVILLQKLIRGRAIQNMMFEGKEKRLELIQELRTTHALQEEGQLL 
Mouse       479 PSLEMTSYEEGEIEMAVIYLQKLLRGRVVQNMMFEGKEKRLELILELRTSHALQEDDKLV 
Human       330 --------------MAVIYLQKLLRGRVVQNMMFEGKEKRLELIQELRTCHALQEDEKLV 
Chimpanzee  480 PTLEMTSNEEEEIEMAVIYLQKLLRGRVVQNMMFEGKEKRLELIQELRTCHALQEDEKLV 






Zebrafish   522 KEVEKQVTLALQRQRDFQIDREAQIESFTAALSGGVIVDMLDFLSKELVRLQEERRIHAF 
Frog        522 KKAEKQATLALQRQRELGEHKASVLDLHLSELEGEVLSDMFDFLSKELVRLQEERRIHAF 
Mouse       539 KKAEKQVTLALQRQRNLHEDKLSVIENHLGDLEGRVLADMFDFLSKELVRLQEERRIHAF 
Human       376 KKAEKQVTLALQRQRNLHEHKVSLVENHLAGLEGRALADMFDFLSKELVRLQEERRIHAF 
Chimpanzee  540 KKAEKQVTLALQRQRNLHEHKVSLVENHLAGLEGRALADMFDFLSKELVRLQEERRIHAF 
consensus   541 *..***.******** . . . .... ... *.*  . **.******************* 
 
 
Zebrafish   582 TLLAERDRRIREAEESGRRQIEERRRREEDEIFKQVVRVHQDTVDMYLEDVILTSINQTA 
Frog        582 AMLAERQRRIREAEESGRRQVEERRRREEDEIFRQLVQVHQSTVDSYLEEIILSATEHTA 
Mouse       599 AMLAERQRRMREAEESGRRQVEQKRLQQEDMIFKEVIKVHQSTVTSYLEDIILNTEERTA 
Human       436 VMLAERQRRVREAEESGRRQVEKQRLREEDEIFKEVVKVHHSTISSYLEDIILNTEANTA 
Chimpanzee  600 VMLAERQRRVREAEESGRRQVEKQRLREEDEIFKEVVKVHHSTISSYLEDIILNTEANTA 
consensus   601  .****.**.**********.*  * ..**.**. ...** .*. .***..** .   ** 
 
 
Zebrafish   642 DAQAREEIHRKAEELNNITYAMEETMNSQQSEEIVAELVYRFLIPEVQKMDFRERVRHSQ 
Frog        642 EEQAREEIQRKAEEINDIAYQMESSRTRIQSEEIVAELVYSFLIPEVQKTSVRERVRRSQ 
Mouse       659 EEQARKEIEKIAEEINNIAYEMENRRTYLQSEEIVAELVYSFLIPEVQKDFVKEKVRNAQ 
Human       496 EEQARAEIEKMAEKINDIAYEMESRRTYLQSEEIVAELVYSFLIPEVQKYFVKEKVRNAQ 
Chimpanzee  660 EEQARAEIEKMAEKINDIAYEMESRRTYLQSEEIVAELVYSFLIPEVQKYFVKEKVRNAQ 
consensus   661 ..*** ** . ** .* *.* **  .. .***********.********  ..*.**  * 
 
 
Zebrafish   702 RRHLQAARLIISPGSTVPTEPQSPSYRASSAILNHILS---------------QVEEVVP 
Frog        702 RRHIQAAHQVICGDTQAFLESRNTFSGNGSAPRDATLQDTHDIETQALLQDTCCIESPYS 
Mouse       719 RKHILAAHEIIHSNTETMLEEQVYKELQSEDF---------ELEEEAESLD--------- 
Human       556 RKHILAAHQIIHSYTESMVQKKLTEGEQDEAS---------NA---AMLLE--------- 
Chimpanzee  720 RKHILAAHQIIHSYTESMVQKRLTEGEQDEAS---------NA---AMLLE--------- 
consensus   721 *.*. **. .*   .   .        .  .               .   .          
 
 
Zebrafish   747 GNLTSRDPEPTQNTLTSHTK-----------TE-DTHNTDGKK-ADSAQGQL-------- 
Frog        762 GNVSTLEREATLQDICGTEREVPAQDICGTKREVPAQDICGTERETPAQDICGTEREVPA 
Mouse       761 -------------------SEVPTVSVSKTSTIKPTQDEGEG------------------ 
Human       595 -------------------KET--------------QNENNS------------------ 
Chimpanzee  759 -------------------KET--------------QNENNS------------------ 
consensus   781                    ..               .                        
 
 
Zebrafish       ------------------------------------------------------------ 
Frog        822 QDICGTERETPAQDICGTERETPAQDICGTEGEVPAQDKCGTERETPAQDICGTEGERET 
Mouse           ------------------------------------------------------------ 
Human           ------------------------------------------------------------ 
Chimpanzee      ------------------------------------------------------------ 
consensus   841                                                              
 
 
Zebrafish       ----------------------------------------------- 
Frog        882 PTQDICGTERERETPAQDICSTEGEVPAQDICGTEREEEQCDTHGTD 
Mouse           ----------------------------------------------- 
Human           ----------------------------------------------- 
Chimpanzee      ----------------------------------------------- 
consensus   901                                                 
 
Figure 7.; Sequence alignment of MAATS1 orthologues. Sequences were 
aligned using Clustal X and shaded by BOXSHADE. Shaded residues indicate 
≥80%. Species and accession numbers are as follows: Zebrafish (Danio rerio, 
GenBank: XP_001333344.3); Frog (Xenopus laevis GenBank: OCT93569.1); 
Mouse (Mus musculus, GenBank: EDK97973.1), Human (Homo sapiens, GenBank: 







Figure 8.; Sequence alignment of ERICH2 orthologues. Sequences were aligned 
using Clustal X and shaded by BOXSHADE. Shaded residues indicate ≥80%. 
Species and accession numbers are as follows: Zebrafish (Danio rerio, GenBank: 
XP_009300384.1); Frog (Xenopus laevis GenBank: XP_018091376.1);, Human 
(Homo sapiens, GenBank: NP_001276876.1); Chimpanzee (Pan troglodytes, 







Figure 9.; Sequence alignment of SPATA24 orthologues. Sequences were aligned using 
Clustal X and shaded by BOXSHADE. Shaded residues indicate ≥80%. Species and 
accession numbers are as follows: Chimpanzee (Pan troglodytes, GeneBank: PNI22565.1); 
Mouse (Mus musculus, GenBank: NP_083761.1); Human (Homo sapiens, GenBank: 












Figure 10.; Sequence alignment of CBE1 orthologues. Sequences were aligned using 
Clustal X and shaded by BOXSHADE. Shaded residues indicate ≥80%. Species and 
accession numbers are as follows: Pig ( Sus scrofa,  GeneBank: XP_020920344.1); 
Mouse (Mus musculus, GenBank: NP_001041470.1); Human (Homo sapiens, GenBank: 
NP_115985.2); Chimpanzee (Pan troglodytes, GeneBank: XP_520543.3).  
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